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Establishing  a  method  to  monitor  replicative  polymerase  usage  genome-­‐
wide  in  human  cells  
The  majority  of  DNA  replication  in  eukaryotic  cells  is  carried  out  by  two  replicative  DNA  
polymerases:    polymerases  d  and  e  (Pols  d  and  e).    Whilst  both  polymerases  exhibit  high  
specificity   for   deoxyribonucleotides,   both   frequently   misincorporate   ribonucleotides  
(rNTPs)   which   are   rapidly   removed   via   ribonucleotide   excision   repair   (RER)   by   the  
heterotrimeric  enzyme  RNase  H2.         
In  yeast,  using  mutant  polymerases  that  incorporate  elevated  levels  of  rNTPs  (and  in  the  
absence  of  the  catalytic  subunit  of  RNase  H2  (RNase  H2A))  unrepaired  rNTPs  serve  as  a  
molecular   footprint   of   the   replicative   polymerases.   This   allows   the   determination   of  
genome-­‐wide  polymerase  usage  using  a  deep  sequencing  methodology  that  we  have  
termed  polymerase  usage  sequencing  (Pu-­‐seq).  
The  aim  of  this  project  is  to  develop  cell  lines  that  can  be  used  for  Pu-­‐seq  in  human  cells.    
Ultimately,   this   system   could   then   be   used   to   monitor   DNA   replication   dynamics   in  
human   cells   to   aid   in   the   study   of   replication   stress   responses.      As   in   yeast,   the  
development  of   the  Pu-­‐seq   system   in  human  cells   requires  an  absence  of  RNase  H2  
activity   and   mutant   alleles   of   Pol   d   and   Pole   that   result   in   excess   ribonucleotide  
incorporation.  
This   thesis  describes  the   steps  taken   towards  developing  Pu-­‐seq   in  human  cell   lines;  
firstly,  by  establishing  that  in  human  cells  expressing  normal  levels  of  p53,  RNase  H2A  is  
an  essential  gene,  then  by  developing  mechanisms  that  allow  for  the  shutoff  of  RNase  
H2  activity  through  the  targeted  downregulation  of  one  of  its  accessory  subunits,  RNase  
H2C.    Attempts  to  develop  a  novel  method  of  quantifying  genomic  ribonucleotides  are  
described   in   addition   to   showing   that   previously   published   protocols   for   assessing  
overall  RNase  H2  activity  and  genomic  ribonucleotide  presence  provide  the  sensitivity  
required   to   screen   candidate   human   Pu-­‐seq   cell   lines.      Finally,   progress   made   in  
screening   mutations   in   Pols   d   and   e   that   may   cause   increased   ribonucleotide  




CHAPTER  1  -­‐  INTRODUCTION  ........................................................................................................  1  
1.1    General  Introduction  ......................................................................................................................  1  
1.2    DNA  Replication  .............................................................................................................................  2  
1.2.1    DNA  replication  overview  ....................................................................................................  2  
1.2.2    Eukaryotic  origin  identity  ....................................................................................................  2  
1.2.3    Establishing  the  pre-­‐replication  complex  .............................................................................  4  
1.2.4    Establishing  the  pre-­‐initiation  complex  ................................................................................  5  
1.2.5    Priming  replication  and  the  replisome  .................................................................................  7  
1.3    Replication  Stress  ...........................................................................................................................  8  
1.3.1    Causes  of  replication  stress  .................................................................................................  8  
1.3.2    Preventing  replication  stress  ..............................................................................................11  
1.3.3    Restarting  stalled  forks  .......................................................................................................12  
1.3.4    The  Intra-­‐S  phase  response  to  replication  stress  .................................................................13  
1.3.5    Restarting  collapsed  replication  forks  by  homologous  recombination  .................................14  
1.4    Ribonucleotides  In  Genomic  DNA  ..................................................................................................15  
1.4.1    Introduction  to  genomic  ribonucleotides  ............................................................................15  
1.4.2    Sources  of  genomic  ribonucleotide  incorporation  ...............................................................15  
1.4.3    Removing  misincorporated  ribonucleotides  from  genomic  DNA  .........................................17  
1.5    Ribonuclease  H2  ............................................................................................................................20  
1.5.1    Ribonuclease  H2  structure  .................................................................................................20  
1.5.2    RNase  H2  and  disease  ........................................................................................................23  
1.6    Polymerase  Usage  Sequencing  ......................................................................................................24  
1.7    Genome  Editing  Using  CRISPR-­‐Cas9  ...............................................................................................27  
1.7.1    A  historical  perspective  of  mammalian  genome  engineering...............................................27  
1.7.2    CRISPR-­‐Cas9  as  a  genome  editing  tool  in  human  cells  .........................................................28  
1.7.3    Decreasing  the  off-­‐target  effects  of  Cas9  ............................................................................31  
1.8    Summary  and  Aims  .......................................................................................................................33  
   VI  
CHAPTER  2  –  MATERIALS  AND  METHODS.................................................................................34  
2.1    Materials  .......................................................................................................................................34  
2.2    Cloning  and  Molecular  Methods....................................................................................................36  
2.2.1    Polymerase  chain  reaction  .................................................................................................36  
2.2.2    Restriction  digests  ..............................................................................................................37  
2.2.3    Ligation  reactions  ...............................................................................................................37  
2.2.4    Design  of  gene  targeting  constructs....................................................................................38  
2.2.5    cDNA  synthesis  ..................................................................................................................38  
2.2.6    Site  directed  mutagenesis  ..................................................................................................38  
2.2.7    Bacterial  transformation  ....................................................................................................39  
2.2.8    Plasmid  purification  ...........................................................................................................39  
2.2.9    Human  genomic  DNA  extraction  ........................................................................................39  
2.3    Western  Blotting  ...........................................................................................................................41  
2.3.1    Preparation  of  human  whole  cell  extract  ............................................................................42  
2.3.2    Preparation  of  S.  pombe  whole  cell  extract  .........................................................................42  
2.3.3    Protein  electrophoresis  and  immunoblotting......................................................................42  
2.4    Human  Cell  Culture  .......................................................................................................................43  
2.4.1    Maintenance  of  cell  lines  ....................................................................................................43  
2.4.2    Plasmid  Transfection  ..........................................................................................................44  
2.4.3    HT1080  6-­‐TG  resistance  colony  formation  assay  .................................................................46  
2.5    S.  pombe  Methods  ........................................................................................................................46  
2.5.1    S.  pombe  growth  media  .....................................................................................................46  
2.5.2    Lithium  acetate  S.  pombe  transformation  ...........................................................................47  
2.5.3    Genomic  DNA  extraction  from  S.  pombe.............................................................................47  
2.5.4    Genetic  cross  and  random  spore  analysis  ...........................................................................47  
2.5.5    S.  pombe  RNase  H2  activity  assay  .......................................................................................48  
2.6    A.  Thaliana  tRNA  Ligase  (AtRNL)  Reactions  ...................................................................................48  
2.6.1    AtRNL  activity  assay  ...........................................................................................................48  
2.6.2    S.  pombe  AtRNL  ribonucleotide  incorporation  assay  ...........................................................49  
2.7    RNase  H2  Activity  Assays  ...............................................................................................................50  
2.7.1    Whole  cell  extract  preparation  ...........................................................................................50  
2.7.2    Fluorometric  substrate  preparation  ....................................................................................50  
2.7.3    RNase  H2  fluorometric  assays  ............................................................................................50  
   VII  
2.8    ALKALINE  COMET  ASSAY  ...............................................................................................................51  
  
CHAPTER  3  –  RESULTS  CHAPTER  1:    ESTABLISHING  A  METHOD  TO  KNOCK  OUT  
RNASEH2A  USING  CRISPR-­‐CAS9  ....................................................................................................52  
3.1    Introduction  ..................................................................................................................................52  
3.2    Transfection  Optimisation  in  HT1080  Cells  ....................................................................................53  
3.2.1    DNA  Transfection  ...............................................................................................................53  
3.2.2    Protein  Transfection  ...........................................................................................................56  
3.3    Using  a  Reporter  Assay  to  Test  Efficiency  of  Gene  Targeting  .........................................................57  
3.3.1    The  human  HPRT  gene  functions  as  a  reporter  gene  to  assess  gene  targeting  efficiency  .....57  
3.3.2    Inaccurate  repair  of  I-­‐SceI-­‐mediated  DSBs  causes  sensitivity  to  6-­‐TG...................................59  
3.2.4    I-­‐SceI  protein  transfection  ..................................................................................................62  
3.2.5    Erroneous  repair  of  Cas9-­‐induced  DSBs  within  HPRT  causes  6-­‐TG  sensitivity  .......................62  
3.4    RNase  H2A  is  Essential  in  Human  TK6  Cells....................................................................................65  
3.5    Discussion  .....................................................................................................................................71  
  
CHAPTER  4  –  RESULTS  CHAPTER  2:    REGULATING  RNASE  H2  IN  HUMAN  CELLS  ................73  
4.1    Introduction  ..................................................................................................................................73  
4.2    Assessing  the  Suitability  of  All  Three  RNase  H2  Subunits  for  Tagging  in  Schizosaccharomyces  
pombe..................................................................................................................................................73  
4.2.1    Tagging  each  of  the  three  subunits  of  RNase  H2  with  a  C  terminal  GFP  ...............................75  
4.2.2    Assessing  the  effect  of  C-­‐terminal  GFP  tags  on  each  of  the  three  subunits  on  catalytic  activity  
of  the  RNase  H2  holoenzyme  .......................................................................................................77  
4.3    Regulation  of  Human  RNase  H2A  with  an  Auxin  Inducible  Degron  Tag.  .........................................80  
4.4    Tagging  the  C-­‐Terminus  of  RNase  H2A  with  a  Novel  Double  Degron  Tag.  ......................................88  
4.5    Regulating  RNase  H2B  and  RNase  H2C  with  a  C-­‐Terminal  Double  Degron  Tag  in  Human  RPE1  Cells
  ............................................................................................................................................................93  
4.5.1    Screening  C-­‐terminal  mAID-­‐SMASh  tagged  RNase  H2B  candidates  for  correct  integration  of  
the  tagging  construct  ...................................................................................................................95  
4.5.2    Screening  C-­‐terminal  mAID-­‐SMASh  tagged  RNase  H2C  candidates  for  correct  integration  of  
the  tagging  construct  and  efficient  protein  degradation  ...............................................................96  
4.6    Two-­‐Tiered  Regulation  of  RNase  H2C  at  the  transcriptional  and  Protein  Level  ............................  100  
   VIII  
4.7    Discussion  ...................................................................................................................................  109  
  
CHAPTER  5  –  RESULTS  CHAPTER  3:    DEVELOPING  AN  ASSAY  TO  QUANTIFY  
RIBONUCLEOTIDE  INCORPORATION  IN  HUMAN  GENOMIC  DNA  .....................................  111  
5.1    Introduction  ................................................................................................................................  111  
5.2    Quantifying  Ribonucleotide  Incorporation  by  Alkaline  Hydrolysis  and  Alkaline  Agarose  Gel  
Electrophoresis  ..................................................................................................................................  112  
5.3    Developing  a  Genomic  Ribonucleotide  Incorporation  Assay  Using  an  Arabidopsis  thaliana  tRNA  
Ligase  .................................................................................................................................................  114  
5.3.1    Arabidopsis  thaliana  tRNA  Ligase  .....................................................................................  114  
5.3.2    Quantifying  ribonucleotide  incorporation  using  biotin  ......................................................  116  
5.3.3    The  principle  of  the  ribonucleotide  incorporation  assay  using  AtRNL  ................................  116  
5.3.4    Optimising  biotin  quantification  using  streptavidin-­‐alkaline  phosphatase  .........................  118  
5.3.5    Optimising  Urea-­‐PAGE  loading  and  18mer  removal  ..........................................................  121  
5.3.6    Optimising  AtRNL  ligation  efficiency  .................................................................................  123  
5.3.7    AtRNL  ligation  assay  with  S.  pombe  gDNA  and  Southern  blotting  ......................................  125  
5.3.8    Reducing  background  signal  caused  by  biotinylated  oligomer  ...........................................  127  
5.4    Using  a  Fret-­‐Based  Assay  to  Assess  RNase  H2  Activity  .................................................................  130  
5.5    Assessing  the  Efficiency  of  mAID-­‐SMASh-­‐Mediated  Knockdown  of  RNase  H2c  in  RPE1  Cells  Using  
the  Fret-­‐Based  Assay  ..........................................................................................................................  133  
5.6    Alkaline  Comet  Assay  ..................................................................................................................  136  
5.7    Discussion  ...................................................................................................................................  138  
  
CHAPTER  6  –  RESULTS  CHAPTER  4:    INVESTIGATING  RIBONUCLEOTIDE-­‐
INCORPORATING  REPLICATIVE  DNA  POLYMERASE  MUTATIONS  .....................................  140  
6.1    Introduction  ................................................................................................................................  140  
6.2    Generating  Human  Cell  Lines  Expressing  Mutant  Polymerase  Delta  ............................................  142  
6.2.1    Human  TK6  cells  can  express  Pold-­‐L606M  heterozygously  ................................................  142  
6.2.2    Human  HT1080  cells  can  express  Pold-­‐L606K  heterozygously  ...........................................  145  
6.2.3    Failure  to  generate  Pold-­‐L606G  and  Pold-­‐L606M  in  the  HT1080  cell  line  ...........................  146  
6.3    Generating  Human  Cell  Lines  Expressing  Mutant  Polymerase  Epsilon  .........................................  147  
6.4    Discussion  ...................................................................................................................................  153  
   IX  
CHAPTER  7  -­‐  DISCUSSION  ............................................................................................................  155  
  
BIBLIOGRAPHY  ..............................................................................................................................  160  
  
     
   X  
List  of  tables  
  
Table  2-­‐1    DNA  plasmids  used  in  this  study………………………………………………………………….40  
  
Table  2-­‐2    Oligonucleotides  used  in  this  study…………………………………………………………….41  
  
Table  2-­‐3    Primary  antibodies  used  in  this  study………………………………………………………….43  
  
Table  3-­‐1    TK6  Neon  transfection  optimization……………………………………………………………70  
  
Table  5-­‐1    Quant*Tag  spectrophotometer  absorbance  values…………………………………..117  
  
Table  6-­‐1    Summary  of  attempts  to  generate  mutant  Pold  HT1080  cell  lines…………….148  
  
Table  6-­‐2    Summary  of  attempts  to  generate  mutant  Pole  HT1080  cell  lines…………….152  
     
   XI  
List  of  figures  
  
  
Figure  1-­‐1    Mechanism  of  eukaryotic  DNA  replication…………………………………………………..3  
  
Figure  1-­‐2    Eukaryotic  DNA  replication  origin  activation……………………………………………….6  
  
Figure  1-­‐3    Ribonucleotide  excision  repair…………………………………………………………………..18  
  
Figure  1-­‐4    RNase  H2  structure  and  AGS  disease  mutations………………………………………..21  
  
Figure  1-­‐5    The  principles  of  polymerase  usage  sequencing………………………………………..26  
  
Figure  1-­‐6    The  CRISPR-­‐Cas  system  of  S.  pyogenes………………………………………………………30  
  
Figure  1-­‐7    S.  pyogenes  Cas9  structure………………………………………………………………………..32  
  
Figure  3-­‐1    Transfection  optimization  in  HT1080  cells  using  a  plasmid  expressing  eGFP  
and  GFP  protein………………………………………………………………………………………………………….55  
  
Figure   3-­‐2      Explanation   of   the   system   used   to   determine   whether   cells   contain   a  
functional  HPRT  gene  using  6-­‐thioguanine  and  aminopterin……………………………………….58  
  
Figure  3-­‐3    Targeting  HPRT  exon  6  with  I-­‐SceI  and  CRISPR-­‐Cas9………………………………….60  
  
Figure  3-­‐4      I-­‐SceI-­‐mediated   transfection  optimization   in  HT1080   cells  using   the  HPRT  
reporter  gene…………………………………………………………………………………………………………….61  
  
Figure  3-­‐5    Optimization  of  Cas9-­‐mediated  gene  knockout  in  HT1080  cells  using  the  HPRT  
reporter  gene…………………………………………………………………………………………………………….63  
  
Figure  3-­‐6    RNASEH2A  knockout  strategy……………………………………………………………………66  
  
Figure   3-­‐7      RNase   H2A   knockout   candidate   TK6   cells   are   only   targeted  
heterozygously…………………………………………………………………………………………………………..68  
  
Figure  4-­‐1    C-­‐terminal  GFP  tagging  strategy  in  S.  pombe……………………………………………..74  
  
Figure  4-­‐2    The  C-­‐termini  of  the  three  subunits  of  S.  pombe  RNase  H2  can  all  be  tagged  
with  GFP  in  a  cdc6L591G  background……………………………………………………………………………..76  
  
Figure  4-­‐3    The  presence  of  a  C-­‐terminal  GFP  tag  on  each  of  the  three  subunits  of  RNase  
H2  in  S.  pombe  has  no  discernible  effect  on  enzyme  activity………………………………………79  
  
Figure  4-­‐4    Crystal  structure  of  the  human  RNase  H2  holoenzyme……………………………..81  
  
   XII  
Figure  4-­‐5    Schematic  illustration  of  the  AID  system……………………………………………………83  
  
Figure  4-­‐6    RNASEH2A  C-­‐terminal  AID  tagging  strategy……………………………………………….84  
  
Figure   4-­‐7      C-­‐terminally   AID-­‐tagged   RNase   H2A   candidate   TK6   cells   are   either   not  
successfully  targeted  or  are  only  targeted  heterozygously  and  the  AID  degron   is  non-­‐
functional…………………………………………………………………………………………………………………..86  
  
Figure  4-­‐8    The  RNase  H2A  C-­‐terminal  AID  degron  tag  in  TK6  cells  is  non-­‐functional…….87  
  
Figure  4-­‐9    Schematic  illustration  of  the  AID-­‐SMASh  system………………………………………..89  
  
Figure  4-­‐10    RNASEH2A  C-­‐terminal  AID-­‐SMASh  tagging  strategy…………………………………92  
  
Figure  4-­‐11    RNASEH2A  C-­‐terminal  AID-­‐SMASh  tagging  alternative  strategy……………….94  
  
Figure  4-­‐12    RNASEH2A  is  not  able  to  be  C-­‐terminally  AID-­‐SMASh  tagged…………………..97  
  
Figure  4-­‐13    Tagging  RNase  H2C  with  a  C-­‐terminal  AID-­‐SMASh  double  degron  tag………98  
  
Figure  4-­‐14     A  C-­‐terminal  AID-­‐SMASh  double  degron  causes  rapid  depletion  of  RNase  
H2C  in  human  RPE1  cells…………………………………………………………………………………………….99  
  
Figure  4-­‐15    Schematic  of  the  Tet-­‐on  method  of  tetracycline-­‐controlled  transcriptional  
activation…………………………………………………………………………………………………………………101  
  
Figure  4-­‐16     Schematic  illustration  of  the  two-­‐tiered  mechanism  of  regulating  ectopic  
expression  of  RNase  H2C………………………………………………………………………………………….102  
  
Figure  4-­‐17    Two-­‐tiered  regulation  of  RNase  H2C  knockin  strategy…………………………..104  
  
Figure  4-­‐18    N-­‐terminally  SMASh-­‐tagged  RNase  H2C  can  be  ectopically  expressed  from  
the   ROSA26   locus   in   human   HT1080   cells   and   is   degraded   via   the   proteasomal  
pathway…………………………………………………………………………………………………………………..106  
  
Figure  4-­‐19      Ectopically  expressed  RNase  H2C  can  be  downregulated   in  a   two-­‐tiered  
manner  by  tetracycline-­‐controlled  transcriptional  activation  and  SMASh  tag-­‐mediated  
degradation……………………………………………………………………………………………………………..108  
  
Figure  5-­‐1    Alkaline  hydrolysis  and  gel  electrophoresis  is  an  unsuitable  method  to  assess  
human  genomic  ribonucleotide  incorporation………………………………………………………….113  
  
Figure  5-­‐2    Arabidopsis  thaliana  tRNA  ligase  mechanism  and  assay  principle……………115  
  
Figure  5-­‐3    Visualizing  biotinylated  DNA  with  streptavidin-­‐alkaline  phosphatase  is  highly  
sensitive…………………………………………………………………………………………………………………..119  
  
   XIII  
Figure   5-­‐4      Quantifying   slot   blotted   biotinylated   DNA  with   an   image   layering-­‐based  
ImageJ  plugin……………………………………………………………………………………………………………120  
  
Figure  5-­‐5    Optimizing  urea-­‐PAGE  DNA  loading  and  18mer  removal…………………………122  
  
Figure  5-­‐6     AtRNL  show  specific  activity  on  an  alkali-­‐treated  ribonucleotide-­‐containing  
70mer………………………………………………………………………………………………………………………124  
  
Figure  5-­‐7    Macherey  Nagel  Nucleospin  column  cleanup………………………………………….126  
  
Figure   5-­‐8      AtRNL   ligates   a   9-­‐nucleotide   biotinylated   oligomer   specifically   onto  
ribonucleotide-­‐terminating  substrates……………………………………………………………………..128  
  
Figure  5-­‐9    The  AtRNL  assay  with  Southern  blotting  lacks  the  desired  sensitivity………129  
  
Figure  5-­‐10     Design  and   implementation  of  a   fluorescence-­‐based  assay  to  determine  
RNase  H2  activity………………………………………………………………………………………………………131  
  
Figure  5-­‐11    Fluorescence-­‐based  RNase  H2  activity  assay  shows  that  depletion  of  RNase  
H2C  causes  a  significant  decrease  in  RNase  H2  activity……………………………………………..135  
  
Figure  5-­‐12    Alkaline  comet  assay  to  assess  genomic  ribonucleotide  incorporation…..137  
  
Figure   6-­‐1      Identification   of   human   polymerase   residues   to   be   targeted   for  
mutagenesis…………………………………………………………………………………………………………….141  
  
Figure  6-­‐2    Polymerase  delta  mutation  strategy………………………………………………………..143  
  
Figure  6-­‐3    Pold-­‐L606M  screening  identifies  heterozygously-­‐targeted  TK6  cells………..145  
  
Figure  6-­‐4    Pold-­‐L606K  screening  identifies  heterozygously-­‐targeted  HT1080  cells…..147  
  
Figure  6-­‐5    Polymerase  epsilon  mutation  strategy…………………………………………………….150  
  
Figure  6-­‐6    Screening  for  incorporation  of  the  Pole-­‐WT  repair  template……………………151     
   XIV  
List  of  abbreviations  
  
ACS        Autonomous  consensus  sequence  
AGS        Aicardi-­‐Goutières  syndrome  
AID        Auxin-­‐inducible  degron  
ARS        Autonomous  replication  sequences  
ASV        Asunaprevir  
AtRNL       Arabidopsis  thaliana  tRNA  ligase  
CFS        Common  fragile  site  
CRISPR     Clustered  regularly  interspaced  short  palindromic  repeats  
DNA        Deoxyribonucleic  acid  
dNTP        Deoxyribonucleotide  
Dox        doxycycline  
DSB        Double  strand  break  
G4        G-­‐quadruplex  
gDNA        Genomic  DNA  
gRNA        guide  RNA  
HR        Homologous  recombination  
IAA        Indole-­‐3-­‐acetic  acid  
mAID        Mini  auxin-­‐inducible  degron  
MCM        Minichromosome  maintenance  complex  
MMR        Mismatch  repair  
NHEJ        Non-­‐homologous  end  joining  
OF        Okazaki  fragment  
OGRE        Origin  G-­‐rich  repeated  element  
ORC        Origin  recognition  complex  
OsTIR1     Oryza  sativa  transport  inhibitor  response  1  
PAM        Protospacer-­‐adjacent  motif  
PCNA        Proliferating  cell  nuclear  antigen  
PIP        PCNA-­‐interacting  protein  
pre-­‐IC        Pre-­‐initiation  complex  
pre-­‐RC     Pre-­‐replication  complex  
Pu-­‐Seq     Polymerase  usage  sequencing  
rDNA        Ribosomal  DNA  
RER        Ribonucleotide  excision  repair  
RFB        Replication  fork  barrier  
RNA        Ribonucleic  acid  
rNTP        Ribonucleotide  
SMASh     Small  molecule-­‐assisted  shutoff  
ssDNA       Single-­‐stranded  DNA  
Tc        Tetracycline  
TCTA        Tetracycline  controlled  transcriptional  activation  




1.1    General  introduction  
   Before   cells   divide   they   must   make   a   copy   of   their   entire   genome   during   a  
process  known  as  DNA  replication.    The  majority  of  DNA  replication  is  carried  out  by  two  
replicative   DNA   polymerases,   Polymerase   delta   (Pold)   which   replicates   the   lagging  
strand   and   Polymerase   epsilon   (Pole)  which   replicates   the   leading   strand.      Accurate  
replication   of   DNA   is   essential   as  mutations   arising   from   endogenous   or   exogenous  
sources  can  lead  to  genome  instability  and  genetic  diseases.  
  
In  yeast,  the  genome-­‐wide  division  of  labour  of  the  two  major  replicative  polymerases  
can   be   mapped   using   mutant   polymerases   that   incorporate   elevated   levels   of  
ribonucleotides.    In  these  cells,  the  catalytic  subunit  of  RNase  H2  (RNase  H2A),  the  major  
enzyme  responsible  for  the  removal  of  misincorporated  ribonucleotides,  is  knocked  out  
allowing  for  unrepaired  ribonucleotides  to  serve  as  a  molecular  footprint  of  the  mutant  
replicative  polymerases.    The  presence  of  unrepaired  genomic  ribonucleotides  allows  
genome-­‐wide  mapping  of  polymerase  usage  using  a  deep  sequencing  methodology  that  
has  been  termed  polymerase  usage  sequencing  (Pu-­‐seq)  (Daigaku  et  al.  2015).  
  
The  aim  of  this  project  is  to  develop  cell  lines  that  can  be  used  for  Pu-­‐seq  in  human  cells.    
As  in  yeast,  the  development  of  the  Pu-­‐seq  system  in  human  cells  requires  an  absence  
of   RNase   H2   activity   and   mutant   alleles   of   Pol   d   and   Pole   that   result   in   excess  
ribonucleotide  incorporation.  This  thesis  described  progress  made  towards  developing  
human  Pu-­‐seq  cell  lines  as  well  as  the  development  of  assays  to  assess  RNase  H2  activity  
and  genomic  ribonucleotide  incorporation.  
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1.2    DNA  replication  
1.2.1    DNA  replication  overview  
   Before  undergoing  mitosis,  cells  have  to  fully  replicate  the  entire  genome  during  
S   phase   in   a   tightly   regulated   and   highly  accurate  manner.      The   process   of   genomic  
duplication  can  be  loosely  divided  into  two  distinct  steps:    unwinding  of  the  DNA  duplex  
to  expose  the  sequence  of  each  strand,  followed  by  semiconservative  replication  of  each  
template.    The  point  at  which  duplex  unwinding  begins  marks  the  site  of  DNA  replication  
initiation  at  specific  sites  termed  replication  origins.    The  majority  of  prokaryotes  have  
single,  circular  chromosomes  that  are  replicated  from  a  single,  sequence-­‐specific  origin  
of  replication.    Following  initiation,  replication  proceeds  in  a  bi-­‐directional  manner  to  
replicate   the  entire   chromosome   (O’Donnell  et   al.   2013).      Eukaryotic   replication   is  a  
more   complicated   process,   with   the   linear,   typically   numerous,   chromosome   pairs  
replicated   from  multiple   origins   interspersed   along   the   length   of   each   chromosome,  
with  each  replication  fork  proceeding  until   it  meets  a  converging  fork  at  which  point  
replication  terminates  (Figure  1-­‐1).    The  number  of  origins  contained  within  an  entire  
genome  correlates  approximately  with  the  total  length  of  the  genome  with  an  estimated  
30,000-­‐50,000  activated  origins  in  human  cells  (Mechali  2010).    The  importance  of  the  
accurate  coordination  of  replication  initiation  is  evident  when  one  considers  that  at  any  
one  time  an  adult  human  body  is  composed  of  an  estimated  3.7´1013  cells  (Bianconi  et  
al.  2013)  requiring  the  correct  propagation  of  in  the  region  of  1.5´1018  replication  forks.  
The  total  number  of  replication  events  increases  significantly  when  one  considers  the  
renewal  of  cells  that  takes  place  constantly  throughout  the  human  lifespan.  
  
1.2.2    Eukaryotic  origin  identity  
   Among   the  widely   used   eukaryotic  model   organisms,   only   the   budding   yeast  
Saccharomyces   cerevisiae   is   known   to   use   consensus   sequence-­‐specific   replication  
origins  known  as  autonomous  replication  sequences  (ARS).    ARS  are  marked  by  a  well-­‐
defined   11-­‐12   bp   AT-­‐rich   consensus   sequence   termed   the   autonomous   consensus  
sequence   (ACS)  which   can   also   function   as   a   replicator  when   inserted   into   plasmids  
(Stinchcomb  et  al.  1979;  Marahrens  &  Stillman  1992;  Shirahige  et  al.  1993;  Rao  et  al.  
1994).    The  presence  of  an  ACS  does  not  however  guarantee  that  replication  will  begin  
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ORIGIN ORIGIN ORIGIN
LEADING STRANDLAGGING STRAND
Pol delta Pol epsilon
Figure 1-1  Mechanism of eukaryotic DNA replication
Eukaryotic DNA replication starts at multiple points along each chromosome termed 
origins.  Once licensed to ﬁre, replication from each origin proceeds in a bidirectional 
manner with continuous synthesis on the leading strand by polymerase (Pol) epsilon and 
discontinuous synthesis on the lagging strand by Pol delta.  Each replication fork proceeds 
until it encounters an oncoming fork, at which point replication terminates.  The result of 
replication is two daughter DNA molecules, each consisting of one strand derived from the 
original parent. 
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at  that  site  since  there  are  over  12,000  potential  ACS  sites  in  the  S.  cerevisiae  genome  
and  only  around  400  are  used  to  initiate  replication  (Nieduszynski  et  al.  2006).  
  
Origin  identity  in  fission  yeast  Schizosaccharomyces  pombe  is  less  well-­‐defined,  although  
origins  are  marked  by  the  presence  of  sequence-­‐independent  AT-­‐rich  regions  up  to  1kb  
in  length  (Clyne  &  Kelly  1995;  Segurado  et  al.  2003).    Furthermore,  replacement  of  AT-­‐
rich  regions   in  S.  pombe  ARS  that  are  essential   for   replication   initiation,  with  regions  
containing  polyA/T  stretches  has  little  effect  on  origin  usage  (Okuno  et  al.  1999).  
  
In  higher  eukaryotes  there  are  no  known  replication  origins  that  are  dependent  upon  
specific  sequences;  rather  origins  are  marked  by  features  of  the  genomic  landscape.    In  
human,  mouse  and  Drosophila,  origins  have  been  found  to  cluster  in  GC-­‐rich  regions  and  
in  regions  within  or  near  to  CpG  islands  (Necsulea  et  al.  2009;  Sequeira-­‐Mendes  et  al.  
2009).      Bioinformatic   analyses   have   identified   G-­‐rich   clusters   termed   origin   G-­‐rich  
repeated  elements  (OGREs)  around  origins  in  the  higher  eukaryotes.    Certain  guanine  
nucleotides  within  OGREs  are  capable  of  forming  G-­‐quadruplexes,  non-­‐canonical  DNA  
structures  which  have  been   identified   in  human  origins   (Besnard  et  al.  2012;  Cayrou,  
Coulombe,  et  al.  2012;  Cayrou,  Gregoire,  et  al.  2012)  and  are  thought  to  play  a  role  in  
replication  initiation  (Valton  et  al.  2014).  
  
1.2.3    Establishing  the  pre-­‐replication  complex  
   The  initial  step  in  replication  initiation,  termed  licensing,  is  the  assembly  of  the  
pre-­‐replication  complex  (pre-­‐RC)  at  all  origins.    This  process  begins  with  the  recognition  
of,  and  the  subsequent  loading  to  origins  of  the  origin  recognition  complex  (ORC).    ORC  
is  a  hetero-­‐hexamer  composed  of  Orc1-­‐Orc6.    In  S.  cerevisiae  and  S.  pombe,  it  is  thought  
that  ORC  remains  bound  to  chromatin  throughout  the  cell  cycle  (Newlon  1997;  Lygerou  
&  Nurse   1999),  whilst   in   humans  ORC  binding   occurs   only   during  G1   (Tatsumi   et   al.  
2003).    Of  the  six  ORC  proteins,  Orc1  is  the  first  to  bind  DNA  upon  assembly  of  the  Pre-­‐
RC.     The  cell  cycle  phase-­‐dependent  binding  of  ORC   in  humans   is  a  result  of  a  tightly  
regulated  process  affecting  Orc1  expression  levels,  with  accumulation  of  Orc1  limited  to  
mid   to   late   G1,   followed   by   ubiquitin-­‐mediated   degradation   of   Orc1   at   the   G2-­‐M  
transition  decreasing  both  ORC  stability  and  its  ability  to  be  recruited  to  origins.    Despite  
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the   absence   of   Orc1   from   chromatin   outside   G1,   other   components   of   ORC   remain  
chromatin-­‐associated  (Ladenburger  et  al.  2002;  Tatsumi  et  al.  2003;  Siddiqui  &  Stillman  
2007;  Kara  et  al.  2015).  This  tight  regulation  of  Orc1  expression,  and  subsequent  levels  
of  ORC  stability,  contributes  to  the  once-­‐per-­‐cell-­‐cycle  nature  of  origin  licensing  (Mechali  
2010;  Yardimci  &  Walter  2014).  
  
Once  ORC  has  bound  origins,  it  acts  as  a  recruitment  factor  for  loading  of  Cdc6,  an  AAA+  
ATPase,  which   interacts  with  ORC  via  Orc3  and  Orc1,  which   in  turn   interact  with  the  
other  ORC  subunits,   forming  a   ring-­‐like   structure  around   the   origin   (Sun  et  al.  2012;  
Yardimci  &  Walter  2014).    The  next  step  in  Pre-­‐RC  assembly  is  the  loading  of  the  core  
motor   of   the   main   replicative   helicase,   the   minichromosome  maintenance   complex  
(MCM)  a  hetero-­‐hexamer  of  six  related  AAA+  ATPases,  MCM2-­‐MCM7,  which  are  initially  
recruited  to  ORC-­‐Cdc6  via  interactions  between  MCM3  and  Cdc6  (Fernandez-­‐Cid  et  al.  
2013;   Deegan   &   Diffley   2016).      Further   stability   of   the   ORC-­‐Cdc6-­‐MCM   complex   is  
provided  by  Cdt1,  which  interacts  with  MCM  principally  via  MCM2,  but  also  via  MCM5  
and  MCM6  (J.  Sun  et  al.  2013)  (Figure  1-­‐2).    Cdt1  plays  an  important  role  in  alleviating  
the  autoinhibitory  effect  of  MCM6,  which  in  the  absence  of  Cdt1  prevents  MCM  loading  
onto  ORC-­‐Cdc6  (Fernandez-­‐Cid  et  al.  2013;  Riera  et  al.  2013).    MCM  loading  is  dependent  
upon  both  the  presence  of  Cdc6  and  subsequent  ATP  hydrolysis  by  Cdc6,  which  in  turn  
leads  to  release  of  Cdt1  from  the  Pre-­‐RC  (Randell  et  al.  2006;  Remus  et  al.  2009).    MCM  
loading  efficiency  is  also  influenced  by  the  chromatin  architecture  surrounding  origins  
(Sugimoto  et  al.  2015).  
  
1.2.4    Establishing  the  pre-­‐initiation  complex  
   In   vitro   studies   have   found   that  MCM   is   loaded   as   an   inactive   head-­‐to-­‐head  
double  hexamer  encircling  double  stranded  DNA  (dsDNA)  via  a  process  requiring  ATP  
hydrolysis   (Remus   et   al.   2009;   Evrin   et   al.   2009;   Gambus   et   al.   2011),   although   the  
precise   mechanism   through   which   the   two  MCM   hexamers   are   sequentially   loaded  
remains  unknown  (Yardimci  &  Walter  2014;  Deegan  &  Diffley  2016).    The  progression  of  
replication   once   the   pre-­‐RC   complex   is   formed   requires   the   association   of   further  
replication   factors   with  MCM   to   form   the   pre-­‐initiation   complex   (pre-­‐IC),   ultimately  
resulting   in   the   active   form   of   the   replicative   helicase,   the   Cdc45-­‐MCM-­‐GINS   (CMG)  




















































Figure 1-2  Eukaryotic DNA replication origin activation
Steps involved in the activation and ﬁring of eukaryotic origins.  i)  recruitment of the MCM 
replicative helicase to the origin recognition complex (ORC) by Cdt1 and Cdc6.  ii)  MCM 
phosphorylation by DDK causing recruitment of Cdc45, Sld3/Treslin and Mcm10.  iii)  CDK 
mediated phosphorylation resulting in recruitment of polymerase epsilon, Sld2/RecQ4, 
Dpb11/TopBP1 and the tetrameric GINS complex.  iv)  Subsequent steps recruit the factors 
necessary to assemble the mature replisome.  Putative human homologues labelled in 
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complex.      In   S.   cerevisiae,   the   loading   and   activation   of   the   CMG   complex   is   well  
characterized  and  requires  further  firing  factors,  including  Sld2,  Sld3,  Sld7,  Dpb11,  and  
Pol  ε,  along  with  the  action  of  two  S-­‐phase  promoting  kinases,  cyclin-­‐dependent  kinase  
CDK  and  Dbf4-­‐dependent  Cdc7  kinase  DDK  (Labib  2010;  On  et  al.  2014)  (Figure  1-­‐2).    
  
The  mechanisms  of  pre-­‐IC  assembly  and  the  roles  of  CDK  and  DDK  in  CMG  activation  in  
mammalian  cells  are  less  well  understood  than  in  yeast  systems.    Nevertheless  several  
homologues   of   yeast   proteins   have   been   identified   in   metazoan   systems,   including  
TopBP1,   RecQ4   and   Treslin/Ticrr,   homologues   of   Dpb11,   Sld2   and   Sld3   respectively  
(Tanaka  &  Araki  2013).    TopBP1  and  Treslin  both  bind  to  the  MCM  hexamer  and  MCM10  
is   recruited   to   the   Pre-­‐IC   and   is   required   for   helicase   activation   following   multiple  
phosphorylations  by  CDK  and  DDK  of  the  MCM  helicase  subunits  and  RecQ4  (Kanke  et  
al.  2012;  Im  et  al.  2015).    Importantly,  MCM10  has  been  shown  to  stimulate  CMG  activity  
~30-­‐fold  (Langston  et  al.  2017).  	  
1.2.5    Priming  replication  and  the  replisome  
   Bidirectional  unwinding  of  origin  DNA  by  the  MCM  helicase  starts  during  CMG  
assembly  and  continues  following  CMG  activation  by  MCM10  exposing  single-­‐stranded  
DNA  (ssDNA)  that  is  coated  with  RPA  (Sun  et  al.  2015;  Burgers  &  Kunkel  2017;  Douglas  
et  al.  2018).     Exposed  origin  ssDNA  is  used  as  a  template  for  priming  by  the  primase  
subunit  of  tetrameric  Polymerase  alpha  (Pola),  which  is  recruited  to  the  replisome  by  
MCM10  and  And-­‐1/Ctf4  (Zhu  et  al.  2007).     Pola   primes  replication  by  polymerizing  a  
short  RNA  (~10-­‐12  nucleotides)-­‐DNA  (~20  nucleotides)  primer;  this  is  an  important  step  
since  neither  of   the   two  major   replicative  polymerases,  Polymerase  delta   (Pold)   and  
Polymerase  epsilon  (Pole)  are  able  to  initiate  nucleotide  polymerization  ab  initio  (Frick  
&  Richardson  2001).  
  
The  recruitment  of  both  Pold  and  Pole  to  the  replisome  is  mediated  by  their  interactions  
with  the  molecular  scaffold  Proliferating  Cell  Nuclear  Antigen  (PCNA).    PCNA  is  loaded  
at  replication  origins  by  replication  factor  C  (RFC)  (Tsurimoto  &  Stillman  1990)  and  its  
presence  increases  the  processivity  of  S.  cerevisiae  Pold  ~100-­‐fold  and  Pole  ~6-­‐fold   in  
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vitro   (Chilkova   et   al.   2007).      PCNA   also   interacts   with   several   other   proteins   at   the  
replication   fork   to   help   mediate   process   such   as   Okazaki   fragment   maturation,  
mismatch   repair,   nucleotide   excision   repair   and   translesion   synthesis   (Boehm   et   al.  
2016).  
  
Following  priming,  replication  proceeds  with  continuous  synthesis  on  the  leading  strand  
by  Polε,  which  in  S.  cerevisiae  is  recruited  to  origins  via  interactions  with  GINS,  Dpb11  
and  Sld2  and  discontinuous  synthesis  on  the  lagging  strand  by  Pold  (Pursell  et  al.  2007;  
Nick  McElhinny  et  al.  2008;  Muramatsu  et  al.  2010;  Miyabe  et  al.  2011;  Langston  et  al.  
2014;  Daigaku  et  al.  2015).  
  
1.3    Replication  stress  
   Replication   stress   is   the   term   used   to   describe   when   impediments   from  
endogenous  and  exogenous   sources   cause   slowing,   stalling  or   collapse  of   replication  
fork   progression   and   the  DNA  damage   that   results   from   such   erroneous   replication,  
including  the  exposure  of  single-­‐stranded  DNA  and  DNA  double  strand  breaks  (Mazouzi  
et  al.  2014;  Zeman  &  Cimprich  2014;  Macheret  &  Halazonetis  2015;  O’Driscoll  2017).      
  
1.3.1    Causes  of  replication  stress  
   Replication  stress  can  be  caused  by  a  wide  range  of  different  phenomena,  mostly  
arising  from  intrinsic  cellular  metabolic  processes  and  features  relating  to  DNA  sequence  
and  topology  but  also  from  exogenous  sources  and  from  the  consequences  of  mutations  
in  genes  regulating  DNA  metabolism  and  the  cell  cycle  (Zeman  &  Cimprich  2014).  
  
Replication  fork  progression  may  be  impeded  by  a  variety  of  endogenously-­‐arising  and  
exogenously-­‐derived  unrepaired  DNA  lesions,  including,  but  not  limited  to  abasic  sites,  
UV-­‐induced  lesions  and  aromatic  DNA  adducts  (Lopes  et  al.  2006;  Ciccia  &  Elledge  2010;  
Zeman  &  Cimprich  2014;  Kidane  et  al.  2014).    Impediments  to  replication  also  arise  due  
to  the  presence  of  non-­‐B  form  secondary  structure  within  DNA,  formed  within  AT-­‐rich  
regions  (Zhang  &  Freudenreich  2007)  and  within  GC-­‐rich  regions  capable  of  forming  G-­‐
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quadruplexes  (G4)  (Burge  et  al.  2006;  Lopes  et  al.  2011).     Hairpin  and  cruciform  DNA  
structures   caused   by   inverted   repeat   sequences   also   present   a   problem   for   active  
replication   forks   (Voineagu  et  al.  2008;   Boyer  et  al.  2013;   Inagaki  et  al.  2013).     DNA  
replication  stress  may  also  be  caused  by  structure-­‐forming  tri-­‐nucleotide  repetitive  DNA  
sequences   that   cause   intramolecular   slippage   of   the   replicative   polymerases  
(Samadashwily   et   al.   1997);   indeed   several   human   diseases   have   been   found   to   be  
caused  by  the  expansion  of  nucleotide  repeats  from  three  up  to  twelve  nucleotides  in  
length,   located   within   the   coding   regions,   3’-­‐   and   5’-­‐untranslated   regions,   intronic  
sequences  and  promoter  regions  of  genes  (Mirkin  2007).      
  
Eukaryotic   telomeres   and   subtelomeric   regions   are   particularly   prone   to   replication  
stress   since   they   contain   G-­‐rich   repetitive   sequences   that   are   prone   to   forming  
secondary  structures  including  G4,  t-­‐loops,  heterochromatin-­‐like  structures  as  well  as  
structures   that   have   not   been   seen   in   vivo  but   are   presumed  possible   from   in   vitro  
studies  such  as  triple  helices,  four-­‐way  junctions  and  D-­‐loops  (Gilson  &  Geli  2007).  
  
Both  DNA  replication  and  RNA  transcription  compete  for  the  same  template.    To  avoid  
collisions   between   replication   and   transcription   machinery,   cells   separate   the   two  
processes  spatially  and  temporally  (discussed  in  section  1.3.2).     Despite  this,  head-­‐on  
collisions   between   replication   and   transcription   machinery   travelling   in   opposing  
directions  and  codirectional   collisions   caused  by   replication  and   transcription   on   the  
same  template  do  occur;  these  collisions  have  been  found  to  cause  fork  stalling  resulting  
in  genome  instability  in  eukaryotes  (Deshpande  &  Newlon  1996;  Prado  &  Aguilera  2005;  
Azvolinsky  et  al.  2009;  Garcia-­‐Rubio  et  al.  2018).    Replication  fork  stalling  as  a  result  of  
transcription  may  not  be  solely  derived  from  steric  hindrance.    The  unwinding  of  DNA  
necessary  for  replication  and  transcription  generates  positive  supercoiling  ahead  of  each  
set  of  machinery.      This   leads   to   topological   stress  between  opposing   replication  and  
transcription   machinery   which   prevents   the   progression   of   the   replication   fork  
(Olavarrieta  et  al.  2002;  Bermejo  et  al.  2011;  Bermejo  et  al.  2012;  Keszthelyi  et  al.  2016).  
  
Opposing  transcription  and  replication  pose  a  further  problem  to  replisomes  due  to  the  
formation   of   three-­‐stranded   structures   composed   of   an   RNA-­‐DNA   duplex   and   free  
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single-­‐stranded  DNA  known  as  R-­‐loops.    During  transcription  R-­‐loops  may  be  formed  by  
the  interaction  of  the  nascent  transcript  with  exposed  DNA  at  the  transcription  bubble  
behind   the   transcription   machinery.      R-­‐loops   form   preferentially   in   negatively  
supercoiled  DNA  such  as  that  found  behind  RNA  polymerases  and  their  stabilization  at  
such  positions  is  aided  by  the  excess  positive  supercoiling  generated  by  the  oncoming  
replisome  (Zeman  &  Cimprich  2014;  Brambati  et  al.  2015).    Transcription  of  long  human  
genes  over  800kb  in  length  can  take  longer  than  one  full  cell  cycle.    In  such  instances,  
transcription  starts  during  G2/M  of  one  cell  cycle  and  proceeds  throughout  an  entire  cell  
cycle,   terminating   in   the   subsequent   G1   or   early   S   phase   of   the   next   cell   cycle.    
Replication   through   long   genes   that   require   longer   than   one   cell   cycle   to   complete  
transcription   increases   the   chances   of   replication-­‐transcription   collision   and   R-­‐loop  
formation  at  these  loci  (Helmrich  et  al.  2011).    The  failure  to  resolve  R-­‐loops  causes  DNA  
damage  and  chromosome  breakage  (Stirling  et  al.  2012).  
  
It  is  thought  that  collisions  between  transcription  and  replication  machinery  may  be  one  
of   the   sources   of   replication   stress   seen   in   cancer   cells   that   overexpress   or   have  
constitutively   activated   oncogenes.      In   such   instances   it   is   likely   that   elevated  
transcription   levels   due   to   excessive   oncogene   expression   increases   the   chances   of  
collision  with  an  oncoming   replication   fork.      Furthermore,   the   increase   in   replication  
caused  by  oncogene  overexpression  may  result  in  a  depletion  of  the  nucleotide  pool,  
hindering  replication  fork  progression,  thereby  increasing  genome  instability  (Bester  et  
al.  2011).    Whilst  the  exact  causes  of  oncogene-­‐induced  replication  stress  are  not  known,  
the  appearance  of  S-­‐phase-­‐specific  ssDNA  foci  thought  to  be  due  to  polymerase-­‐helicase  
uncoupling,   and   the   colocalization   of   markers   of   DNA   damage   with   PCNA   staining  
following   Cyclin   E   overexpression,   implicate   aberrant   oncogene   expression   in  
replication-­‐specific  DNA  damage  (Bartkova  et  al.  2006).  
  
DNA   breaks   formed   at   genomic   regions   in   which   there   is   frequent   concomitant  
replication  and  transcription  such  as  in  the  long  genes  described  above  often  map  to  
common  fragile  sites  (CFSs)  (Helmrich  et  al.  2006;  Helmrich  et  al.  2011).    CFSs  can  be  
defined  as  hotspots  for  replication  stress-­‐induced  DNA  breaks  seen  in  a  majority  of  cells.    
To  date,  over  200  CFSs  have  been  identified  in  human  lymphocytes,  ranging  in  size  from  
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just  under  1  Mb  to  over  10  Mb  (Mazouzi  et  al.  2014;  Bhowmick  &  Hickson  2017).    CFSs  
can   be   reproducibly   induced   in   the   presence   of   agents   that   specifically   impede  
replication  such  as  aphidicolin,  an  inhibitor  of  replicative  DNA  polymerases  (Glover  et  al.  
1984;  Arlt  et  al.  2006)  and  hydroxyurea  (HU),  an  inhibitor  of  ribonucleotide  reductase  
(Lundin   et   al.   2002).      CFSs   are   often   found   around   genomic   loci   containing   AT-­‐rich  
stretches   that  affect  helix   flexibility  and   those   regions   capable  of   forming   secondary  
structure  described  above  (Arlt  et  al.  2006;  Bhowmick  &  Hickson  2017).  
  
CFS  expression  also  correlates  with  regions  of  highly  condensed  chromatin,  marked  by  
histone  hypoacetylation.    It  is  thought  that  the  increased  compaction  of  DNA  at  these  
points  may  be  inhibitory  to  the  establishment  and  activation  of  replication  complexes  at  
sites  that  otherwise  may  serve  as  replication  origins  and  that  the  paucity  of  replication  
in  these  areas  may  be  the  source  of  replication  stress  (Jiang  et  al.  2009;  Ozer  &  Hickson  
2018).      Similarly,   human   cancers   often   have   elevated   mutation   rates   surrounding  
regions   of   heterochromatic   histone   modifications   (e.g.   H3K9me3   and   H4K20me3)  
although   whether   the   high   incidence   of   DSBs   in   these   regions   and   in   regions   of  
hypoacetylation   is   due   to   the   repressive   nature   of   the   chromatin   landscape   on  
replication   or   the   inhibitory   effect   of   heterochromatin   on  DNA   repair   remains   to   be  
elucidated  (Schuster-­‐Böckler  &  Lehner  2012;  Tubbs  &  Nussenzweig  2017).  
  
1.3.2    Preventing  replication  stress  
   Cells  have  evolved  several  mechanisms  to  help  prevent  the  occurrence  of  events  
that  may  lead  to  replication  stress  and  to  resolve  replication  stress  when  it  arises.    As  
described  in  section  1.3.1,  clashes  between  replication  and  transcription  machinery  are  
common  sources  of  replication  stress  in  eukaryotes.    Transcription  and  replication  are  
often  temporally  distinct,  with  the  majority  of  transcription  occurring  during  G1-­‐phase  
of  the  cell  cycle  and  replication  occurring  during  S-­‐phase  (Bertoli,  Skotheim,  et  al.  2013).    
This  is  principally  regulated  by  the  E2F  family  of  transcription  factors.    Before  the  onset  
of   S-­‐phase,   E2F6   transcriptional   repressors   replace   activating   E2Fs   at   promoters   to  
inhibit   transcription   during   DNA   replication.      In   response   to   replication   stress,   the  
checkpoint  kinase  Chk1  phosphorylates  E2F6  causing  E2F6  to  dissociate  from  promoters  
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and  to  be   replaced  by  activating  E2F  transcription  factors  to  activate  transcription  of  
DNA  repair  and  nucleotide  synthesis  genes  (Bertoli,  Klier,  et  al.  2013;  Bertoli  et  al.  2016).  
  
Transcription-­‐replication  clashes  often  result  in  the  formation  of  R-­‐loops.    It  is  therefore  
important  that  cells  have  pathways  in  place  to  suppress  R-­‐loop  formation  and  to  remove  
R-­‐loops  once  formed.    One  of  the  principle  mechanisms  by  which  R-­‐loops  are  repaired  
is   RNase   H1-­‐mediated   degradation   of   the   RNA   in   a   DNA:RNA   hybrid   in   a   process  
requiring  replication  protein  A  (RPA)  which  recognizes  ssDNA  and  is  thought  to  recruit  
RNase   H1   to   R-­‐loops   (Parajuli   et   al.   2017;   Nguyen   et   al.   2017).      Although   less  well-­‐
understood,  DNA  Topoisomerase  I  (Top1)  also  plays  a  role  in  the  processing  of  R-­‐loops,  
particularly  in  the  context  of  genes  that  are  difficult  to  transcribe  (Tuduri  et  al.  2009;  
Manzo  et  al.  2018).  
  
Transcription   and   replication   can   be   spatially   separated   to   avoid   replication   stress  
caused   by   transcription-­‐replication   collisions   in   highly   transcribed   genes   such   as  
eukaryotic   ribosomal   DNA   (rDNA).      This   spatial   separation   prevents   replication   over  
actively   transcribed   templates   and   is   achieved   by   the   presence   of   sequence-­‐specific  
replication  fork  barriers  (RFBs)  at  the  3’  ends  of  pre-­‐ribosomal  RNA  coding  regions  that  
are  tightly  bound  by  proteins  to  arrest  replication  fork  progression.    This  prevents  head-­‐
on   collisions   between   the   incoming   replication   fork   and   transcription   machinery  
travelling  in  the  opposite  direction.    Replication  of  these  regions  is  then  completed  by  a  
replication   fork   originating   from   a   region   flanking   the   rDNA   repeat   travelling   co-­‐
directionally  with  transcription  (Brewer  &  Fangman  1988).      
  
The  majority  of  replication  fork  barriers  discovered  in  yeasts  and  higher  eukaryotes  are  
polar,   i.e.   they  stop  replication  from  one  direction  only,  however  some  human   rDNA  
RFBs  are  bidirectional  causing  arrest  of  incoming  replication  forks  from  either  direction  
(Akamatsu  &  Kobayashi  2015;  Gadaleta  &  Noguchi  2017).      
  
1.3.3    Restarting  stalled  forks    
A   failure   to   restart   and   process   replication   forks   that   stall   due   to   replication   stress-­‐
causing  factors  is  a  major  source  of  genetic  instability.    Stalled  forks  can  be  defined  as  
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replication  forks  whose  progress  is  impeded  by  the  presence  of  an  inhibitory  factor  but  
whose  activity  can  be  resumed  following  removal  of  the  impediment  without  further  
intervention  (Lambert  &  Carr  2013).  
  
Some   stalled   forks   are   restarted   by   repriming   downstream   of   the   lesion,   leaving   a  
stretch  of  single  stranded  DNA  that  is  subsequently  repaired  by  postreplicative  repair  
(PRR)  mechanisms  (Yeeles  et  al.  2013).    Stalled  forks  may  also  be  rescued  by  a  converging  
replication  fork  that  may  have  resulted  from  the  programmed  firing  of  dormant  origins  
in  response  to  replication  stress  (Woodward  et  al.  2006;  Ge  et  al.  2007).    Stalled  forks  
may  also  activate  pathways   that  allow   translesion  polymerases   to   replicate  over   the  
template  containing  the  damaged  bases  in  a  process  termed  translesion  synthesis  (TLS).    
Such  polymerases  have  larger  active  sites  than  the  major  replicative  polymerases  that  
allow  for  the  accommodation  of  the  helix  distortions  caused  by  the  damaged  bases,  but  
the   larger   active   site   also   reduces   the   fidelity   of   translesion   polymerases   when  
replicating  undamaged  bases  (Hubscher  &  Maga  2011;  Zahn  et  al.  2011).      
  
1.3.4    The  Intra-­‐S  phase  response  to  replication  stress  
One  of  the  key  features  in  triggering  the  DNA  damage  response  to  replication  
stress   is   the   generation   of   single-­‐stranded   DNA   (ssDNA)   caused   by   the   continued  
unwinding  of  duplex  DNA  by  the  MCM  replicative  helicase  having  become  uncoupled  
from  the  replicative  polymerase  (Byun  et  al.  2005).    ssDNA  is  recognized,  and  bound  by  
RPA  which  recruits  a  key  protein  kinase,  ataxia  telangiectasia  mutated  and  Rad3-­‐related  
(ATR),  to  sites  of  replication  stress  via  interactions  with  ATR-­‐interacting  protein  (Zou  &  
Elledge  2003).    Once  activated  at  sites  of  ssDNA  following  phosphorylation  by  TopBP1,  
ATR  phosphorylates  hundreds  of  targets,   the  most   important  of  which   is  its  principle  
downstream  effector,  the  checkpoint  kinase  Chk1  which  can  act  locally  and  globally  to  
help  overcome  replication  stress  (Mazouzi  et  al.  2014).      
  
Following  HU-­‐induced  replication  stress,  the  S.  cerevisiae  Chk1  homologue,  Rad53  acts  
directly  on  the  CMG  helicase  to  prevent  further  unwinding  of  duplex  DNA.    This  prevents  
CMG  from  advancing  away  from  the  site  of  DNA  incorporation,  thereby  preventing  the  
formation  of  excess  ssDNA  (Gan  et  al.  2017).  
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Chk1  plays  an  important  role  in  inhibiting  the  global  late  firing  of  origins  in  response  to  
replication  stress  whilst  at  the  same  time  allowing  the  firing  of  dormant  origins  in  the  
vicinity  of  stalled  replication  forks  under  low  replication  stress  conditions  (Ge  et  al.  2007;  
Ge  &  Blow  2010).    The  suppression  of  global  origin  firing  by  ATR-­‐Chk1  signalling  protects  
cells  by  ensuring  that  the  level  of  ssDNA  generated  by  DNA  replication  does  not  exceed  
that   which   can   be   bound   by   the   cellular   RPA   pool,   since   RPA   depletion   causes  
widespread  DNA  breaks  (Toledo  et  al.  2013).  
  
A  reduction  in  global  origin  firing  in  favour  of  rescuing  replication  in  the  vicinity  of  stalled  
replication  forks   is  also  mediated  by  the  activity  of  ATR  on  a  member  of  the  Fanconi  
anaemia  DNA   repair  pathway,   FANCI,  which  along  with   its  partner  FANCD2   interacts  
with  the  replisome  via  interactions  with  the  MCM  helicase  (Lossaint  et  al.  2013).    Under  
normal  growth  FANCI  plays  a  role  in  activating  DDK,  which  in  turn  promotes  origin  firing  
as   described   in   section   1.2.4.      However,   under   conditions   of   replication   stress,   ATR  
phosphorylates  FANCI,  which  causes  a  shift  in  the  pool  of  FANCI  from  dormant  origins  
to   stalled   replication   forks  where   it   promotes   replication   fork  protection,   repair  and  
restart  (Chen  et  al.  2015).  
  
1.3.5    Restarting  collapsed  replication  forks  by  homologous  recombination  
       If  a  stalled  fork  is  not  correctly  stabilized  following  the  onset  of  replication  stress  
and  requires  the  involvement  of  a  replication  restart  mechanism  to  resume,  it  is  referred  
to  as  a  collapsed  fork  (Lambert  &  Carr  2013).    This  collapse  may  cause  the  dissociation  
of  some  components  of  the  replisome  (Katou  et  al.  2003;  Lucca  et  al.  2004;  Cobb  et  al.  
2005),   although   it   is   more   likely   that   the   replisome   remains   intact   although   the  
replicative  helicase  may  continue  to  separate  the  DNA  duplex  ahead  of  the  collapsed  
fork  (Lopes  et  al.  2006;  De  Piccoli  et  al.  2012;  Dungrawala  et  al.  2015).  
  
One  of  the  main  mechanisms  by  which  cells  protect  and  restart  collapsed  replication  
forks  is  the  use  of  homologous  recombination  (HR)  (Carr  &  Lambert  2013).    In  human  
cells,   this   response   is   mediated   by   BRCA2   which   binds   to   RPA-­‐coated   ssDNA   and  
promotes   the   displacement   of   RPA   by   the   RAD51   recombinase   to   establish   the  
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nucleoprotein  filament  required  to  initiate  the  search  for  homology  (Jensen  et  al.  2010;  
Thorslund  et  al.  2010).     Collapsed   replication   forks  may  be   restarted  by  homologous  
recombination  either  with  or  without  DSB  formation  in  mammalian  cells  (Lundin  et  al.  
2002),  although  this  process  can  be  error-­‐prone  if  the  incorrect  template  for  restart  is  
selected  (Carvalho  et  al.  2015;  Zou  et  al.  2017).    Similar  findings  in  yeast  (Mizuno  et  al.  
2009;   Mizuno   et   al.   2013)   suggest   that   error-­‐prone   HR-­‐mediated   fork   restart  
mechanisms  are  conserved  throughout  evolution.  
  
1.4    Ribonucleotides  in  genomic  DNA  
1.4.1    Introduction  to  genomic  ribonucleotides  
   The  maintenance  and  heritability  of  genetic  information  is  dependent  upon  the  
highly  accurate  duplication  of  genomic  DNA  (gDNA)  prior  to  cell  division.     The  use  of  
deoxyribonucleotides   (dNTPs)   as   the   building   blocks   for   genetic   storage   offers   an  
advantage  over  ribonucleotide  (rNTP)-­‐based  genomes  due  to  the  increased  stability  of  
dNTP  polymers.    Polynucleotide  chains  are  linked  via  chemically  stable  phosphodiester  
bonds   that   form  between   the   5’-­‐phosphate  and  3’-­‐hydroxyl  of  adjacent  nucleotides.    
Phosphodiester  bonds  involving  ribonucleotides  are  more  susceptible  to  hydrolysis  than  
bonds  between  adjacent  dNTPs  due  to  the  presence  of  the  2’-­‐hydroxyl  group  on  the  
ribose  sugar  moiety  of  rNTPs  (Li  &  Breaker  1999).    It   is  therefore  important  that  cells  
have   mechanisms   to   detect   and   repair   any   misincorporated   ribonucleotides.      The  
following  sections  will  discuss  the  source  of  genomic  ribonucleotides  and  the  pathways  
that  cells  have  evolved  to  remove  them.  
  
1.4.2    Sources  of  genomic  ribonucleotide  incorporation  
   Ribonucleotides   may   be   present   in   the   genome   as   a   result   of   programmed  
inclusion  or  as  the  result  of  erroneous  incorporation  by  DNA  polymerases,  in  addition  to  
stochastic  events  such  as  the  spontaneous  hydrolysis  of  the  deoxyribose  sugar  in  DNA  
to  ribose  by  free  radicals  to  generate  an  embedded  genomic  ribonucleotide  (Randerath  
et  al.  1992).  
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As   described   in   section   1.2,   the   major   replicative   polymerases,   Pold   and   Pole,   are  
incapable  of  initiating  de  novo  replication  events  and  rely  upon  the  primase  activity  of  
Pola.    Pola  initiates  nucleotide  chain  extension  on  both  the  leading  strand  and  lagging  
strands  by   inserting  ~8-­‐10  nucleotide   long  RNA  primers.     Due  to  the  requirement  for  
priming  to  initiate  replication  at  the  start  of  every  Okazaki  fragment  (OF)  on  the  lagging  
strand,   eukaryotic   cells   incorporate   an   RNA   primer   every   ~200   bases,  meaning   that  
replication  of  the  entire  3´109  human  genome  requires  the  incorporation  of  ~1.5´108  
ribonucleotides   into   the   nascent   DNA   (Williams   &   Kunkel   2014).      RNA   primers   are  
subsequently   removed   from   gDNA   during   OF   maturation,   a   process   similar   to  
ribonucleotide  excision  repair  (described  in  section  1.4.3)  but  without  the  requirement  
for  RNase  H2  (Qiu  et  al.  1999).    It  is  likely  that  this  process  involves  strand  displacement  
synthesis  by  Pol  d  followed  by  cleavage  of  the  resultant  flap  by  FEN1  (Garg  et  al.  2004)  
or  in  the  absence  of  FEN1  by  DNA2  (Balakrishnan  &  Bambara  2013).  
  
Replicative   DNA   polymerases   have   strong   selectivity   for   deoxyribonucleotides   over  
ribonucleotides,  largely  mediated  by  the  presence  of  well-­‐conserved  steric  gate  residues  
at  their  active  sites  that  clash  with  the  2’hydroxyl  group  on  the  ribose  moiety  of  rNTPs  
(Brown  &   Suo   2011).      In   spite   of   this   structural   discrimination,   several   studies   have  
shown   that   in   vivo,  and   in   in   vitro   studies   under   physiologically   relevant   conditions,  
eukaryotic  replicative  polymerases  incorporate  rNTPs  at  a  rate  of  1  rNTP/650  dNTPs  (S.  
cerevisiae  Pola);  1/5000  (S.  cerevisiae  Pold);  1/1250  (S.  cerevisiae  Pole);  1/500  (human  
Pola);   1/20000   (bovine   Pola)   and   1/7600   (mean   for   all   replicative   polymerases   in  
mouse)  (Kuchta  et  al.  1992;  Richardson  et  al.  2000;  Nick  McElhinny,  Watts,  et  al.  2010;  
Reijns  et  al.  2012).    The  rate  of  rNTP  incorporation  by  human  Pold  and  Pole  (1/2000  and  
1/1500  respectively)  indicate  that  it  is  possible  that  replication  of  mammalian  genomes  
results  in  the  stable  incorporation  (not  including  RNA  primers)  of  more  than  3´106  rNTPs  
(Goksenin  et  al.  2012;  Clausen  et  al.  2013;  Williams  &  Kunkel  2014).    That  polymerases  
incorporate   ribonucleotides   despite   possessing   structural   barriers   to   increase  
discrimination  for  the  correct  sugar  can  possibly  be  explained  by  the  fact  that  the  cellular  
pool  of  rNTPs  is  greater  than  that  of  dNTPs  in  both  yeast  (Nick  McElhinny,  Watts,  et  al.  
2010)  and  mammalian  cells  (Traut  1994;  Ferraro  et  al.  2010).    
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1.4.3    Removing  misincorporated  ribonucleotides  from  genomic  DNA  
   RNA:DNA   hybrids   are   formed   during   several   cellular   process   including   DNA  
replication   (Nick   McElhinny,   Watts,   et   al.   2010;   Clausen   et   al.   2013),   transcription  
(Garcia-­‐Benitez  et  al.  2017)  and  telomere  elongation  (Forstemann  &  Lingner  2005).    The  
majority  of   repair  of   such  RNA:DNA  hybrids   is   initiated  by   the  activity  of  a   family  of  
enzymes  called  ribonucleases  H  (RNases  H).    In  both  prokaryotes  and  eukaryotes,  two  
classes  of  RNase  H  have  been  described,  type  1  and  type  2  (Cerritelli  &  Crouch  2009).    
RNases  H1  and  H2  differ  in  their  overall  structure  and  their  substrate  specificity.    RNase  
H1  is  monomeric  and  requires  the  2’-­‐OH  groups  of  a  stretch  of  at  least  4  ribonucleotides  
for  efficient  catalytic  activity  (Nowotny  et  al.  2007).    The  predominant  RNase  activity  in  
mammalian  cells  is  derived  from  RNase  H2  (Busen  1980),  a  heterotrimer  consisting  of  
three  subunits:    the  catalytic  subunit,  RNase  H2A,  and  two  accessory  subunits,  RNase  
H2B  and  RNase  H2C  (Jeong  et  al.  2004;  Crow,  Leitch,  et  al.  2006;  Shaban  et  al.  2010;  
Reijns  et  al.  2011).    RNase  H2  has  been  shown  to  act  on  single  genomic  ribonucleotides  
(Eder  et  al.  1993;  Rychlik  et  al.  2010)  and  on  longer  stretches  of  genomic  RNA  (Chon  et  
al.  2009).    Since  the  focus  of  this  thesis  is  on  the  misincorporation  of  ribonucleotides  by  
replicative  polymerases  during  DNA  replication,  and  since  the  chances  of  polymerases  
incorporating  two  or  more  successive  ribonucleotide  are  presumed  to  be  very  rare,  this  
section  will   concentrate   on   the   catalytic   activity   of   RNase  H2   since   it   is   the   enzyme  
responsible   for   the   removal   of   single   ribonucleotides   embedded   in   gDNA.      Further  
details  relating  to  the  structure  and  function  of  RNase  H2  will  be  discussed  in  more  detail  
in  section  1.5.  
  
The  principle  pathway  by  which  single  ribonucleotides  misincorporated  by  polymerases  
are   removed   is   called   ribonucleotide   excision   repair   (RER).      RER   starts   with   the  
recognition  of  the  embedded  ribonucleotide  by  RNase  H2  which  then  cleaves  the  5’-­‐
phosphodiester  bond  of  the  ribonucleotide  (Eder  et  al.  1993).    The  resultant  nick  allows  
for  strand  displacement  synthesis  by  Pold  (and  less  efficiently  by  Pole)  generating  a  flap  
which  acts  as  a  substrate  for  flap  removal  by  FEN1  and/or  DNA2  with  DNA  Ligase  1  (LIG1)  
sealing  the  gap  between  the  newly  synthesized  and  the  original  DNA  strands  (Sparks  et  
al.   2012)   (Figure   1-­‐3).      The   requirement   for   RNase   H2   and   FEN1   in   RER   were   first  














RNase H2 incision at ribonucleotide
Polδ/PCNA/RPA/RFC strand displacement 
synthesis from 3’OH end









Figure 1-3  Ribonucleotide excision repair
A genomic ribonucleotide (red R) is recognised by RNase H2 which makes an incision on the 5’ side 
of the ribonucleotide leaving a 3’-OH end.  Strand displacement synthesis requiring Polδ, PCNA, 
the clamp loader, RFC and RPA creates a ribo-terminating ﬂap which is a substrate for FEN1.  FEN1 
cleaves the ﬂap and the remaining gap is sealed by DNA ligase 1.  Adapted from Klein (2017).
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identified  in  a  study  in  S.  cerevisiae  in  which  deletion  RNase  H2A  resulted  in  decreased  
incision   at   ribonucleotides   and   deletion   of   RAD27/FEN1   decreased   ribonucleotide  
liberation  (Rydberg  &  Game  2002).  
  
RER  can  be  reconstituted   in  vitro  using  RNase  H2,  FEN1,  Pold  and  LIG1  (Sparks  et  al.  
2012).    All  four  enzymes  have  been  shown  to  interact  with  PCNA,  raising  the  possibility  
that   the  RER  machinery  may   travel  with   the   replication   fork.      Interaction  with  PCNA  
stimulates  the  endonuclease  activity  of  FEN1  (Li  et  al.  1995)  but  has  no  effect  on  the  
ligation   efficiency   of   LIG1   (Montecucco   et   al.   1998).      RNase  H2   contains   a  motif   for  
interaction  with  PCNA  termed  a  PCNA-­‐interacting  protein  (PIP)  box  which  is  located  in  
RNase  H2B  (Chon  et  al.  2009),  the  presence  of  which  is  essential  for  the  colocalization  
of  RNase  H2  with  active  replisomes   in  mammalian  cells   (Bubeck  et  al.  2011).     Whilst  
PCNA  greatly  stimulates  RER  in  vitro,  the  RNase  H2  PIP-­‐box  is  dispensable  for  catalysis  
in  vitro  (Sparks  et  al.  2012).    Whilst  these  latter  results  may  have  been  an  artefact  of  the  
experimental  design,   they  perhaps   indicate  that  RNase  H2  may  be  able  to  effect  RER  
without   interacting   directly   with   PCNA.      It   seems   that   a   repair   system   in   which  
misincorporated   ribonucleotides   could   be   repaired   by   RER   after   the   replisome   has  
advanced   away   from   the   site   of   misincorporation   would   be   favoured   by   evolution,  
rather  than  relying  on  damage  to  be  repaired  concomitantly  with  replication.    Indeed,  
genomic  ribonucleotides  have  been  found  to  act  as  a  marker  of  newly  synthesized  DNA  
to  allow  for  strand  discrimination  in  mismatch  repair  (MMR),  and  RNase  H2  activity  at  
such  sites  may  generate  the  nicks  required  to  initiate  MMR  (Ghodgaonkar  et  al.  2013;  
Lujan  et  al.  2013).    These  findings  indicate  that  RER  probably  occurs  independently  of  
the  interaction  of  RNase  H2  with  PCNA  at  the  replication  fork.  
  
Recent  work  in  S.  cerevisiae  has  indicated  a  role  for  Topoisomerase  1  (Top1)  in  the  repair  
of  single  embedded  genomic  ribonucleotides.    In  yeast,  the  absence  of  RNase  H2  results  
in  an  increase  in  Top1-­‐dependent  2-­‐5  bp  deletions  (N.  Kim  et  al.  2011).    Top1  activity  at  
ribonucleotides  generates  single  strand  breaks  with  2’,3’-­‐cyclic  phosphate  termini.    Top1  
also   nicks   two   nucleotides   upstream   of   the   cleaved   ribonucleotide,   generating   a  
covalently  linked  Top1-­‐DNA  complex  with  a  2  nucleotide  gap  (Sparks  &  Burgers  2015).    
Subsequent   Top1-­‐mediated   cleavage   on   the   opposite   strand   generates   irreversible  
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double  strand  breaks  which  can  be   repaired   in  an  error-­‐free  manner  by  homologous  
recombination   (Huang  et  al.  2017).      The   Top1-­‐DNA  complex  may  be   repaired  before  
double   strand   break   formation   by   a   process   requiring   Exo1   and   the   Sgs1   and   Srs2  
helicases  (Niu  et  al.  2016).    Interestingly,  having  generated  a  2’,3’-­‐cyclic  phosphate,  Top1  
is   able   to   reverse   this   nick   formation   to   provide   once   again   a   suitable   substrate   for  
conventional  RNase  H2-­‐mediated  repair  (Sparks  &  Burgers  2015)  
  
1.5    Ribonuclease  H2  
1.5.1    Ribonuclease  H2  structure  
   As  described  in  section  1.4.3,  eukaryotic  RNase  H2  is  a  trimer  consisting  three  
subunits:    one  catalytic  subunit,  RNase  H2A  and  two  accessory  subunits,  RNase  H2B  and  
RNase  H2C  (Figure  1-­‐4  A).    In  humans  the  three  subunits  are  composed  of  299,  312  and  
164  amino  acids  respectively.    The  core  domains  of  the  three  subunits  stack  in  a  linear  
manner,  with  RNase  H2C  flanked  by  the  other  two  subunits.    The  C-­‐terminal  17  residues  
of  RNase  H2A  (283-­‐299)  form  an  a/b  motif  that  forms  part  of  a  central  b-­‐barrel  at  the  
core  of  the  holoenzyme  that  is  required  for  binding  to  the  RNase  H2BC  heterodimer.    
Mutational  peptide  array  analysis  revealed  Tyr-­‐287,  Phe-­‐288,  Arg-­‐291,  Leu-­‐293  and  Ala-­‐
296   as   the   key   residues   required   to   mediate   this   interaction.      Indeed,   deletion   of  
residues  248-­‐299  of  the  C-­‐terminal  extension  of  RNase  H2A  not  only  prevented  trimer  
formation  following  expression  in  E.  coli,  but  also  abolished  catalytic  activity  when  mixed  
with  purified  RNase  H2BC   in  vitro   (Reijns  et  al.  2011).     Deletion  of  the  N-­‐terminal  23  
residues  of  RNase  H2A  also  prevents  trimer  formation  following  expression  of  all  three  
subunits  in  E.  coli  (Figiel  et  al.  2011).    The  requirement  for  a  stable  interaction  between  
all  three  subunits  for  catalytic  activity  is  suggested  in  studies  using  purified  human  and  
S.   cerevisiae   RNase   H2.      In   these   studies   it   was   found   that   all   three   subunits   are  
necessary   for   catalytic   activity   and   that   RNase   H2A   alone   is   insufficient   for   catalysis  
(Jeong  et  al.  2004;  Chon  et  al.  2009;  Figiel  et  al.  2011).  
  
The   discovery   that   RNase   H2B   and   RNase   H2C   form   stable   soluble   dimers   after  
expression  in  E.  coli,  and  that  excess  RNase  H2C  accumulated  in  the  insoluble  fraction  
led  Chon  and  colleagues  to  postulate  that  the  RNase  H2BC  heterodimer  may  serve  as  a  
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nucleation  site   for  trimer  formation  (Chon  et  al.  2009).      Indeed,  structural  studies  of  
RNase   H2   showed   an   important   role   for   RNase   H2C   in   mediating   the   interactions  
between  the  other  two  subunits  via  a  C-­‐terminal  kinked  helix  formed  by  residues  143-­‐
160  which  interact  with  both  RNase  H2A  and  RNase  H2B.    Furthermore,  two  central  b-­‐
strands  in  RNase  H2C  (residues  118-­‐126  and  128-­‐134)  form  part  of  two  b-­‐sheets  found  
within  a  key  central  b-­‐barrel  architecture  that  mediates  interactions  between  all  three  
subunits.    Accordingly,  the  C-­‐terminal  residues  117-­‐164  of  RNase  H2C  are  essential  for  
trimer  formation  and  catalytic  activity  (Reijns  et  al.  2011).    Interactions  between  RNase  
H2A  and  the  RNase  H2BC  heterodimer  appear  to  be  mediated  principally  by  interactions  
between  an  a-­‐helix  and  three  loops  within  RNase  H2A  and  four  regions  within  RNase  
H2C,  suggesting  an  important  role  for  RNase  H2C  in  RNase  H2  complex  stability  (Figiel  
et  al.  2011).  
  
1.5.2    RNase  H2  and  disease  
   RNase  H2  is  presumed  to  be  essential  in  human  cells  expressing  normal  levels  of  
p53  (this  study)  and  loss  of  RNase  H2  is  embryonic  lethal  in  mice  (Hiller  et  al.  2012a;  
Reijns   et   al.   2012).      Hypomorphic   mutations   in   RNase   H2   cause   Aicardi-­‐Goutières  
Syndrome  (AGS),  a  rare  inherited  autoimmune  disease  resulting  in  upregulation  of  type  
1   interferon   signaling   (Reijns  &   Jackson   2014;   Crow  et   al.   2015).      Although  AGS   is   a  
monogenic   disorder,   AGS   patients   have   been   described   with   mutations   in   seven  
different  genes:    RNASEH2A,  RNASEH2B,  RNASEH2C  (Crow,  Leitch,  et  al.  2006),  TREX1  
(Crow,  Hayward,  et  al.  2006),  SAMHD1  (Rice  et  al.  2009),  ADAR1  (Rice  et  al.  2012)  and  
IFIH1  (Rice  et  al.  2014),  all  of  which  are  involved  in  nucleic  acid  metabolism  or  signaling.    
AGS   is   a   phenotypically   variable   disease   with   some   cases   being   diagnosed   several  
months  after  birth  whilst  other  cases  are  evident  at  birth  and  can  result  in  premature  
death  (Rice  et  al.  2007).  
  
Defects   in  AGS-­‐causing  genes  are  thought  to   lead  to  an   intracellular  accumulation  of  
aberrant  nucleic  acid  species.    The  autoimmune  response  seen  in  AGS  is  triggered  by  the  
sensing  of  these  nucleic  acids  by  cyclic  GMP-­‐AMP  synthase  (cGAS)  and  its  adaptor  STING  
which   lead   to   an   upregulation   of   transcription   of   interferon-­‐stimulated   genes  
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(Mackenzie  et  al.  2016).    TREX1  is  a  3’  DNA  exonuclease  that  functions  within  the  host  
immune  response  and  prevents  the  activation  of  cGAS  by  degrading  reverse  transcribed  
DNA  from  endogenous  retroelements  (Li  et  al.  2017).    SAMHD1  is  thought  to  prevent  
activation   of   the   immune   response   by   preventing   the   interaction   of   innate   immune  
sensors  with  intracellular  nucleic  acid  species  (Martinez-­‐Lopez  et  al.  2018).    ADAR1  is  
thought  to  prevent  the  accumulation  of  double  stranded  RNA  (dsRNA)  transcribed  from  
genomic  Alu  repeat  elements  (Rice  et  al.  2012).    Whilst  AGS  is  thought  to  be  caused  by  
loss  of  function  mutations  in  TREX1,  SAMHD1,  ADAR1  and  the  three  RNase  H2  subunits,  
AGS  can  be  caused  by  a  gain  of  function  mutation  in  IFIH1.    IFIH1  is  a  cytosolic  dsRNA  
sensor  and  gain  of  function  mutations  in  this  gene  cause  IFIH1  to  bind  more  avidly  to  
dsRNA  resulting  in  a  robust  upregulation  in  interferon  signaling  (Rice  et  al.  2014).    
  
Mutations  in  subunits  of  RNase  H2  account  for  over  50%  of  reported  cases  of  AGS,  with  
mutations   in   RNase   H2B   accounting   for   68%   of   those   AGS   patients   with   RNase   H2  
mutations  (RNase  H2A:     9%;  RNase  H2B:     68%;  RNase  H2C:     23%)  (Crow  et  al.  2015).    
Several  of   these  mutations  have  been  mapped  to  the  structures  of  human  RNase  H2  
(Figure   1-­‐4   B)   and   are   predicted   to   affect   RNase   H2   activity   in   three   ways:      i)   by  
decreasing  stability  of  the  trimer  due  to  mutations  either  within  the  hydrophobic  core  
or   in   residues   at   the   interface   between   adjacent   subunits;      ii)   by   decreasing   the  
efficiency  of  substrate  hydrolysis  due  to  mutations  within  the  enzyme  active  site;    iii)  by  
decreasing   the  ability  of  RNase  H2   to   interact  with  putative  protein  partners  due   to  
mutations  on  the  surface  of  the  trimer  (Figiel  et  al.  2011;  Reijns  et  al.  2011).  
  
  
1.6    Polymerase  Usage  Sequencing          
   The  assignment  of  Pole   and  Pold   as   the  major   replicative  polymerases  of   the  
leading   and   lagging   strand   respectively  was   carried   out   using  mutant   alleles   of   each  
polymerase  that  introduced  a  biased  mutation  spectrum  in  S.  cerevisiae  (Pursell  et  al.  
2007;  Nick  McElhinny  et  al.  2008).    Further  work  using  an  equivalent  mutator  allele  of  
Pold   found  that  Pold   is  also  responsible   for  the  majority  of  replication  on  the   lagging  
strand   in   S.   pombe;   in   the   same   study   Pole   was   assigned   as   the   leading   strand  
   25  
polymerase   by   using   a   Pole   mutant   allele   that   incorporated   elevated   levels   of  
ribonucleotides  into  DNA  upon  replication  in  the  absence  of  RNase  H2  (Miyabe  et  al.  
2011).      Human   tumour   cells   containing   mutations   in   the   proofreading   exonuclease  
domain  of  Pole  exhibit  a  strand-­‐specific  mutational  bias  (Shinbrot  et  al.  2014)  suggesting  
that  the  role  of  Pole  as  the  major  leading  strand  polymerase  and  the  division  of  labour  
at  the  eukaryotic  replication  fork  are  evolutionarily  conserved.  
  
The  Carr  laboratory  has  developed  a  system  termed  Polymerase  Usage  Sequencing  (Pu-­‐
seq)  to  determine  if  this  division  of  labour  is  true  genome-­‐wide  in  S.  pombe  (Daigaku  et  
al.  2015).    The  Pu-­‐seq  system  uses  strains  of  S.  pombe  containing  mutations  in  either  
Pold   or   Pole   that   incorporate   elevated   levels   of   ribonucleotides   upon   genome  
replication.    In  addition,  the  catalytic  subunit  of  RNase  H2  (RNase  H2A),  encoded  by  the  
gene  rnh201,  is  knocked  out  in  these  strains,  preventing  the  repair  of  misincorporated  
ribonucleotides  by  ribonucleotide  excision  repair  (RER).    In  the  absence  of  RER,  genomic  
ribonucleotides  act  as  a  molecular  footprint  of  the  mutant  polymerases.  
  
The  presence  of  a  ribonucleotide  in  genomic  DNA  renders  the  DNA  duplex  at  that  point  
more  susceptible  to  alkaline  hydrolysis.    By  treating  gDNA  extracted  from  Pu-­‐seq  strains  
of  S.  pombe  with  alkali  and  using  a  deep-­‐sequencing  methodology  on  gDNA  extracted  
from  ~108  cells   to  map  the  5’-­‐end  of  ribo-­‐terminating  fragments  to  genomic  loci,   the  
relative   contributions   of   each   polymerase   to   genome-­‐wide   replication   can   be  
determined  (Figure  1-­‐5A).    The  Pu-­‐seq  method  identifies  the  location  of  origins,  marked  
by   the   point   at   which   synthesis   on   one   strand   switches   from   being   carried   out  
predominantly   by   one   of   the   two   replicative   polymerases   to   being   carried   out  
predominantly   by   the   other   (with   a   concomitant,   but   inverse,   switch   seen   on   the  
opposite  strand)  (Figure  1-­‐5).    Furthermore,  the  Pu-­‐seq  method  offers  a  direct  measure  
of   origin   efficiency,   as  well   as   an   indirect   inferral   of   replication   timing   (Figure   1-­‐5C)  
(Daigaku  et  al.  2015;  Keszthelyi  et  al.   2015).      This   is   in   contrast   to  other  methods  of  
monitoring  genome-­‐wide  replication  dynamics  that  generally  produce  replication  timing  
data   directly,   from   which   origin   efficiency   is   inferred   (occasionally   with   not   much  
accuracy)   (Peace   et   al.   2016;  Marchal   et   al.   2018).      There   exists   therefore   a   certain  
complementarity  between  our  Pu-­‐seq  system  and  other  genome-­‐wide  systems.  











Figure 1-5  The principle of polymerase usage sequencing
A.  Strains of S. pombe containing riboincorporating mutant polymerase delta or polymerase 
epsilon and lacking RNase H2 are allowed to go through replication.  Treatment of genomic DNA 
from these strains is treated with alkali, hydrolysing the DNA backbone at sites of misincorporated 
ribonucleotides (blue dots, Polδ; red dots, Polε).  The fragmented DNA from ~108 cells is pooled 
and the sites of ribonucleotide incorporation determined from deep sequencing.  B.  Smoothed 
data showing the mean proportion of synthesis by Polδ (blue) and Polε (red) on each strand along 
a 200 kb stretch of S. pombe chromosome II.  Origins of replication are marked by the point at 
which synthesis on one strand switches from being carried out by mostly Polδ to mostly Polε (or 
vice-versa) with a concommitant opposing switch seen at the same locus on the oppsite strand.   C.  
Representative data from a Pu-seq experiment.  i) Mean Polε usage on the Watson strand (blue) 
and Polδ on the Crick strand (red).  ii) Differential of the polymerase usage plots in i.  iii) Origin 
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The  Pu-­‐seq  method  therefore  allows  for  in-­‐depth  study  of  replication  dynamics  genome-­‐
wide  in  a  variety  of  genetic  backgrounds.  
  
1.7    Genome  editing  using  CRISPR-­‐Cas9  
1.7.1    A  historical  perspective  of  mammalian  genome  engineering  
An  early  breakthrough  in  the  field  of  genome  editing  was  made  in  the  mid  1980s  
with  the  discovery  that  targeted  gene  disruption  could  be  effected  by  the  homologous  
recombination-­‐mediated   introduction   of   exogenous   DNA   into   mammalian   genomes  
(Smithies  et  al.  1985;  Thomas  et  al.  1986;  Capecchi  1989).    Despite  the  benefits  of  this  
system  it  suffered  from  low  rates  of  integration  and  the  risk  of  random  integration  at  
unintended  sites  elsewhere  in  the  genome  (Adli  2018).  
  
The  discovery  that  the  efficiency  of  integration  of  exogenous  DNA  was  greatly  increased  
by  the  induction  of  a  restriction  endonuclease-­‐induced  double  strand  break  at  the  target  
site  (Rouet  et  al.  1994)  provided  a  new  breakthrough  in  genome  editing.    This  method  
is   however   limited   by   the   paucity   of   rare   enzyme   cutting   sites   within   eukaryotic  
genomes.      The   discovery   that   precise   genomic  DNA  mutagenesis   could   be   achieved  
using  novel  hybrid  restriction  endonucleases  termed  zinc  finger  nucleases  (ZFNs)  helped  
to  overcome  this  problem.    ZFNs  are  engineered  by  fusing  sequence-­‐specific  zinc  finger  
DNA-­‐binding   domains   with   dimerization-­‐dependent,   sequence-­‐independent   FokI  
nuclease  domains  (Kim  et  al.  1996).    DSB  induction  using  ZFNs  requires  the  engineering  
of  two  separate  ZFNs  that  recognize  adjacent  sequences  on  opposite  strands,  separated  
by   a   5-­‐7bp   spacer.      Binding   of   the   two   ZFNs   to   their   cognate   sequences   induces  
dimerization   and   activation   of   the   two   FokI   nuclease   domains   and   subsequent   DSB  
formation  at  the  target  site  (Bibikova  et  al.  2001).  
  
ZFN  technology  was  used  for  several  years  as  the  principal  method  genome  editing  in  
higher  eukaryotes,  however  the  technology  was  not  widely  adopted  due  to  the  inherent  
difficulties   of   designing   zinc   finger   domains   with   a   high   enough   level   of   specificity  
(Doudna   &   Charpentier   2014).      In   2009   a   new   technique   for   genome   editing   was  
discovered   using   transcription   activator-­‐like   (TAL)   effectors   derived   from   plant  
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pathogenic  bacteria.      TALs  bind   to   specific  DNA   sequences  via  a   series  of  around   34  
amino  acid  repeats,  with  each  repeat  forming  specific  interactions  with  single  base  pairs.    
As  with  zinc   finger  domains,   these  proteins  are  fused  with  FokI  nuclease  domains  to  
generate  sequence-­‐specific  nucleases,  termed  TAL  effector  nucleases  (TALENs)  (Boch  et  
al.  2009;  Christian  et  al.  2010).  
  
1.7.2    CRISPR-­‐Cas9  as  a  genome  editing  tool  in  human  cells  
Whilst  TALENs  benefit  from  greater  specificity  in  comparison  to  ZFNs  (Ul  Ain  et  al.  2015)  
they   retain   the  complications  associated  with  ZFNs  of  having   to  engineer  novel  DNA  
binding  subunits  for  each  target.    The  solution  to  this  problem  arrived  with  the  discovery  
of  the  mechanism  of  action  of  the  Clustered  Regularly   Interspaced  Short  Palindromic  
Repeats   (CRISPR)-­‐CRISPR-­‐associated   (CRISPR-­‐Cas)   immune   defence   system   of  
Streptococcus   pyogenes   (Jinek   et   al.   2012)   and   the   subsequent   discovery   that   this  
system  can  be  used  to  induce  targeted  double  strand  breaks  in  human  cells  (Cong  et  al.  
2013;  Jinek  et  al.  2013;  Mali,  Yang,  et  al.  2013).      
  
Prokaryotic  CRISPR   loci   are   composed  of   several  Cas  genes  arranged   in  one  or  more  
operons,   flanked   by   an   array   of   unique   spacer   regions   derived   from   foreign   DNA,  
separated  by  several  identical  repeat  sequences  (Terns  &  Terns  2011;  Wiedenheft  et  al.  
2012).    The  Streptococcus  pyogenes  CRISPR-­‐Cas  system  belongs  to  the  type  II  CRISPR-­‐
Cas  bacterial  adaptive  immunity  system  and  uses  the  Cas9  RNA-­‐guided  endonuclease  
(RGEN)   to   cleave   target   DNA   (Gasiunas   et   al.   2012).      Each   of   the   three   CRISPR-­‐Cas  
systems   (types   I,   II   and   III)   differs   in   their   mechanisms   of   RNA   processing   and  
interference  (Makarova  et  al.  2006;  Bhaya  et  al.  2011)  but  only  the  type  II  system  of  S.  
pyogenes  will  be  described  here.      
During   the   adaptive   phase   of   immunity   acquisition,   20bp   sequences   of   foreign  DNA  
(protospacers)   are   incorporated   into   the   CRISPR   array   between   the   identical   repeat  
sequences.      Protospacer   identification   is   determined   by   the   presence   of   a   sequence  
termed   the   protospacer-­‐adjacent   motif   (PAM)   immediately   3’-­‐wards   of   a   20bp  
sequence,  usually  NGG,  although  NAG  PAMs  can  target  a  sequence  for  cleavage  by  Cas9  
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(Hsu  et  al.  2013;   Jiang  et  al.  2013).  During   the   immune   response  phase,  a  precursor  
CRISPR  RNA  (pre-­‐crRNA)  is  transcribed  from  a  spacer  sequence  complementary  to  the  
target  foreign  DNA,  and  its  adjacent  repeat  sequence.    A  second  RNA  molecule,  termed  
trans-­‐activating   CRISPR   RNA   (tracrRNA),   is   transcribed   and   base   pairs   with   a  
complementary  region  within  the  repeat  sequence  of  the  pre-­‐crRNA.    This  RNA  duplex  
is  processed  by  the  double-­‐stranded  RNA-­‐dependent    RNase  III   in  a  process  requiring  
Cas9  to  yield  a  mature  CRISPR  RNA  (crRNA)  hybridized  to  the  tracrRNA,  the  3’  portion  of  
which  interacts  with  Cas9  (Deltcheva  et  al.  2011)  (Figure  1-­‐6).    The  mature  crRNA  then  
directs  Cas9  to  its  complementary  sequence  within  target  DNA,  whereupon  Cas9  cleaves  
both  strands  of  the  target  DNA,  typically  3  bp  upstream  from  the  PAM  (Ran  et  al.  2015).  
Successful   genome  editing   in   human   cells   can   be   achieved   by   targeting   Cas9  with   a  
chimeric  RNA  formed  by  fusing  the  target  sequence-­‐containing  portion  of  the  crRNA  at  
with  the  dsRNA  scaffold  portion  of  the  tracrRNA  (Jinek  et  al.  2012).    This  chimeric  RNA  
is  termed  a  single  guide  RNA  (sgRNA)  or  more  simply,  guide  RNA  (gRNA).    This  discovery  
carried  great  importance  as  it  allowed  the  DNA  cleavage  mechanisms  of  the  S.  pyogenes  
CRISPR-­‐Cas   system   to   be   reconstituted   in   such   a   way   that   it   required   only   two  
components  to  target  DSBs  at  any  site  within  a  genome  with  an  upstream  NGG  PAM:    a  
Cas9   protein   and   a   single   RNA  molecule,   both   of  which   can   be   encoded  on   a   single  
plasmid  (Jinek  et  al.  2012;  Cong  et  al.  2013).    
Despite   the   advantages   offered   by   the   simplicity   of   programming   unique   gRNAs   for  
target  sequences,  the  system  is  not  entirely  perfect  and  suffers  from  variable  levels  of  
off-­‐target  activity.    Cas9  can  tolerate  several  mismatches  between  gRNA  and  DNA  and  
as   such   is  prone   to   cutting  at  undesired  off-­‐target   locations.     Mismatch   sensitivity   is  
dependent  upon  the  number,  distribution  and  position  of  mismatches,  with  mutations  
in  the  PAM-­‐distal  region  more  tolerated  than  those  in  the  PAM-­‐proximal  region.    The  
first  8-­‐14  nucleotides  at  the  PAM-­‐proximal  end  of  the  gRNA  form  a  key  seed  region  in  
which  mismatches  are  less  tolerated  (Hsu  et  al.  2013).  
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Figure 1-6  The CRISPR-Cas system of S. pyogenes
A 20 base pair section of foreign genomic DNA termed the protospacer is incorporated into the 
CRISPR locus in the S. pyogenes genome.  The protospacer itself is marked by the presence of a 
NGG trinucleotide immediately downstream of the protospacer in the foreign genome.  This NGG 
trinucleotide is termed a protospacer adjacent motif (PAM).  Each 20 base pair protospacer is 
incorporated into the CRISPR array, separated by identical repeat sequences.  Once incorporated, 
the 20 base pair sequence is termed a spacer.  Each unique spacer is co-transcribed with its 
adjacent identical repeat sequence to form a crRNA which forms Watson-Crick base pairs with a 
trans-activating CRISPR RNA (tracrRNA) transcribed from a nearby locus.  Processing by RNase III 
(blue dashed arrow) in a process requiring Cas9 results in the formation of a mature CRISPR RNA 
(crRNA) which directs Cas9 to its target sequence. .
crRNA
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1.7.3    Decreasing  the  off-­‐target  effects  of  Cas9  
Several  methods  have  been  developed   to  help   overcome   the  problems  of   off-­‐target  
cleavage  by  Cas9:      
i)      Cas9   contains   two   nuclease   domains,   an   HNH   domain   which   cleaves   the   strand  
complementary   to   the   gRNA   sequence   and   a   RuvC   domain   which   cleaves   the   non-­‐
complementary  strand  (Anders  et  al.  2014)   (Figure  1-­‐7).     Mutations  which  knock  out  
nuclease  function   in  either  of  these  domains  (D10A   in  RuvC  &  H840A   in  HNH)  create  
Cas9  nickases,  each  capable  of  cleaving  only  one  strand  of  the  target  DNA.    Using  offset  
paired  nCas9  nickases  targeted  to  adjacent  20bp  sequences  on  opposite  strands  by  two  
different  gRNAs,  can  reduce  off-­‐target  cleavage  by  50  to  1,500-­‐fold.    This  strategy  offers  
a  much  higher  level  of  specificity  in  comparison  to  wild  type  Cas9,  since  DSB  formation  
is  dependent  upon  two  single-­‐strand  nicks  being  formed  in  close  proximity  to  each  other  
(F.  Ann  Ran  et  al.  2013;  Mali,  Aach,  et  al.  2013).  
ii)    The  use  of  gRNAs  bearing  2  or  3  nucleotide  5’  truncations  to  target  Cas9  reduces  off  
target   activity   since   these   PAM-­‐distal   terminal   nucleotides   are   thought   to   help  
compensate  for  mismatches  in  the  PAM-­‐proximal  seed  region  (Fu  et  al.  2014).  
iii)      Mutating   both   Cas9   nuclease   domains   (RuvCD10A   and   HNHH840A)   results   in   a  
catalytically   inactive   Cas9   (dCas9)   that   retains   its   ability   to   be   targeted   to   specific  
sequences  by  a  gRNA  (Qi  et  al.  2013).    Fusing  dCas9  to  FokI  endonuclease  (dCas9-­‐FokI)  
has  been  successfully  used  to  make  targeted  DSBs  in  genomic  DNA.    Acting  via  a  similar  
mechanism   to   ZFNs   and   TALENs,   this   system   relies   upon   two   fused   dCas9-­‐FokI  
monomers  being  targeted  to  adjacent  half  sites  whereupon  DSBs  are  induced  following  
dimerization  of  the  two  FokI  subunits.    Whilst  this  system  can  greatly  reduce  off-­‐target  
activity,  it  is  restrained  by  the  requirement  for  half  sites  to  be  situated  either  15  or  25bp  
apart  due  to  the  helical  twist  of  DNA  (Guilinger  et  al.  2014;  Tsai  et  al.  2014).  
iv)      Reduced   off-­‐target   specificity   has   also   been   achieved   through   transfection   of  
ribonucleoprotein  (RNP)  complexes  consisting  of  recombinant  Cas9  protein  and  in  vitro  
transcribed  gRNAs  (Kim,  Kim,  Cho,  Kim  &  J.  Kim  2014).    It  is  thought  that  the  persistence  
of   plasmid  DNA   following   transfection   results   in   excessive   transcription   of   Cas9   and  
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Figure 1-7  S. pyogenes Cas9 structure
A.  Crystal structure of Cas9 in complex with gRNA and PAM-containing target DNA.  Orange:  gRNA; 
light blue:  complementary DNA strand; black:  non-complementary DNA strand; yellow:  PAM 
(PDB:  4UN3).  B.  Domain architecture of Cas9 showing the location of the D10A and H840A 
mutations used to generate Cas9 nickases.
1 718 775 909 1099 136860
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gRNA.    The  resultant  persistence  of  Cas9  and  gRNA  within  the  cell  increases  the  chances  
of   off-­‐target   activity,  whereas   RNPs   are   rapidly   degraded  within   the   cells   (Gaj   et   al.  
2012).    Furthermore,  RNP-­‐mediated  delivery  of  CRISPR-­‐Cas  components  increases  cell  
survival  in  comparison  to  plasmid-­‐mediated  delivery  (Kim,  Kim,  Cho,  Kim  &  J.  Kim  2014),  
since   plasmid   DNA   can   trigger   cyclic   GMP-­‐AMP   synthase   activation   and   subsequent  
activation  of  the  type  I  interferon  pathway  (L.  Sun  et  al.  2013).  
  
1.8    Summary  and  aims  
   The  ability  of  cells  to  respond  in  an  error-­‐free  and  efficient  manner  to  replication  
stress  is  key  to  the  maintenance  of  genetic  stability.    Inaccurate  restart  of  stalled  and  
collapsed  replication  forks  is  a  major  source  of  a  range  of  genetic  aberrations  that  play  
a  part  in  the  progression  of  cancer.    Knowledge  of  how  cells  respond  to  replication  stress  
is  therefore  key  to  our  understanding  of  the  development  of  cancer  and  other  genetic  
diseases.    The  development  of  a  human  Pu-­‐seq  methodology  will  allow  detailed  analysis  
of   DNA   replication   dynamics   in   human   cells   in   response   to   a   variety   of   sources   of  
replication  stress,  such  as  whether  cells  activate  otherwise  dormant  replication  origins  
in  the  vicinity  of  stalled  or  collapsed  replication  forks  in  response  to  induced  replication  
stress.    In  addition,  the  human  Pu-­‐seq  cell  lines  can  be  used  to  knock  out  other  genes  
that  are  thought  to  be  involved  in  programming  replication  timing  and  efficiency  to  see  
whether  the  absence  of  those  genes  alters  the  replication  pattern.  
  
The   requirements   for   human   Pu-­‐seq   cell   lines   are:      i)   establishing   a   method   to  
downregulate   ribonucleotide   excision   repair   by   targeting   one   of   the   subunits   of   the  
heterotrimeric  enzyme  RNase  H2.    ii)  knocking  in  mutations  to  each  of  the  two  major  
replicative   polymerases,   polymerases   d   and   e   such   that   they   incorporate   excess  
ribonucleotides  upon  replication.    iii)    developing  assays  to  assess  RNase  H2  activity  and  
genomic  ribonucleotide  incorporation  by  the  two  replicative  polymerases.  
  
This  thesis  will  describe  progress  made  towards  developing  the  cell  lines  necessary  to  
carry  out  human  Pu-­‐seq.      
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Chapter  2  
Materials  and  methods  
  
2.1    Materials  
   All  solutions  were  made  using  distilled  water  where  appropriate.    Materials  and  
solutions  were  autoclaved  at  125°C  for  15  minutes  when  possible.    Solutions  and  buffers  
were  filter  sterilized  using  a  0.2  µM  filter  (Nalgene)  and  stored  at  room  temperature,  
-4°C  or  -20°C  according  to  requirements.  
  
LB  Broth  (Autoclaved)  
10  g  tryptone  
5  g  yeast  extract  
10  g  NaCl  
Adjusted  to  pH7.5  made  up  to  1  L  with  ddH2O  
  
LB  Agar  (Autoclaved)  
7.5  g  Agar  
Made  to  500  mL  of  prepared  LB  broth  
  
TBE  (5´)  –  for  1  L  of  5´  stock  
54  g  Tris  base  
27.5  g  Boric  acid  
20  mL  0.5M  EDTA  pH8.0  
  
Western  blot  transfer  buffer  (10´)  –  for  1  L  of  10´  stock  
31  g  Tris  base  
144  g  Glycine  
Made  to  1  L  using  ddH2O    
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Western  blot  transfer  buffer  (1´)  
100  mL  10´  transfer  buffer  
100  mL  Methanol  
800  mL  ddH2O  
  
Tris-­‐Glycine  Electrophoresis  buffer  (Western  blot  running  buffer)  
31  g  Tris  base  
144  g  Glycine  
100  mL  10%  SDS  
Made  to  1  L  using  ddH2O  
  
Protein  loading  buffer  (human)  
40%  Glycerol  
240  mM  Tris-­‐HCl  pH6.8  
8%  SDS  
0.04%  Bromophenol  blue  
5%  beta-­‐mercaptoethanol  added  just  prior  to  use  
  
Southern  blot  depurination  buffer  
0.25  M  HCl  
  
Southern  blot  denaturing  buffer  
1.5  M  NaCl  
0.5  M  NaOH  
  
Southern  blot  neutralizing  buffer  
1  M  Tris-­‐HCl  
1.5  M  NaCL  
Made  to  pH7.4  with  NaOH    
  
10´  SSC  
1.5  M  NaCl  
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0.15  M  Sodium  citrate  
  
20%  (w/v)  TCA  
100  g  trichloroacetic  acid  in  500  mL  ddH2O  
  
4´  SDS-­‐PAGE  sample  buffer  (S.  pombe)  
250  mM  Tris-­‐HCl  pH6.8  
8%  SDS  
20%  glycerol  
0.4%  Bromophenol  blue  
10%  beta-­‐mercaptoethanol  
  
1´  SDS-­‐PAGE  sample  buffer  (S.  pombe)  
1  vol  4´  SDS-­‐PAGE  sample  buffer  
1  vol  1M  Tris-­‐HCl  pH8  
2  vol  ddH2O  
2.5%  beta-­‐mercaptoethanol  added  just  prior  to  use  
  
2.2    Cloning  and  molecular  methods  
2.2.1    Polymerase  chain  reaction  
   PCRs   were   carried   out   using   Phusion   High-­‐Fidelity   DNA   Polymerase   (NEB)  
according   to   the   manufacturer’s   guidelines.      Generally,   for   amplification   of   plasmid  
template,   initial  denaturation  was  carried  out  at  98°C  for  30  seconds  followed  by  30  
rounds   of   denaturation   at   98°C   for   5   seconds,   annealing   at   3°C   above   the   melting  
temperature  of   the  primer  with   the   lowest  melting   temperature   for   15   seconds  and  
extension   at   72°C   for   15   seconds/kb.      Generally,   for   amplification   of   genomic   DNA  
template,  initial  denaturation  was  carried  out  at  98°C  for  30  seconds  followed  by  ~30  
rounds   of   denaturation   at   98°C   for   10   seconds,   annealing   at   3°C   above   the  melting  
temperature  of  the  primer  with  the  lowest  melting  temperature  (minimum  60°C)  for  15  
seconds  and  extension  at  72°C  for  30  seconds/kb.      
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2.2.2    Restriction  digests  
   Restriction  digests  were  carried  out  using  enzymes  from  NEB  and  Thermo  Fisher  
Scientific.      Digestion   reaction   were   incubated   at   the   required   temperatures   for   15  
minutes   in   the   case   of   NEB   HF   enzymes   or   1-­‐2   hours   for   other   enzymes.      Digested  
fragments  were  run  on  1%  or  2%  agarose  gels  (%  w/v  in  1´  TBE)  according  to  fragment  
size.      The   desired   fragments   were   then   excised   and   purified   using  Macherey-­‐Nagel  
NucleoSpin  Gel  and  PCR  Clean-­‐up  kit.  
  
2.2.3    Ligation  reactions  
2.2.3.1    Conventional  ligation  reactions  
   Conventional  sticky-­‐end  and  blunt-­‐end  ligation  reactions  were  carried  out  using  
T4  DNA  ligase  (NEB)  or  Quick  Ligation  Kit  (NEB)  according  to  manufacturer’s  instructions.    
Briefly,   reactions   using   T4  DNA   ligase  were   carried   out   at   room   temperature   for   10  
minutes  and  reactions  using  Quick  Ligation  Kit  were  carried  out  at  room  temperature  
for   5  minutes.      Following   ligation,   samples  were   placed   on   ice   for   5  minutes   before  
transformation  into  competent  DH5a  E.  coli  cells.    Amplified  sequences  were  sent  for  
sequencing   to   check   for   the   absence   of   unwanted   mutations   (GATC   and   Source  
Bioscience).  
  
2.2.3.2    Homology-­‐dependent  cloning  
   Homology-­‐dependent  cloning  was  carried  out  using  GeneArt  Seamless  Cloning  
and   Assembly   Kit   (Invitrogen)   according   to   the   manufacturer’s   instructions.      Briefly,  
fragments  were  designed  such  that  adjacent  fragments  contained  15  bp  of  overlapping  
homology.    50  ng  of  cut  vector  was  used  in  a  reaction  with  3-­‐fold  molar  excess  of  insert  
and  incubated  at  room  temperature  for  20  minutes.    Cloning  reactions  were  then  on  ice  
for   5   minutes   before   transformation   into   competent   DH5a   E.   coli   cells.      Amplified  
sequences  were  sent  for  sequencing  as  previously  described.  
  
2.2.3.3    Assembly  of  pX330  plasmids  
   pX330-­‐U6-­‐Chimeric_BB-­‐CBh-­‐hSpCas9  (referred  to  as  pX330  in  this  thesis)  was  a  
gift  from  Feng  Zhang  (Addgene  plasmid  #  42230).    Cloning  of  pX330  plasmids  was  carried  
out  as  per  the  protocol  provided  by  the  Zhang  laboratory  (F  Ann  Ran  et  al.  2013).    Briefly,  
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phosphorylated  and  annealed  oligos  containing  the  desired  gRNA  sequence  were  used  
in  a  dual  restriction  digest-­‐ligation  reaction  with  pX330,  FastDigest  BbsI  (Thermo  Fisher)  
and  T7  DNA  ligase  (NEB)  and  incubated  for  6  cycles  of  37°C  for  5  minutes  and  21°C  for  5  
minutes.      Following   ligation,   samples   were   treated   with   PlasmidSafe   exonuclease  
(Epicentre)  and  transformed  into  competent  DH5a  E.  coli  cells.  
  
Guide   RNA   sequences   were   selected   using   the   online   software   at   CRISPRdirect  
(http://crispr.dbcls.jp)  or  Benchling  (www.benchling.com).  
  
2.2.4    Design  of  gene  targeting  constructs  
   The  gene   targeting  vectors  used   in   this   study  were  a  kind  gift   from  Professor  
Shunichi   Takeda.      Gene   targeting   plasmids  were   designed   such   that   they   contained  
homology  arms  of  between  ~750  and  ~1250  bp   in   length.     For  each  plasmid,  the  left  
homology  arm  was  inserted  at  the  AflII  restriction  site  on  the  parental  plasmid  and  the  
right  homology  arm  was  inserted  at  the  ApaI  restriction  site.  
  
The   ROSA26   knockin   construct   used   in   this   thesis   was   a   kind   gift   from   Dr.   Helfrid  
Hochegger.  
  
2.2.5    cDNA  synthesis  
   cDNA  was  either  synthesized  by  IDT  DNA  or  amplified  by  reverse-­‐transcription  
PCR   from  whole   cell   RNA   extract   using   SuperScript   III  One-­‐Step  RT-­‐PCR   System  with  
Platinum  Tag  High  Fidelity  (Invitrogen)  according  to  manufacturer’s  instructions.    Whole  
cell  RNA  was  extracted  using  RNeasy  Plus  Minikit  (Qiagen)  according  to  manufacturer’s  
instructions.  
  
2.2.6    Site  directed  mutagenesis  
   Site  directed  mutagenesis  was  carried  out  using  a  two-­‐step  fusion  PCR  method.    
Firstly,  two  fragments  were  amplified  using  the  wild-­‐type  template:    one  fragment  was  
amplified  using  a  wild  type  sequence  forward  primer  and  a  reverse  primer  containing  
the  desired  mutation  and  the  other  fragment  was  amplified  using  a  wild  type  sequence  
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reverse   primer   and   a   forward   primer   containing   the   desired  mutation.      The   primers  
containing  the  point  mutations  were  designed  such  that  the  melting  temperature  of  the  
overlapping   sequences   was   the   same   as   the   melting   temperature   of   the   wild   type  
sequence   primers.      The   full-­‐length   mutant   fragment   was   amplified   using   equimolar  
amounts  of  each  of  the  fragments  generated  in  the  first  step  as  template  with  primers  
containing  15  bp  extensions  for  the  subsequent  Seamless  cloning  step.  
  
2.2.7    Bacterial  transformation  
100  µL  of  competent  DH5a  E.  coli  cells  were  transformed  with  1  µL  of  previously  
generated  miniprep  plasmid  or  the  full  volume  of  ligation  reaction.    The  DNA-­‐E.  coli  mix  
was  gently  mixed  by  tapping  and  heat  shocked  at  42°C  for  30  seconds  then  placed  on  
ice  for  2  minutes.     For  plasmids  conferring  resistance  to  ampicillin,   transformed  cells  
were   streaked   immediately   onto   LB   agar   plates   supplemented   with   ampicillin.      For  
plasmids  conferring  resistance  to  kanamycin,  1  mL  LB  broth  was  added  and  the  tube  was  
incubated  at  37°C  in  a  shaking  benchtop  incubator  for  1  hour  before  streaking  onto  LB  
plates  supplemented  with  kanamycin.    LB  plates  were  supplemented  with  ampicillin  or  
kanamycin  to  a  final  concentration  of  100  µg/mL.    
  
2.2.8    Plasmid  purification  
   Plasmid  minipreps  were  purified  from  E.  coli  using  NucleoSpin  Plasmid  Miniprep  
kit  (Macherey-­‐Nagel)  or  QIAprep  Spin  Miniprep  kit  (Qiagen).    Plasmid  midipreps  were  
purified  from  E.  coli  using  NucleoBond  Xtra  Midi  kit  (Macherey-­‐Nagel)  or  Plasmid  Midi  
Kit  (Qiagen).  
  
2.2.9    Human  genomic  DNA  extraction  
   Human  genomic  DNA  was  extracted  from  cells  using  DNeasy  Blood  and  Tissue  
Kit  (Qiagen)  according  to  the  manufacturer’s  instructions.  
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Table 2.1  DNA plasmids used in this study
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Table 2.2  Oligonucleotides used in this study
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2.3    Western  Blotting  
2.3.1    Preparation  of  human  whole  cell  extract  
   Human  cells  were  grown  to  confluency  in  6  well  plates  or  T75  flasks,  trypsinized  
as  required  and  washed  with  PBS.     Samples  were  pelleted  and  resuspended   in  50  µL  
Western  lysis  buffer  (9M  urea,  50  mM  Tris,  pH7.5,  1%  (v/v)  beta-­‐mercaptoethanol  added  
just  prior  to  use)  and  incubated  at  room  temperature  for  15  minutes  then  incubated  on  
ice.    Samples  were  lysed  in  a  Bioruptor  Pico  sonication  device  (Diagenode)  for  6  cycles  
of  30s  on/30s  off  and  spun  at  full  speed  for  10  minutes  at  4°C.    The  supernatant  was  
transferred   to   a   new   tube   and   1  µL   of   supernatant   used   to   assess   protein   yield   by  
Bradford  assay.    Samples  were  mixed  with  an  equal  volume  of  2´  Protein  loading  buffer  
and  incubated  at  98°C  for  2  minutes  just  prior  to  loading.  
  
2.3.2    Preparation  of  S.  pombe  whole  cell  extract  
   5   OD595   of   overnight   culture   was   pelleted   and   resuspended   in   200   µL   20%  
trichloroacetic  acid  (TCA).    Glass  beads  (Sigma)  were  added  up  to  the  level  of  TCA  and  
samples  were  treated  in  a  multi-­‐beads  shocker  (Yasui  Kakui)  for  20  ´  60  seconds  at  2.5  
m/s.    The  bottom  of  the  tube  was  punctured  with  a  hot  needle  and  the  contents  spun  
into  a  fresh  tube.    The  samples  were  then  spun  at  13000  RPM  in  a  microcentrifuge  and  
the   supernatant   removed.      The   extracts   were   resuspended   in   200   µL   1´   SDS-­‐PAGE  
sample   buffer   and   boiled   for   5  minutes.      Samples  were   spun   at   13000   RPM   before  
loading.  
  
2.3.3    Protein  electrophoresis  and  immunoblotting  
   Whole   cell   protein   extracts   were   resolved   by   sodium   dodecyl   sulphate  
polyacrylamide  gel  electrophoresis  (SDS-­‐PAGE).    The  samples  were  resolved  through  a  
5%  acrylamide  stacking  gel  at  80V  for  ~15  minutes  and  separated  on  a  12%  acrylamide  
resolving  gel  at  180V  for  ~30  minutes.    The  stacking  gel  consisted  of  5  %  acrylamide  from  
a  30%  acrylamide  stock  (National  Diagnostics),  0.125M  Tris  pH6.8,  0.1  %  (w/v)  SDS,  0.1%  
(w/v)  ammonium  persulphate  and  0.1  %  (v/v)  N,N,N’,N’-­‐Tetramethylethylenediamine  
(TEMED).    The  resolving  gels  were  made  up  with  12%  acrylamide  from  a  30%  acrylamide  
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stock  (National  Diagnostics),  0.375M  Tris  pH8.8,  0.1%  (w/v)  SDS,  0.1%  (w/v)  ammonium  
persulphate  and  0.04%  (v/v)  TEMED.  
  
Proteins   were   transferred   from   the   gel   to   Hybond   nitrocellulose   membrane   (GE  
Healthcare)  via  wet  transfer  for  90  minutes  on  ice  at  90V  constant  in  1´  transfer  buffer.    
The  membrane  was  blocked  in  5%  milk  PBST  (Marvel  dried  skimmed  milk  in  phosphate  
buffered  saline,  0.1%  Tween  (Sigma)  for  1  hour  at  room  temperature  and  incubated  at  
4°C  overnight  in  5%  milk  PBST  with  an  appropriate  dilution  of  primary  antibody.    The  
membrane  was   then  washed  with   PBST   for   2  ´   5  minutes   and   incubated   for   20-­‐60  
minutes   in  5%  milk  PBST  with  an  appropriate  dilution  of  secondary  antibody.     Excess  
secondary  antibody  was  washed  off  with  PBST  for  2  ´  5  minutes  and  bound  antibody  
was  detected  by  chemiluminescence  using  ECL  Western  Lightning  Plus  (Perkin  Elmer).    
Emission  was  captured  using  autoradiograph  film  and  developed.  
  
Table  2.3    Primary  antibodies  used  in  this  study  
Antibody   Host  species   Supplier   Dilution  
RNase  H2A   Rabbit   Bethyl  A304-­‐149A   1:1000  
RNase  H2A   Rabbit   Bethyl  A304-­‐150A   1:1000  
RNase  H2B   Mouse   Invitrogen  MA5-­‐23523   1:2000  
RNase  H2C   Rabbit   Atlas  HPA065375   1:2000  
FLAG   Mouse   Invitrogen  MA1-­‐91878   1:500  
GFP   Mouse   Roche  11814460001   1:1000  
Tubulin   Mouse   Sigma  T5168   1:25000  
Histone  H2Z   Rabbit   Merck  07-­‐594   1:1000  
  
  
2.4    Human  cell  culture  
2.4.1    Maintenance  of  cell  lines  
   Primary  human  cell  lines  were  cultured  at  37°C  with  5%  CO2  in  Gibco  RPMI-­‐1640  
medium  supplemented  with  15%  foetal  calf  serum  (FCS),  2  mM  L-­‐glutamine,  100  U/mL  
penicillin,  100  µg/mL  streptomycin  and  1  mM  sodium  pyruvate.    TK6  cells  were  cultured  
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at  37°C  with  5%  CO2  in  Gibco  RPMI-­‐1640  medium  supplemented  with  5%  horse  serum,  
2  mM  L-­‐glutamine,  100  U/mL  penicillin,  100  µg/mL  streptomycin  and   1  mM  sodium  
pyruvate.      RPE1   cells   were   cultured   at   37°C   with   5%   CO2   in   DMEM-­‐F12   (Sigma)  
supplemented  with  10%  FCS,  100  U/mL  penicillin  and  100  µg/mL  streptomycin  and  1  
mM  sodium  pyruvate.      
  
HT1080  HP-­‐I-­‐RT  cells  were  cultured  at  37°C  with  5%  CO2  in  Gibco  DMEM  supplemented  
with  10%  FCS,  100  U/mL  penicillin,  100  µg/mL  streptomycin,  2  mM  L-­‐glutamine  and  1  
mM  sodium  pyruvate.    To  avoid  spontaneous  6-­‐TG  resistant  colonies  cells  were  grown  
in  HAT  (5mM  Sodium  Hypoxanthine,  20μM  Aminopterin,  0.8mM  Thymidine,  Invitrogen).    
Following  I-­‐SceI  or  Cas9-­‐mediated  knockout  of  HPRT,  HT1010  HP-­‐I-­‐RT  cells  were  grown  
in   Gibco   DMEM   supplemented   with   10%   FCS,   100   U/mL   penicillin,   100   µg/mL  
streptomycin,   2   mM   L-­‐glutamine,   1   mM   sodium   pyruvate   and   HT   (5mM   Sodium  
Hypoxanthine,  0.8mM  Thymidine,  Invitrogen).  
  
2.4.2    Plasmid  Transfection  
2.4.2.1    Lipofectamine  2000     
HT1080  cells  were  seeded  24  hours  prior  to  transfection  in  24  well  plates  and  
grown  to  ~80%  confluency.    100  μL  serum-­‐free  medium  was  mixed  with  the  appropriate  
volume  of  Lipofectamine  2000  solution  and  incubated  with  1  μg  plasmid  DNA  made  up  
to  100μl  with  serum-­‐free  medium  at  room  temperature  for  5  minutes.    200μl  of  solution  
was   added   to   each   well   and   samples   incubated   for   24   hours   prior   to   checking   for  
expression  of  GFP  or  expanded  into  a  larger  volume  after  48  hours  for  6-­‐TG  assays.  
  
2.4.2.2    FuGENE  HD  
HT1080  cells  were  seeded  24  hours  prior  to  transfection  in  24  well  plates  and  
grown  to  ~80%  confluency.    Varying  quantities  of  FuGENE  HD  reagent  were  added  to  2  
μg  plasmid  DNA  made  up   to  50  μL  with   culture  medium  to  give  the  desired   ratio  of  
FuGENE  HD  (μL):DNA  (μg).    Each  solution  was  added  immediately  to  cells  and  samples  
were  incubated  for  24  hours  prior  to  checking  for  expression  of  GFP  or  expanded  into  a  
larger  volume  after  48  hours  for  6-­‐TG  assays.  
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2.4.2.3    Xfect  
HT1080  cells  were  seeded  24  hours  prior  to  transfection  in  24  well  plates  and  
grown  to  ~60%  confluency.    The  appropriate  mass  of  plasmid  DNA  was  suspended  in  50  
μL  Xfect  buffer  to  which  was  added  0.3  μL  Xfect  polymer/μg  DNA.     The  solution  was  
added   to   cells   following  10  minutes   incubation  at   room  temperature.     4  hours  post-­‐
transfection   cells   were   washed   with   PBS   and   culture   medium   replaced   with   fresh  
medium.    Samples  were  checked  for  expression  of  GFP  24  hours  after  transfection  or  
expanded  into  a  larger  volume  after  48  hours  for  6-­‐TG  assays.  
  
2.4.2.4    Amaxa  nucleofection  
HT1080  cells  were  passaged  48  hours  prior  to  transfection.    Prior  to  transfection,  
cells  were  trypsinized,  washed  with  PBS  and  106  cells  suspended  in  100  μL  Nucleofector  
Solution  T  with  2  μg  DNA.      Samples  were   transferred   to  a   cuvette  and   treated  with  
Nucleofector   program   L-­‐005.      Immediately   after   transfection,   500   μL   pre-­‐warmed  
culture  medium  was  added  to  the  cuvette  and  samples  transferred  to  6  well  plates.    24  
hours  after  transfection,  samples  were  checked  for  expression  of  GFP  or  expanded  into  
a  larger  volume  after  48  hours  for  6-­‐TG  assays.    For  knockin  and  knockout  experiments,  
samples  were   cultured   for   48   hours   after   transfection   then   transferred   into   96  well  
plates   in   selective   media   with   the   appropriate   antibiotic(s)   to   isolate   successfully  
targeted  clones.    
  
2.4.2.5    Neon  electroporation  
To  transfect  TK6  cells,  106  cells  and  1  µg  DNA  were  suspended  in  10  µL  solution  
R  and  electroporated  using  the  10  µL  Neon  tip  and  the  following  settings:    1350  V,  10  
ms,  ´3  pulse.    Following  transfection,  cells  were  cultured  in  2  mL  10%  horse  serum  for  
48  hours  before  transferring  into  96  well  plates  in  selective  media  supplemented  with  
the  appropriate  antibiotic(s)  to  isolate  successfully  targeted  clones.  
To   transfect   RPE1   cells,   106   cells   and   1.5   µg   DNA   were   suspended   in   30   µL  
solution  R  and  electroporated  three  times  using  the  10  µL  Neon  tip  and  the  following  
settings:    1350  V,  20  ms,  ´2  pulse.    Following  transfection,  cells  were  transferred  into  2  
mL  culture  medium  and  cultured  for  48  hours  before  transferring  into  96  well  plates  in  
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selective  media  supplemented  with  the  appropriate  antibiotic(s)  to  isolate  successfully  
targeted  clones.  
  
2.4.3    HT1080  6-­‐TG  resistance  colony  formation  assay  
   48  hours  after  transfection  with  plasmids  encoding  either  I-­‐SceI  or  Cas9  and  a  
gRNA  targeting  the  HPRT  gene,  the  appropriate  number  of  cells  was  transferred  to  a  10  
cm2   dish   in   10   mL   growth   medium.      5   days   after   seeding   the   growth   medium   was  
replaced  with  medium  containing  6-­‐thioguanine   (6-­‐TG)  at  a   final  concentration  of  15  
µg/mL.    After  10  days  growth  in  6-­‐TG,  plates  were  stained  with  methylene  blue  (0.4%  
w/v  in  50%  methanol)  and  6-­‐TG-­‐resistant  colonies  counted.  All  plasmids  used  for  this  
assay  were  a  kind  gift  from  Dr.  Andy  Porter.    
2.5    S.  pombe  methods  
2.5.1    S.  pombe  growth  media  
  
Yeast  Extract  (YE)  media  
5  g/L  yeast  extract  
30  g/L  glucose  
Supplemented  as  necessary  with:  
0.2  g/L  Adenine  
0.1  g/L  each  of  leucine,  uracil,  histidine  and  arginine.  
  
YE  Agar  (YEA)  plates  
As  for  YE  media  plus:  
12.5  g/L  agar  
  
Extremely  Low  Nitrogen  (ELN)  plates  
27.3  g/L  Formedium  EMM  broth  (w/o  nitrogen)  
0.05  g/L  Ammonium  chloride  
0.2  g/L  Adenine  
0.1  g/L  each  of  leucine,  uracil,  histidine  and  arginine  
25  g/L  Agar  
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2.5.2    Lithium  acetate  S.  pombe  transformation  
   108  cells  from  an  overnight  culture  grown  in  YE  were  pelleted  and  washed  once  
with  ddH2O  and  once  with  1  mL  LiAc-­‐TE  (0.1  M  LiAc,  10  mM  Tris-­‐HCl,  1  mM  EDTA,  pH7.5).    
Cells  were  then  resuspended  in  100  µL  LiAc-­‐TE  to  which  was  added  2  µl  of  salmon  sperm  
DNA   (Invitrogen)   and   10   µg   of   PCR   product.      This   mixture   was   incubated   at   room  
temperature  for  10  minutes  after  which  260  µL  of  40%  PEG-­‐4000/LiAc-­‐TE  was  added.    
The  cell  suspension  was  then   incubated  at  30°C   for  ~45  minutes.     43  µL  of  dimethyl  
sulfoxide  (DMSO)  was  added  and  the  cells  heat  shocked  at  42°C  for  5  minutes.    Cells  
were  then  pelleted  by  centrifugation  and  the  pellet  washed  with  1  mL  of  ddH2O  and  
resuspended  in  200  µL  ddH2O.     Samples  were  then  plated  onto  plates  containing  the  
relevant  supplements.  
  
2.5.3    Genomic  DNA  extraction  from  S.  pombe    
   Cells  were  grown  overnight  in  YE  and  5  OD595  cells  were  spun  down.    The  pellet  
was  resuspended  in  1mg/ml  zymolyase  in  CSE  and  incubated  at  37°C  for  30  minutes.    
The  cells  were  pelleted  again  and  resuspended  in  450  µL  5´  TE  to  which  was  added  50  
µL  10%  SDS,  then  incubated  for  5  minutes  at  room  temperature.    150  µL  of  5  M  KAc  was  
added  and  the  sample  was  incubated  on  ice  for  10  minutes.    The  lysed  cells  were  spun  
at  13000  RPM  for  10  minutes  and  the  supernatant  transferred  to  a  fresh  tube.    1  volume  
of  isopropanol  was  added  and  the  sample  was  spun  at  13000  RPM  at  4°C  for  10  minutes.    
The   supernatant  was   removed  and   the  pellet  washed  with  500  µL  ethanol  and   spun  
again  for  5  minutes.    The  supernatant  was  removed  and  the  pellet  resuspended  in  200  
µL  ddH2O  and  5  µL  RNase  A.  
  
2.5.4    Genetic  cross  and  random  spore  analysis  
   h+  and  h-­‐  S.  pombe  were  mixed  in  5  µL  ddH2O  and  plated  onto  an  ELN  plate.    The  
cells  were  incubated  for  2  days  at  25°C  and  crossing  efficiency  verified  by  microscopy.  A  
loopful  of  the  crossed  cells  was  suspended  in  1  mL  ddH2O  and  2  µL  of  b-­‐galactosidase  
from  Helix  pomentia.    The  spores  were  incubated  overnight  on  a  rotating  wheel  at  room  
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temperature.      The   following  day,  ~1000  spores  were  plated  onto  YEA  and  the  plates  
incubated  at  30°C  for  5  days.  
  
2.5.5    S.  pombe  RNase  H2  activity  assay  
   To  test  the  integrity  and  to  estimate  the  yield  of  extracted  gDNA,  1  µL  of  DNA  
was  mixed  with  9  µL  H2O  and  2  µL  DNA  loading  dye.    6  µL  of  this  mixture  was  run  on  a  
1%   agarose   gel   alongside   6   µL   DNA   ladder.      DNA   concentration   was   calculated   by  
comparing  the  signal  intensity  of  each  gDNA  sample  with  a  band  of  known  concentration  
in   the  DNA   ladder   using   ImageJ.      To  assess   the  extent  of   ribonucleotide  presence   in  
extracted  gDNA,  equal  concentrations  of  untreated  gDNA  from  different  strains  were  
run  on  a  1%  agarose  gel  alongside  3-­‐fold  greater  quantities  of  gDNA  treated  with  0.3  M  
KOH  at  55°C   for  1  hour.      RNase  H2  activity  was   inferred   from   the  extent  of  alkaline  
hydrolysis.  
  
2.6    A.  thaliana  tRNA  ligase  (AtRNL)  reactions  
2.6.1    AtRNL  activity  assay  
   Substrates   were   prepared   by   treating   a   ribonucleotide-­‐containing   70mer  
oligonucleotide   or   a  DNA-­‐only   70mer   oligonucleotide  with   0.3  M  KOH   at   55°C   for   2  
hours.    10  µL  reactions  were  set  up  containing  10  pmol  of  alkali-­‐treated  substrate  and  
50  pmol  of  internally  biotinylated  oligo  (5’-­‐rAppCTGTAGGCACCA-­‐iBiodT-­‐CAATddC-­‐3’  or  
5’-­‐rAppCAGCAT-­‐iBiodT-­‐AddC-­‐3’),  1´  tRNA  ligase  buffer  (10  mM  Tris–HCl  pH7.5,  100  mM  
KOAc,   0.3   mM   spermine,   6   mM   Mg(OAc)2,   0.5   mM   DTT,   0.5%   Triton   X-­‐100),   14%  
polyethylene   glycol,   and  A.   thaliana  tRNA   ligase   (1   or   2   μL)   and   incubated   at   room  
temperature  for  30  minutes  or  2  hours.    1  µL  of  reaction  mixture  was  diluted  in  4  µL  
ddH2O  and  combined  with  5  µL  2´   loading  buffer   (90%  formamide,  0.5%  EDTA,  0.1%  
xylene  cyanol,  0.1%  bromophenol  blue)  and  run  on  a  10  mL  15%  denaturing  acrylamide  
gel  at  170V  for  20  minutes  and  250V  until  the  dye  front  neared  the  bottom  of  the  gel.  
  
10  mL  15%  denaturing  acrylamide  gel  
4.8  g  urea  
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3.75  mL  40%  acrylamide  
100  μL  10%  APS  
2  mL  5´  TBE  
4  μL  TEMED  
Make  up  to  10  mL  with  ddH2O  
  
2.6.2    S.  pombe  AtRNL  ribonucleotide  incorporation  assay  
   ³  3  μg  S.  pombe  gDNA  was  treated  in  16.67  μL  0.3  M  NaOH  at  55°C  for  2  hours,  
then  neutralized  with  5  μL  1  M  HCl  and  1  μL  Tris  base  (2  M,  pH7).    500  ng  alkali-­‐treated  
gDNA   was   used   in   a   ligation   reaction   with   50   pmol   of   internally   biotinylated  
oligonucleotide,  1´  tRNA  ligase  buffer  (10  mM  Tris–HCl  pH7.5,  100  mM  KOAc,  0.3  mM  
spermine,  6  mM  Mg(OAc)2,  0.5  mM  DTT,  0.5%  Triton  X-­‐100),  14%  polyethylene  glycol,  
and   2   μL  A.   thaliana  tRNA   ligase   and   incubated   at   room   temperature   for   2   hours.    
Reaction  mixtures  were  cleaned  up  using  Nucleospin  Gel  and  PCR  Clean-­‐up  columns  
(Macherey-­‐Nagel)  or  Illustra  G-­‐50  columns  (GE  healthcare).    Samples  were  resolved  on  
a  400  mL  1%  Mega  Base  Rapid  Agarose  (Cambridge  reagents)  gel  at  90V  overnight.    After  
running,  the  gel  was  washed  in  Southern  blot  depurination  buffer  for  10  minutes  then  
washed  in  Southern  blot  denaturing  buffer  for  45  minutes  and  finally  washed  twice  in  
Southern  blot  neutralisation  buffer  for  30  minutes  then  15  minutes.      
  
DNA   was   transferred   onto   Genescreen   nylon   membrane   (Perkin   Elmer)   by   capillary  
transfer  overnight  using  10´  SSC.    The  membrane  was  allowed  to  dry  and  the  DNA  was  
crosslinked  to  the  membrane  using  a  Stratalink  UV  crosslinker  at  1200  ´  100µJ/cm2.    The  
membrane  was  then  washed  for  2  ´  5  minutes  in  blocking  buffer  (0.5%  SDS,  0.2%  (w/v)  
I-­‐Block  reagent  (Tropix)  in  1´  PBS)  then  incubated  for  10  minutes  in  blocking  buffer.    The  
membrane  was  then  incubated  in  streptavidin-­‐alkaline  phosphatase,  diluted  1:20000  in  
blocking  buffer   for  20  minutes  with  shaking.     The  membrane  was  then  washed  for  5  
minutes  in  blocking  buffer  then  6  ´  15  minutes  in  wash  buffer  (0.5%  SDS  in  1´  PBS).    The  
membrane  was  next  washed  for  2  ´  2  minutes  in  1´  assay  buffer  (dilute  10´  assay  buffer  
1:10  in  ddH2O;  10x  assay  buffer  (200  mM  Tris-­‐HCl  pH9.8,  10  mM  MgCl2)).    Samples  were  
   50  
visualized   using   CDP-­‐Star   chemiluminescent   substrate   (GE   Healthcare)   in   an  
ImageQuant  LAS  4000  imager  (GE  Healthcare).  
  
2.7    RNase  H2  activity  assays  
2.7.1    Whole  cell  extract  preparation  
   ~6   ´   106   cells   were   pelleted   and   washed   once   with   PBS.      Pellets   were  
resuspended  in  50  µL  lysis  buffer  (50  mM  Tris  pH8,  280  mM  NaCl,  0.5%  NP-­‐40,  0.2  mM  
EDTA,   0.2   mM   EGTA,   10%   glycerol   (v/v),   1   mM   DTT,   1´   Roche   Complete   Protease  
Inhibitor  Tablet)  and  incubated  on  ice  for  10  minutes.    An  equal  volume  of  cytoplasmic  
buffer  (20  mM  HEPES  pH7.9,  10  mM  KCl,  1mM  EDTA,  10%  glycerol  (v/v)  1  mM  DTT,  1´  
Roche  Complete  Protease  Inhibitor  Tablet)  was  added,  incubated  on  ice  for  10  minutes  
and  extracts  were  cleared  by  centrifugation  for  5  minutes  at  13000  RPM  at  4°C.    Final  
protein  concentration  was  determined  by  Bradford  assay.  
  
2.7.2    Fluorometric  substrate  preparation  
   10  µM  of  3’-­‐fluorescein  labelled  oligonucleotides  (GATCTGAGCCTGGG(rA)GCT-­‐
3'fluorescein  for  RNase  H2-­‐specific  activity  or  GATCTGAGCCTGGGAGCT-­‐3'fluorescein  for  
non-­‐RNase  H2-­‐mediated  activity;  IDT  DNA)  were  annealed  to  10  µM  of  complementary  
5’-­‐dabcyl  labelled  oligonucleotides  (5'Dabcyl-­‐AGCTCCCAGGCTCAGATC;  IDT  DNA)  in  60  
mM  KCl,  50  mM  Tris-­‐HCl  pH8  by  denaturing  at  95°C  followed  by  gradual  cooling  to  room  
temperature.  
  
2.7.3    RNase  H2  fluorometric  assays  
   100  µL  reactions  were  set  up  using  the  desired  mass  of  whole  cell  protein  extract  
with  250  nM  substrate  in  60  mM  KCl,  50  mM  Tris-­‐HCl  pH8,  10  mM  MgCl2,  0.01%  bovine  
serum  albumin,  0.01%  Triton  X-­‐100.    Reactions  were  carried  out  in  black,  flat  bottomed  
96-­‐well   plates   (Nunc).      For   end-­‐point   assays,   reactions   were   carried   out   at   room  
temperature  for  90  minutes  and  quenched  with  a  final  concentration  of  20  mM  EDTA.    
For  time  course  assays,  reactions  were  carried  out  at  room  temperate  with  fluorescence  
readings   taken   at   10-­‐minute   intervals.      Fluorescence   intensity   was   read   using   a  
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CLARIOstar   plate   reader   (BMG   labtech)   using   a  480   nm  excitation   filter   and   535   nm  
emission  filter.  
  
2.8    Alkaline  comet  assay  
   Frosted  slides  (Fisher)  were  pre-­‐coated  with  0.6%  agarose  (w/v  in  1´  PBS).    Cells  
were  suspended  in  pre-­‐chilled  PBS  and  mixed  with  an  equal  volume  (150  µL)  of  1.2%  
Low  Melting   Point   agarose   (Sigma)   that   had   been   pre-­‐incubated   at   42°C.      The   cell  
suspension  (~3  ´  105  cells/mL)  was  dispersed  onto  the  pre-­‐coated  slides  and  maintained  
at  4°C  in  the  dark  until  set.    All  subsequent  steps  were  carried  out  in  the  dark.    After  
gelling,  slides  were  immersed  in  lysis  buffer  (2.5  M  NaCl,  10  mM  Tris-­‐HCl,  100  mM  EDTA  
pH  8.0,  1%  Triton  X-­‐100,  1  %  DMSO;  pH  10)  for  1  hour  then  washed  for  2  ´  10  minutes  
with  pre-­‐chilled  ddH2O.    Slides  were  then  incubated  in  alkaline  electrophoresis  buffer  
(50  mM  NaOH,  1  mM  EDTA,  1  %  DMSO)  for  45  minutes.    Electrophoresis  was  carried  out  
at  12V  for  25  minutes  followed  by  neutralization  with  0.4M  Tris  pH7  for  1  hour.    DNA  
was  stained  with  SYBR  Green  (1:10000  dilution)  and  mean  comet  tail  length  of  50  cells  
scored  using  Comet  Assay  IV  software  (Perceptive  Instruments).  
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Chapter  3  
Establishing  a  method  to  knock  out  
RNASEH2A  using  CRISPR-­‐Cas9  
  
3.1    Introduction  
Previous  work  in  the  Carr  laboratory  has  established  a  system  called  Polymerase  
Usage  Sequencing  (PU-­‐Seq)  to  monitor  genome-­‐wide  replicative  polymerase  usage  in  S.  
pombe   (Daigaku  et  al.  2015).     This  system  requires  two  different  strains  of  S.  pombe  
containing  mutations   in  either  of  the  two  major   replicative  polymerases,  polymerase  
delta  (Pol  d)  or  polymerase  epsilon  (Pol  e),  that  result  in  higher  then  wild  type  levels  of  
ribonucleotide  (rNTP)   incorporation  during  DNA  replication.      In  each  of  these  strains,  
RNase  H2A,  the  catalytic  subunit  of  RNase  H2,  the  enzyme  responsible  for  the  removal  
of  the  majority  of  misincorporated   rNTPs,   is  knocked  out.     As  a  result,   rNTPs   remain  
embedded  within  the  genome  and  serve  as  a  molecular  footprint  of  the  mutant  DNA  
polymerases.    In  S.  pombe,  RNase  H2A  is  encoded  by  the  gene  rnh201.      
  
The  overall  aim  of  this  project  is  to  set  up  a  system  to  monitor  replicative  polymerase  
genome-­‐wide  in  human  cells.    To  set  up  this  system  in  human  cells,  two  criteria  must  
therefore  be  met:    1)  to  establish  mutations  in  both  Pol  d  and  Pol  e  that  will  result  in  
higher  than  wild  type  levels  of  rNTP  incorporation  in  either  the  lagging  strand  or  leading  
strand  respectively  and  2)  to  prevent  the  removal  of  misincorporated  rNTPs  by  RNase  
H2.    In  the  first  instance  it  was  decided  to  attempt  to  knock  out  RNase  H2A  in  human  
cells  using  CRISPR-­‐Cas9.  
  
As   described   in   section   1.7.2   CRISPR-­‐Cas   systems   provide   bacteria   and   archaea  with  
adaptive   immunity   against   foreign   DNA.      The   system   relies   upon   the   endonuclease  
activity  of  a  CRISPR-­‐associated  (Cas)  protein  which  is  targeted  to  viral  and  plasmid  DNA  
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by  an  antisense  RNA  molecule  (Jinek  et  al.  2012).    This  system  was  recently  repurposed  
to  allow  for  precise  genome  editing  in  human  cells  via  the  induction  of  Streptococcus  
pyogenes  Cas9-­‐mediated  double  strand  breaks  (DSBs)  (Mali,  Yang,  et  al.  2013;  Cong  et  
al.  2013).  
  
Due  to  the  recent  discovery  of  CRISPR-­‐Cas9  for  genome  editing,  the  aim  of  this  chapter  
was  therefore  to  set  up  a  working  protocol  for  gene  knockout  using  CRISPR-­‐Cas9  and  to  
use  this  protocol  to  attempt  to  regulate  RNase  H2  by  knocking  out  RNase  H2A  in  human  
cells.  
  
3.2    Transfection  optimization  in  HT1080  cells  
3.2.1    DNA  Transfection  
     Genome   editing   depends   upon   efficient   transfection   of   the   required  
components  into  cells.    If  the  transfection  method  used  is  inefficient  less  DNA  enters  the  
cells  and  as  such  fewer  cells  express  the  genome  editing  machinery.    As  such,  to  prevent  
the  delivery  of  plasmid  DNA  into  cells  being  a  major  limiting  factor  in  gene  editing  it  is  
important   to   optimize   transfection   for   each   cell   line   to   achieve   the   best   possible  
transfection   efficiency.      For   transfection   optimization   we   used   the   HT1080   cell   line  
which  is  a  human  fibrosarcoma  cell  line  derived  from  a  male  patient.    HT1080  cells  have  
the  benefit  of  a  relatively  stable  karyotype  with  a  modal  chromosome  number  of  46  
(range  44-­‐48).    In  addition,  the  presence  of  one  single  X  chromosome  allows  for  accurate  
gene   targeting   optimization   using   a   reporter   gene   located   on   the   X   chromosome  
(described  in  further  detail   in  section  3.3.1).     All  of  the  HT1080  cells  described  in  this  
project  were  a  kind  gift  from  Dr.  Andy  Porter.      
  
To  establish  the  most  effective  means  of  delivering  DNA  into  HT1080  cells,  four  plasmid-­‐
based  transfection  methods  were  chosen:  1)  FuGENE  HD  (Promega),  2)  Xfect  (Clontech),  
3)  Amaxa  Nucleofection  (Lonza)  and  4)  Lipofectamine  2000  (Invitrogen).    These  reagents  
were   chosen   to   provide   four   different   methods   of   delivering   DNA   into   cells:      non-­‐
liposomal,  polymer-­‐based,  electroporation  and  lipid-­‐based  respectively.  
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To  assess   transfection  efficiency  using   the  different   transfection   reagents,   cells  were  
transfected  with  a  plasmid  expressing  human  codon  optimized  eGFP  using  a  range  of  
conditions  as  suggested  by  the  manufacturers  and  transfection  efficiency  was  scored  as  
a  percentage  of  cells  expressing  GFP:total  number  of  cells  in  field  of  view,  with  at  least  
60   cells   scored   per   experiment   (Figure   3-­‐1).      Data   shown   are   from   one   single  
experimental  repeat.  
  
For  transfection  with  FuGENE  HD  ~5  ´  105  HT1080  cells  were  transfected  with  2  µg  DNA  
with  differing  ratios  of  transfection  reagent  volume  (1.5  µl  reagent/1  µg  DNA;  2  µl/µg;    
2.5   µl/µg;   3   µl/µg;   3.5   µl/µg   or   4   µl/µg).      Transfection   with   FuGENE   HD   led   to  
transfection  efficiencies  of  0%  (1.5  µl  reagent/1  µg  DNA);  1%  (2  µl/µg);  5%  (2.5  µl/µg);  
0%  (3  µl/µg);  46%  (3.5  µl/µg)  and  76%  (4  µl/µg)  (Figure  3-­‐1  A).  
  
For  transfection  with  Xfect  ~5  ´  105  HT1080  cells  were  transfected  with  1  µg,  1.5  µg,  2  
µg  or  2.5  µg  DNA  with  Xfect  reagent  added  at  a  ratio  of  0.3  µl   reagent  per  µg  DNA.    
Transfection  with  Xfect  led  to  transfection  efficiencies  of  55%  (1  µg  DNA);  93%  (1.5  µg  
DNA);  95%  (2  µg  DNA)  and  98%  (2.5  µg  DNA)  (Figure  3-­‐1  B).      
  
For  transfection  with  Amaxa  nucleofection,  106  HT1080  cells  were  transfected  with  2  µg  
DNA  using  Kit  T  and  program  L-­‐005.     Transfection  with  Amaxa  nucleofection   led  to  a  
transfection  efficiency  of  80%  (Figure  3-­‐1  C).  
  
For  transfection  with  Lipofectamine  2000  ~5  ´  105  HT1080  cells  were  transfected  with  
1  µg  DNA  with  differing  ratios  of  transfection  reagent  volume  (1  µl  reagent/1  µg,DNA;  
2.5  µl/µg;    5  µl/µg;  7.5  µl/µg  or  10  µl/µg).    Transfection  with  Lipofectamine  2000  led  to  
transfection  efficiencies  of  15%  (1  µl  reagent/1  µg,DNA);  86%  (2.5  µl/µg);  65%  (5  µl/µg;  
42%  (7.5  µl/µg)  and  37%  (10  µl/µg).    Lipofectamine  2000-­‐mediated  transfection  using  
7.5  µl  reagent/µg  DNA  and  10  µl  reagent/µg  DNA  caused  cell  sickness  as  inferred  from  
cell  morphology   so   even   if   transfection   efficiency   had   been   higher   using   these   two  
conditions,  they  would  not  have  been  suitable  conditions  for  further  transfections.  
  




Figure 3-1  Transfection optimisation in HT1080 cells using a plasmid expressing 
eGFP and GFP protein
A-D.  Transfection eﬃciency deﬁned as a percentage of GFP-positive cells 24 hours 
after transfection with a plasmid expressing eGFP using a variety of commerically 
available transfection reagents and a range of reaction conditions as noted:  FuGENE 
HD (A), Xfect (B), Amaxa Nucleuofection (C) and Lipfectamine 2000 (D).  Images to 
the right of each chart show GFP-positive cells following transfection with optimal 
conditions for each reagent.  E.  Attempts to transfect cells with GFP protein yielded 
no GFP-positive cells using either Amaxa Nucleofection or Xfect and caused 
substantial cell death in the case of Amaxa nucleofection.
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Optimal  transfection  efficiency  (98%)  was  obtained  by  transfecting  cells  with  Xfect  using  
2.5  µg  of  plasmid  DNA  (Figure  3-­‐1B,  right  panel).    Despite  Amaxa  nucleofection  giving  a  
lower  transfection  efficiency  (80%)  than  Xfect  or  Lipofectamine  2000  (2.5µg  DNA:    86%;  
Figure   3-­‐1D)   experiments   using   HT1080   cells   described   in   chapters   4   and   6   were  
transfected  using  Amaxa  nucleofection  since  this  system  does  not  require  cells   to  be  
seeded  the  day  before  transfection,  reducing  experimental  workflow  by  1  day.  
  
3.2.2    Protein  Transfection     
There   is   evidence   that   gene   targeting   achieved   by   transfection   of   a  
ribonucleoprotein  (RNP)  complex  consisting  of  Cas9  protein  and  an  in-­‐vitro  transcribed  
guide   RNA   is   both   efficient   and   accurate   (Kim,   Kim,   Cho,   Kim   &   J.-­‐S.   Kim   2014).    
Furthermore,  RNP-­‐mediated  genome  editing  offers   several  advantages  over  plasmid-­‐
based  delivery  of  CRISPR-­‐Cas9:  1)  Plasmid  DNA  transfected  into  cells  can  be  randomly  
incorporated  into  the  genome,  or  at  on-­‐target  or  off-­‐target  sites  of  Cas9-­‐induced  DSBs,  
allowing  stable  and  persistent  expression  of  Cas9  and/or  gRNA.    2)  Transfected  DNA  can  
trigger  immune  responses  within  cells  and  can  cause  stress  to  cells  via  activation  of  cyclic  
GMP-­‐AMP   synthases.      3)   Plasmid  DNA   can   persist  within   cells   for   several   days   after  
transfection,   increasing   the   chances   of   off-­‐target   activity   by   Cas9.      In   contrast,   both  
elements  of  the  Cas9-­‐gRNA  RNP  are  degraded  rapidly  within  cells,  allowing  only  a  small  
window  for  genome  editing,  reducing  the  chances  of  off-­‐target  effects  (Kim,  Kim,  Cho,  
Kim  &  J.-­‐S.  Kim  2014).      
  
In  the  event  that  we  would  try  RNP-­‐mediated  genome  editing,  attempts  were  made  to  
optimise  protein  transfection  using  recombinant  GFP  protein.    For  these  experiments,  
transfection  was  attempted  using  Amaxa  nucleofection   (Lonza)  and  Xfect   (Clontech).    
For  transfection  with  Amaxa  nucleofection  (Figure  3-­‐1E;   left  panel),  106  HT1080  cells  
were  transfected  with  10  µg  GFP  using  programme  L-­‐005  and  Kit  T.    For  transfection  
with  Xfect  (Figure  3-­‐1E;  right  panel),  ~106  HT1080  cells  were  transfected  with  2  µg  GFP.    
For   both   methods   no   intracellular   GFP   could   be   seen   24   hours   after   transfection.    
Furthermore,   nucleofection   proved   particularly   toxic   to   cells.      These   results   suggest  
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either  it  is  not  possible  to  transfect  HT1080  with  GFP,  or  that  some  component  of  the  
storage  buffer  or  GFP  itself  is  toxic  to  cells.  
  
3.3    Using  a  reporter  assay  to  test  efficiency  of  gene  targeting  
3.3.1     The  human  HPRT  gene  functions  as  a  reporter  gene  to  assess  gene  targeting  
efficiency  
Whilst  transfection  efficiency  can  be  inferred  by  GFP  plasmid  transfection,  this  
method  suffers  from  the  disadvantage  that  high  levels  of  GFP  within  cells  can  prove  toxic  
(Liu  et  al.  2001).    To  mitigate  this  problem  and  to  take  account  of  the  requirement  to  
optimize  transfection  in  the  context  of  gene  targeting,  we  took  advantage  of  a  previously  
established  reporter  gene  system  (Gravells  et  al.  2015).      
  
The  reporter  gene  hypoxanthine  phosphoribosyl  transferase  (HPRT)  is  located  on  the  X  
chromosome  and  is  involved  in  the  salvage  pathway  of  purine  biosynthesis  by  catalyzing  
the  transfer  of  the  5-­‐phosphoribosyl  group  of  5-­‐phosphoribosyl  1-­‐pyrophosphate  (PRPP)  
onto  hypoxanthine  to  form  inosine  monophosphate  (Figure  3-­‐2A)  (Stout  &  Caskey  1985;  
Caskey  &  Kruh  1979).    Cells  expressing  functional  HPRT  can  be  selected  in  HAT  medium  
(Hypoxanthine  Aminopterin  Thymidine).    In  the  presence  of  aminopterin  which  inhibits  
dihydrofolate   reductase   (DHFR),   cell   survival   is   dependent   on   functional   HPRT   to  
synthesize  nucleotides  via  the  salvage  pathway  (Figure  3-­‐2B).    Following  targeted  DSB  
formation  within  the  HPRT  gene  and  inaccurate  repair  by  non-­‐homologous  end  joining  
(NHEJ),  cells  that  no  longer  have  functional  HPRT  can  be  selected  in  medium  containing  
6-­‐thioguanine   (6-­‐TG),   a   nucleoside   analogue   that   is   converted   by   HPRT   into   a   toxic  
product  (Figure  3-­‐2C;  Figure  3-­‐2D).  
  
Within   exon   6   of   the  HPRT   gene   is   a   region   that   can   be   mutated   to   introduce   the  
recognition  sequence  for  the  restriction  endonuclease  I-­‐SceI  such  that  there  is  only  a  
single  amino  acid  change   in  the  resulting  protein  (ITLLSL>QTLLSL)  that  does  not  alter  
protein  function  (Gravells  et  al.  2015).    Human  HT1080  cells  harbouring  the  I-­‐SceI  site  
within  HPRT  exon  6  are  referred  to  as  HP-­‐I-­‐RT.      In  these  cells,  the  HPRT  gene  can  be  
targeted  with   a  DSB   by   I-­‐SceI   or   by   Cas9   (Figure   3-­‐3A).      Targeting   efficiency   can   be  
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Figure 3-2  Explanation of the system used to determine whether cells contain a functional HPRT 
gene using 6-thioguanine and aminopterin
A.  HPRT transfers the 5-phosphoribosyl group of 5-phosphoribosyl 1-pyrophosphate (PRPP) onto 
hypoxanthine to form inosine monophosphate.  B.  De novo synthesis (black arrows) of both 
purines and pyrimidines requires dihydrofolate reductase (DHFR).  When DHFR is inhibited by 
aminopterin, purines and pyrimidines can still be synthesised via salvage pathways (blue arrows) 
that require hypoxanthine phosphoribosyl transferase (HPRT) and thymidine kinase (TK) 
respectively.  C.  HPRT transfers the 5-phosphoribosyl group of PRPP onto the purine analogue 
6-thioguanine (6-TG) to form a cytotoxic product, thioguanine monophosphate (TGMP).  D.  Cells 
with functional HPRT grown in HAT medium are unable to synthesise nucleotides de novo but 
survive by using salvage pathways.  In the absence of HPRT, cells grown in HAT medium die as DHFR 
is inhibited by aminopterin and salvage pathways are no longer functional.  Cells with functional 
HPRT convert 6-TG into a cytotoxic product, TGMP and as such die when grown in 6-TG.  In the 
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inferred   from   the   proportion   of   cells   that   are   able   to   grow   in   the   presence   of   6-­‐TG  
following  I-­‐SceI-­‐  or  Cas9-­‐induced  DSBs.  
  
3.3.2    Inaccurate  repair  of  I-­‐SceI-­‐mediated  DSBs  causes  sensitivity  to  6-­‐TG  
To   test   that   this   system  would  work   in   our   hands,   we   carried   out   the   I-­‐SceI  
cleavage   assay   as   described   in   Gravells   et   al.,   2015.      The   initial   gene   targeting  
transfection   optimization   study   involved   transfecting   HT1080   HP-­‐I-­‐RT   cells   with   a  
plasmid   expressing   I-­‐SceI   using   the   same   four   commercially-­‐available   transfection  
reagents  and  conditions  as  described  in  section  3.2.1.    24  hours  after  transfection  500,  
2000  and  5000  cells  from  each  transfection  condition  were  seeded  into  10  cm  dishes  in  
growth   medium   without   6-­‐TG.      After   a   further   4   days,   growth   medium   was  
supplemented  with  6-­‐TG  (15  µg/ml).    The  5-­‐day  delay  between  transfection  and  addition  
of   6-­‐TG   allows   for   depletion   of   existing   HPRT   protein   in   cells   that   have   lost   HPRT  
genetically  following  inaccurate  repair  of  I-­‐SceI-­‐induced  DSBs.    After  10  days  growth  in  
6-­‐TG  colony  formation  was  assessed  by  staining  with  methylene  blue  (representative  
colony  formation  assay  can  be  seen  in  figure  3-­‐3B).    Transfections  were  carried  out  in  
triplicate,  seeding  500,  2000  and  5000  cells/10  cm  dish  from  which  mean  cell  survival  (a  
measure  of  successful  I-­‐SceI-­‐induced  DSB  formation  and  inaccurate  repair  by  NHEJ)  was  
calculated  (Figure  3-­‐4).  
  
Transfection  with  FuGENE  HD  led  to  cell  survival  of  2.48%  (1.5  µl   reagent/1  µg,DNA);  
2.01%  (2  µl/µg);  1.9%  (2.5  µl/µg);  1.89%  (3  µl/µg);  7.13%  (3.5  µl/µg)  and  7.5%  (4  µl/µg).    
Transfection  with  Lipofectamine  2000  led  to  cell  survival  of  2.03%  (2  µl   reagent/1  µg  
DNA);   11.11%   (4   µl/µg);   6.98%   (6   µl/µg);   3.97%   (8   µl/µg)   and   1.63%   (10   µl/µg).    
Transfection  with  Amaxa  nucleofection  led  to  cell  survival  of  2.84%.    Transfection  with  
Xfect  led  to  cell  survival  of  12.12%  (1  µg  DNA);  3.96%  (1.5  µg  DNA);  2.96%  (2  µg  DNA)  
and  3.95%  (2.5  µg  DNA).  
For  both  FuGENE  HD  and  Lipofectamine  2000,   transfection  efficiency   of   the  plasmid  
expressing  eGFP  (Figure  3-­‐1)  correlates  well  with  cell  survival  following  I-­‐SceI-­‐induced  
DSB   formation   within   HPRT   and   selection   in   6-­‐TG   (Figure   3-­‐2)   across   each   of   the  









Figure 3-3  Targeting HPRT exon 6 with I-SceI and CRISPR-Cas9
A.  Mutation of the region shaded in green to the sequence shaded in orange introduces an I-SceI 
restriction enzyme site into exon 6 of the HPRT gene.  The site of the I-SceI cut site is marked by the 
dashed black line and scissors.  The guide RNA sequence used to induce double strand breaks by 
Cas9 is underlined in blue, with the corresponding PAM sequence highlighted in blue.  B.  Following 
transient expression of I-SceI,  the stated numbers of HT1080HP-I-RT cells were plated in 10 cm2 dishes 
and surviving colonies counted following growth for 10 days in 6-TG.  Cells transfected with a 
plasmid expressing eGFP served as a negative control.  Seeding 20000 cells per 10 cm2 dish resulted 
in a colony density too high for accurate data to be obtained.  Figure shows results from 
























































































































Figure 3-4  I-SceI-mediated transfection optimisation in HT1080 cells using the HPRT reporter 
gene
A.  HT1080 cells were transfected with a plasmid encoding I-SceI using a range of commercially 
available transfection reagents then plated in varying numbers and their survival quantiﬁed as a 
percentage of total cells seeded per 10 cm2 dish following treatment with 6-TG.  Cell survival 
calculated as a mean of three independent biological repeats seeding 500, 2000 or 5000 cells using 
the stated transfection reagents and conditions.  Error bars:  SEM (n=3).  Fugene ratio = Fugene HD 
reagent (μl):DNA mass (μg); Lipofectamine value = μl of Lipofectamine 2000 reagent.
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individual  conditions,  suggesting  that  the  efficiency  of  gene  targeting  is  increased  with  
efficient  delivery  of  DNA  into  cells.    
  
Whilst  both  Lipofectamine  2000  4μl  (11.1%  mean  surviving  colonies,  standard  error  (SE):    
5.84)  and  Xfect  1μg  (12.1%,  SE:    7.16)  produced  higher  mean  cell  survival  than  FuGENE  
HD  4  µl  reagent:1  µg  DNA  (7.5%;    SE:    1.58),  the  latter  was  chosen  to  be  used  in  CRISPR-­‐
Cas9  studies  due  to  the  smaller  amount  of  variability  (standard  error)  in  I-­‐SceI-­‐mediated  
gene  targeting  efficiency.  
  
3.2.4    I-­‐SceI  protein  transfection    
In   addition   to   plasmid-­‐mediated   delivery   of   I-­‐SceI,   attempts   were   made   to  
transfect  I-­‐SceI  protein  (NEB)  into  HT1080  cells  using  Xfect  (~106  cells;  2  μg  I-­‐SceI)  and  
Amaxa  nucleofection  (106  cells;  10  μg  I-­‐SceI;  Kit  T,  programme  L-­‐005).    Both  methods  
proved  highly  toxic  to  cells  with  very  little  (Xfect)  or  no  (Amaxa;  data  not  shown)  colony  
formation  following  6-­‐TG  treatment.    As  with  GFP  protein  transfection  it  was  assumed  
that  some  component  of  the  protein  storage  buffer  was  toxic  to  cells.      
  
At  this  point  having  failed  to  transfect  HT1080  cells  with  two  different  proteins  it  was  
decided   that   protein   transfection   would   not   be   a   viable   option   for   gene   targeting  
experiments  and  as  such  future  experiments  focused  on  gene  targeting  using  plasmid-­‐
based  methods.  
  
3.2.5    Erroneous  repair  of  Cas9-­‐induced  DSBs  within  HPRT  causes  6-­‐TG  sensitivity  
Having  established  that  the  HPRT  reporter  system  works  well  in  our  hands  as  a  
measure  of  gene  targeting  efficiency  and  that  optimum  transfection  efficiency  for  the  
HT1080   cell   line   can   be   achieved   using   FuGENE   HD   (4   μl   reagent/1   μg  DNA),   it  was  
important  to  identify  the  most  effective  way  of  delivering  into  HT1080  HP-­‐I-­‐RT  cells  the  
two  components  necessary  for  CRISPR-­‐Cas9  gene  targeting:    a  guide  RNA  (gRNA)  and  
the  Cas9  endonuclease.    A  gRNA  was  designed  to  target  the  region  within  exon  6  of  HPRT  
containing   the   sequence   mutated   to   the   I-­‐SceI   recognition   sequence  
(ACTGCCTGACTAGGGATAAC  -­‐  Figure  3-­‐3A;  bottom).     Cells  were  either  co-­‐transfected  
   63  
Figure 3-5  Optimisation of Cas9-mediated gene knockout in HT1080 cells using the HPRT reporter 
gene
HT1080 cells were transfected either with diﬀerent molar ratios of Cas9:gRNA plasmid (1μg total 
DNA; purple bars) or an all-in-one Cas9+gRNA expression vector (1μg or 2μg DNA; blue bars) using 
a gRNA targeting exon 6 of HPRT.  Following transfection, 1000 cells were seeded per 10 cm2 dish 
and mean colony survival calculated from three biological replicates following growth in 6-TG for 10 
days.  Error bars:  SEM (n=3).
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with  two  separate  plasmids,  one  expressing  the  gRNA  and  the  other  expressing  human  
codon   optimised   Cas9   (both   a   gift   from  Dr.   Andy   Porter)   in   differing  molar   ratios   of  
Cas9:gRNA  (1:1;  1:2,  1:3,  1:5,  1:10)  or  with  a  single  plasmid  that  expresses  both  gRNA  
and   Cas9   (CRISPR   nuclease   vector,   Geneart).      ~5   ´   105   HT1080   HP-­‐I-­‐RT   cells   were  
transfected  with  1  μg  total  DNA  using  FuGENE  HD  (4  μl  reagent/1  μg  DNA).  
  
24  hours  after  transfection  103  cells  were  seeded  in  10  cm  dishes.    After  a  further  4  days,  
growth  medium  was  supplemented  with  6-­‐TG  (15  µg/ml).    After  10  days  growth  in  6-­‐TG,  
surviving   colonies   were   stained   with   methylene   blue   and   counted,   with   targeting  
efficiency  scored  from  the  number  of  colonies  that  grew  as  a  percentage  of  the  total  
number   of   cells   plated.      Mean   survival   was   calculated   from   three   independent  
experiments.      Perhaps   unsurprisingly,   among   cells   transfected   with   two   separate  
plasmids,  transfection  with  equimolar  quantities  of  separate  gRNA  and  Cas9  plasmids  
led  to  the  highest  mean  colony  formation  (4.77%  ±  standard  error  of  the  mean  (SEM):  
1.98)  with  lower  targeting  efficiency  seen  for  molar  excesses  of  gRNA  vector  (1:2:    2.87%  
±  SEM:  0.77;  1:3:     1.40%  ±  SEM:  0.98;  1:5:       1.23%  ±  SEM:  0.17;  1:10:    1.30%  ±  SEM:  
0.56).     When  transfected  with  the  CRISPR  nuclease  vector  containing  both  gRNA  and  
Cas9,  targeting  efficiency  was  higher  when  1μg  DNA  was  used  (3.77%  ±  SEM:  0.79)  than  
when  transfected  with  2μg  DNA  (1.87%  ±  SEM:  0.12)  (Figure  3-­‐5).    This  difference  can  
presumably  be  accounted  for  by  the  increased  toxicity  associated  with  increased  mass  
of  transfected  DNA  (Sun  et  al.  2013).    
  
In  this  section  I  have  shown  that  I  can  successfully  transfect  and  target  the  HPRT  gene  in  
human  HT1080   cells   using   the   I-­‐SceI   restriction  endonuclease   and  CRISPR-­‐Cas9.      For  
gene  targeting  with  CRISPR-­‐Cas9  transfection  of  one  single  plasmid  expressing  both  the  
guide  RNA  and  Cas9  results  in  a  greater  gene  targeting  efficiency  than  expressing  each  
component  from  separate  plasmids,  presumably  due  to  the  absence  of  requirement  for  
two  different  plasmids  to  enter  a  cell  for  gene  targeting  to  occur.  
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3.4    RNase  H2A  is  essential  in  human  TK6  cells  
In  parallel  to  the  previous  work  a  gRNA  was  designed  using  the  online  software  
CRISPRdirect  (Naito  et  al.  2015)  to  knock  out  RNASEH2A  in  human  lymphoblastoid  TK6  
cells  using  a  strategy  developed  in  the  laboratory  of  Professor  Shunichi  Takeda  at  Kyoto  
University,  Japan.    TK6  cells  have  the  advantage  of  being  p53  positive  and  having  a  stable  
diploid  karyotype  (Lalle  et  al.  1995;  Crompton  et  al.  2002).    Furthermore,  TK6  cells  grow  
in  suspension  and  therefore  do  away  with  the  requirement  for  trypsinisation  and  have  
a  relatively  fast  doubling  time  of  ~13  hours  making  them  easy  to  work  with  and  allowing  
for  faster  workflow.      In  this  system,  gene  knockout  is  achieved  through  the  replacement  
of   the   first   exon   of   a   gene  with   a   LoxP-­‐flanked   antibiotic   resistance   gene   under   the  
control  of  its  own  promoter.    It  is  hoped  that  removal  of  the  first  coding  exon  is  sufficient  
to  prevent  gene  expression;   it   is  however   important  to  check  that  no  splice   isoforms  
exist  for  the  gene  that  exclude  exon  1.    It  is  possible  that  in  addition  to  targeting  the  first  
exon,  knockout  of  gene  function  can  be  achieved  by  replacing  an  exon  containing  codons  
for  amino  acids  key  to  catalytic  function.    In  the  case  of  RNASEH2A,  the  first  exon  is  an  
excellent   candidate   for   targeting   since   it   not   only   contains   the   start   codon  but   also  
contains  the  codon  for  glycine  37,  an  amino  acid  that  plays  an  important  role  in  catalysis  
(Crow,  Leitch,  et  al.  2006).    Furthermore  the  ensembl  database  (Zerbino  et  al.  2018)  lists  
no  splice  isoforms  for  human  RNASEH2A.  
  
To   attempt   to   knock   out   RNASEH2A,   106   TK6   cells   were   co-­‐transfected   using   Neon  
electroporation  (Invitrogen;  1350  V,  10  ms,  ×3  pulse,  10μl  Neon  tip)  with  two  plasmids,  
one   to   co-­‐express   both   Cas9   and   a   gRNA   (pX330;   200   ng)   and   one   to   be   used   as   a  
template  for  homology  directed  repair  following  a  Cas9-­‐induced  DSB  (800  ng).    The  gRNA  
was   designed   such   that   Cas9   was   targeted   within   RNASEH2A   exon   1.      The   repair  
template  was  designed  with  ~1  kb  arms  homologous  to  regions  within  ~100  bp  either  
side   of   the   gRNA   sequence,   such   that   upon   repair,   the   entire   first   exon   would   be  
excluded.    Furthermore,  the  design  of  the  repair  template  excludes  the  gRNA  sequence  
to  prevent  cutting  of  the  plasmid  by  Cas9  (Figure  3-­‐6).    The  use  of  a  plasmid  to  be  used  
as  a  template  for  homology  directed  repair  and  resultant  incorporation  of  an  antibiotic  
resistance  gene  offers  the  advantage  of  screening  by  antibiotic  selection  rather  than  the  












Figure 3-6  RNASEH2A knockout strategy
A Cas9-induced double strand break in exon 1 is repaired by homology-directed repair such 
that exon 1 is replaced by a cassette containing an antibiotic resistance gene (M1/M2) 
driven by a PGK promoter, ﬂanked by two LoxP sites allowing subsequent marker removal 
via expression of Cre recombinase.
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potentially  more  time-­‐consuming  screening  required  when  gene  knockout  is  achieved  
by  inaccurate  repair  of  a  Cas9-­‐induced  DSB  by  non-­‐homologous  end  joining.    
  
Cells   can   be   transfected   with   either   one   repair   template   with   a   single   antibiotic  
resistance  gene  or  two  repair  templates  containing  different  antibiotic  resistance  genes.    
Selection  with  two  different  antibiotics  increases  the  chances  that  clones  picked  up  after  
selection  are  homozygously  targeted,  although  since  it  is  thought  that  the  efficiency  of  
targeting  one  single  allele  of  a  gene  in  TK6  cells  using  this  system  is  ~1:103,  the  use  of  
two   different   selection   markers   reduces   the   efficiency   of   targeting   to   ~1:106.    
Furthermore,  whilst  selection  with  only  one  antibiotic  increases  the  chances  of  picking  
up  heterozygously   targeted  clones,   it  does  not  preclude   the   possibility  of  picking  up  
clones  targeted  homozygously  with  the  same  antibiotic  resistance  gene  present  at  both  
alleles.      
  
Candidate  knockout  cells  were  generated  in  the  Takeda  laboratory  using  the  parameters  
stated  above.    We  were  provided  with  one  candidate  clone  that  had  been  selected  using  
one  single  antibiotic  resistance  marker  and  screened  by  PCR  to  verify  the  presence  of  
the  marker  at   the   correct   locus   (data   not   shown).      The  PCR  was  carried  out  using  a  
forward  primer  that  annealed  within  the  antibiotic  resistance  gene  and  a  reverse  primer  
that  annealed  outside  the  sequence  used  for  the  right  homology  arm.     Once  we  had  
received  the  cells,  this  clone  was  screened  by  immunoblotting  using  an  antibody  against  
RNase  H2A  (Figure  3-­‐7)  but  the  presence  of  a  band  at  ~32  kDa  suggests  that  this  clone  
expresses  RNase  H2A  and  is  therefore  assumed  to  only  be  targeted  heterozygously.    The  
similarity  in  protein  level  between  wild  type  and  the  clone  that  we  presumed  to  have  
lost  a  single  copy  of  RNASEH2A  can  be  explained  in  one  of  three  ways:    1)    the  plasmid  
used   for   homology   directed   repair   of   the   Cas9-­‐induced   DSB   randomly   integrated  
somewhere   in   the   genome   conferring  G418   resistance   to   cells   and   the   PCR  used   to  
screen  for  the  presence  of  the  knockin  construct  at  the  correct  locus  somehow  produced  
an   amplicon   of   the   correct   size;   2)      the   knockout   is   indeed   heterozygous   and   the  
intensity  of  the  band  in  the  knockout  candidate  clone  is  lower  than  wild  type  but  the  
Western   blot   is   overexposed   or   3)      the   knockout   is   heterozygous   but   protein   levels  
remain   the   same   due   to   transcriptional   upregulation   of   the   remaining   copy   of  















Figure 3-7  RNase H2A knockout candidate TK6 cells are only targeted 
heterozygously
Immunoblot of wild type and RNASEH2A knockout candidate TK6 cells probed 
with an anti-RNase H2A antibody shows that the candidate knockout cells still 
express RNase H2A protein (~32 kDa) and as such are presumed to be only 
targeted heterozygously.
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RNASEH2A.    Whatever  the  reason  for  the  band  intensity  seen  at  the  size  corresponding  
to  RNase  H2A  in  the  Western  blot,  it  was  clear  that  these  cells  would  be  no  use  to  us.  
  
Having   discovered   that   the   cells   provided   to   us   by   the   Takeda   laboratory  were   not  
homozygously  knocked  out  for  RNase  H2A,  another  two  attempts  were  made  to  knock  
the  gene  out  using  one  or  two  repair  templates  to  attempt  to  pick  up  heterozygous  or  
homozygous   knockouts   respectively.      106   TK6   cells   were   transfected   as   previously  
described  with  either  200  ng  pX330  and  800  ng  G418R  repair  template  or  200  ng  pX330  
and   400   ng   each   of   G418R   and   hygromycinR   repair   templates   for   selection   of  
heterozygous  or  homozygous  knockout  respectively.    Two  days  after  transfection,  cells  
were  selected  in  1  mg/ml  G418  (heterozygous  targeting)  or  1  mg/ml  G418  and  0.625  
mg/ml   hygromycin   (homozygous   targeting).      In   both   instances,   individual   colonies  
started  to  grow  but  after  approximately  5  or  6  rounds  of  mitosis,  no  further  cell  division  
was  seen  and  the  cells  ultimately  died,  suggesting  that  RNase  H2A  function  is  indeed  
essential  for  cell  viability.  
  
It  is  possible  that  the  failure  to  generate  cells  in  which  RNase  H2A  was  knocked  out  may  
have   been   due   to   low   transfection   efficiency   resulting   in   only   a   small   proportion   of  
transfected    cells  taking  up  the  required  plasmid  DNA.    Indeed  concomitant  transfection  
of   a   plasmid   expressing   GFP   to   act   as   a   control   for   transfection   showed   very   low  
transfection  efficiency  for  all  four  transfections  described  in  the  previous  section  when  
using  the  same  transfection  reagent  and  parameters  as  used  in  the  Takeda  laboratory  
(Neon;  1350  V,  10  ms,  ×3  pulse,  100μl  Neon  tip).    To  attempt  to  increase  transfection  
efficiency   a   transfection   optimisation   was   carried   out   using   a   range   of   parameters  
defined  by  the  manufacturer.    Cells  were  transfected  with  a  plasmid  expressing  GFP  and  
transfection   efficiency   scored   as   a   percentage   of   GFP-­‐positive   cells   24   hours   post-­‐
transfection.    Transfection  parameters  resulting  in  >20%  GFP-­‐positive  cells  were  further  
qualitatively  scored  for  cell  health  based  on  morphology  and  survival  post  transfection  
(Table  3-­‐1).    The  highest  transfection  efficiency  (29.1%  GFP-­‐positive)  was  obtained  using  
a  pulse  voltage  of  1400  V,  pulse  width  of  30  ms  and  a  pulse  number  of  1,  however  due  
to  the  decreased  toxicity  to  cells  it  was  decided  to  use  conditions  of  1500  V,  20  ms,  ´  1  
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Table 3-1.  TK6 Neon transfection optimisation.
TK6 cells (105/condition) were transfected with a plasmid expressing GFP using Neon 
electroporation (10 μl tip) under the stated transfection parameters.  The percentage of 
GFP-positive cells 24 hours after transfection was used as a measure of transfection 
eﬃciency.  Transfection parameters causing >20% eﬃciency were scored qualitatively based 
upon cell morphology to take into account the eﬀect of the electroporation conditions on cell 
health 24 hours after transfection.  Green indicates an abundance of cells displaying normal 
morphology and low numbers of dead cells.  Amber indicates that the electroporation 
conditions proved moderately harmful to cells, whilst red indicates that the transfection 
conditon caused high levels of cell sickness and death.
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pulse   for   further   TK6   transfections   despite   the   slightly   lower   transfection   efficiency  
(27.2%  GFP-­‐positive).  
  
A  further  unsuccessful  attempt  was  made  to  knockout  RNASEH2A  either  heterozygously  
or   homozygously   using   the   optimised   electroporation   parameters,   however   no   cells  
grew   after   10   days   in   selective   media   (G418   only   or   G418   and   hygromycin   for  
heterozygous  and  homozygous  targeting  respectively).    
  
The   results   of   our   attempts   to   knockout   RNase   H2A   in   human   TK6   cells   and   since  
attempts  to  generate  RNase  H2  knockout  mice  by  independently  targeting  either  the  B  
or  C  accessory  subunits  show  that  RNase  H2  deficiency  causes  embryonic  lethality  and  
is  therefore  not  compatible  with  life  in  mammals  (Reijns  et  al.  2012;  Hiller  et  al.  2012b)  
and  that  there  are  no  known  loss-­‐of-­‐function  pathogenic  RNase  H2  mutations  (Reijns  et  
al.  2012;  Crow,  Leitch,  et  al.  2006)  we  assume  that  RNASEH2A   is  an  essential  gene  in  
human  cells.  
  
3.5    DISCUSSION  
In  this  chapter  I  have  created  a  protocol  for  gene  knockout  using  CRISPR-­‐Cas9.    
Whilst   gene   knockout   can   be   achieved   through   transfection   of   a   single   plasmid  
expressing  both  Cas9  and  gRNA,  relying  on  gene  knockout  through  inaccurate  repair  of  
Cas9-­‐induced  DSBs  by  NHEJ,  this  system  does  have  limitations  in  terms  of  screening  for  
successfully   targeted   clones.      Current   strategies   to   screen   for   NHEJ-­‐mediated   gene  
knockout  can  be  time  consuming  requiring  optimisation  and  can  be  sequence-­‐limited  
(Hua  et  al.  2017)  and  do  not  take  account  of  the  possibility  that  repair  may  exclude  one  
or  more  codons  but  that  functional  protein  may  still  be  expressed.    Gene  knockout  by  
replacing  an  entire  exon  with  an  antibiotic  resistance  marker  as  we  did  with  RNASEH2A  
offers   the   advantage   of   antibiotic   selection   but   has   the   disadvantage   of   not   being  
seamless  since  even  after  marker  removal  by  expression  of  Cre  recombinase,  the  LoxP  
sequence  remains  in  the  genome.  
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In   this   chapter   I  have  also   shown   that  different   transfection   reagents   show  differing  
levels  of  transfection  efficiency  and  furthermore  that  the  same  transfection  reagent  and  
conditions  used  with  the  same  cell  line  may  vary  in  efficiency  in  different  laboratories.    
This  is  probably  particularly  true  in  the  case  of  electroporation  platforms  which  may  not  
necessarily   treat   the   cells   with   exactly   the   parameters   that   are   set.      It   is   therefore  
advisable   that   before   genome   editing   is   attempted   in   an   unfamiliar   cell   line   that   a  
transfection   optimisation   is   carried   out   using   a   range   of   transfection   reagents   and  
conditions.  
  
I  have  shown  that  whilst  it  may  be  possible  to  knockout  one  copy  of  RNASEH2A  in  TK6  
cells,  heterozygous  knockout  is  insufficient  to  significantly  reduce  overall  cellular  protein  
levels.    It  would  have  been  advantageous  to  try  to  knockout  RNASEH2A  in  other  cell  lines  
to  see  if  the  presumed  upregulation  seen  in  heterozygous  knockout  cells  was  specific  to  
TK6  cells,  but  the  existing  evidence  for  the  requirement  for  RNase  H2A  for  cell  viability  
meant  that  further  research  in  this  area  would  not  have  proved  fruitful.  
  
In  conclusion,  I  have  shown  that  homozygous  knockout  of  RNASEH2A  in  the  human  TK6  
cell  line  is  not  possible  and  since  we  presume  this  to  be  the  case  across  most,  if  not  all  
human  cell  lines,  it  will  be  necessary  to  regulate  expression  of  the  RNase  H2  complex.    
Work  carried  out  to  attempt  to  regulate  RNase  H2  can  be  seen  in  results  chapter  2.  
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Chapter  4  
Regulating  RNase  H2  in  human  cells  
  
4.1    Introduction  
   Due  to  the  essential  nature  of  RNase  H2A  in  TK6  cells  it  was  necessary  to  develop  
a  system  to  induce  the  rapid  shutoff  of  RNase  H2  function.    Several  mechanisms  have  
been   used   to   downregulate   production   of   specific   proteins   by   either   transcriptional  
shutoff  of  the  gene  of  interest,  by  degrading  the  messenger  RNA  (mRNA)  encoding  the  
protein  or  by  targeting  the  protein  itself  post-­‐translationally.  
  
In   this   chapter   I  will   discuss   three  mechanisms   of   downregulating   expression   of   the  
different  subunits  of  human  RNase  H2:     auxin-­‐inducible  degron  (AID),  a  novel  double  
degron   tag   composed  of  a  mini  AID  degron   (mAID)   tag   fused  with  a  small  molecule-­‐
assisted  shutoff  (SMASh)  tag  and  a  SMASh-­‐tagged  RNase  H2  subunit  under  control  of  
tetracycline-­‐regulated  transcriptional  expression.  
  
Finally,  I  will  show  that  RNase  H2C  can  be  strongly  downregulated  via  a  C-­‐terminal  mAID-­‐
SMASh  double  degron  tag.  
  
4.2    Assessing  the  suitability  of  all  three  RNase  H2  subunits  for  
tagging  in  Schizosaccharomyces  pombe    
Tagging  proteins  can  often  be  problematic  due  to  the  possibility  of  negatively  
affecting  protein  folding  or  of  disrupting  a  protein  domain  required  for  the  stability  of  a  
multi-­‐subunit  protein  complex.    To  identify  the  suitability  of  each  of  the  three  RNase  H2  
subunits  for  tagging,  we  carried  out  an  initial  study  in  S.  pombe.    We  hypothesized  that  
if  we  were  able  to  separately  tag  the  C-­‐termini  of  each  of  the  three  RNase  H2  subunits  
with  GFP   in  S.  pombe  without  affecting   the   ribonuclease  activity  of   the  holoenzyme,  








Figure 4-1  C-terminal GFP tagging strategy in S. pombe
A GFP tag is added to the C-terminus of RNase H2 subunits via recombination with a plasmid 
which excludes the endogenous stop codon.  The plasmid also confers kanamycin resistance 
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then  there  was  a  good  chance  that  the  presence  of  C-­‐terminal  tags  on  the  human  RNase  
H2  subunits  would  not  affect  catalytic  activity  of  the  enzyme.    Similarly,  it  was  presumed  
that  any  decrease  in  catalytic  activity  would  likely  have  been  due  to  the  destabilizing  
effect  of  the  tag  on  trimer  formation.  
  
4.2.1    Tagging  each  of  the  three  subunits  of  RNase  H2  with  a  C  terminal  GFP  
   In  S.  pombe,  the  three  subunits  of  RNase  H2,  are  encoded  by  the  genes  rnh201,  
rnh202  and  rnh203  coding  for  RNase  H2A,  RNase  H2B  and  RNase  H2C  respectively.    A  
strain   of   S.   pombe   containing   C-­‐terminally   GFP   tagged   rnh201   already   existed.      To  
introduce  C-­‐terminal  GFP  tags  to  rnh202  and  rnh203,  a  cassette  containing  GFP  and  a  
kanamycin  resistance  gene  (KanMX6)  was  amplified  by  polymerase  chain  reaction  from  
a  plasmid  (Bahler  et  al.  1998)  using  forward  and  reverse  primers  containing  ~100  bp  
extensions   containing   sequences   homologous   to   the   regions   to   be   targeted.      The  
homologous  regions  were  designed  such  that  upon  integration  of  the  cassette  at  the  C-­‐
terminus  of  each  of  the  genes  the  endogenous  stop  codon  would  be  excluded  (Figure  4-­‐
1).    108  cells  were  transformed  with  10  µg  purified  PCR  product  using  lithium  acetate  
and  DMSO  and  selected  on  kanamycin  plates.  
  
To  screen  for  the  presence  of  the  GFP  tag  on  rnh202  and  rnh203,  gDNA  was  extracted  
from  5  and  8  colonies  respectively  and  used  as  a  template  for  PCR  using  a  forward  primer  
that  annealed  within  the  KanMX6  fragment  and  a  reverse  primer  that  annealed  outside  
the  right  homology  arm.    4  of  the  5  rnh202-­‐GFP  candidates  and  8  out  of  8  rnh203-­‐GFP  
candidates  screened  were  found  to  have  the  GFP  tag   integrated  at  the  correct   locus  
(Figure  4-­‐2  A).    To  further  verify  the  presence  of  the  GFP  tag,  2  colonies  of  each  strain  
(rnh201-­‐GFP,   rnh202-­‐GFP  &   rnh203-­‐GFP)  were  analysed  by   immunoblotting  using  an  
antibody  against  GFP   (Figure  4-­‐2  B).     All   colonies   screened  were   found   to   contain  C-­‐
terminal  GFP  tags  on  each  of  the  three  RNase  H2  subunits.  
  
In  order   to  assess   the  catalytic  activity  of   the  RNase  H2  holoenzyme  containing  a  C-­‐
terminal  GFP  tag  on  each  of  the  three  subunits,  we  used  a  system  previously  established  
in  the  Carr   laboratory  (unpublished)  that  assesses  the  ability  of  RNase  H2  to  remove  
ribonucleotides  misincorporated  into  gDNA  at  higher  than  wild  type  levels  by  a  mutant  




Figure 4-2  The C-termini of the three subunits of S. pombe RNase H2 can all be tagged with GFP 
in a cdc6L591G background
A.  Following transformation with the C-terminal GFP tagging plasmid and selection on kanamycin, 
colonies were screened by PCR to check for the presence of the kanMX6 marker at the correct 
locus using a forward primer that anneals within, and a reverse primer that anneals outside 
kanMX6.  B.  Immunoblot using an anti-GFP antibody shows that all three subunits express a 
C-terminal GFP tag.  C.  After crossing with strains containing mutant cdc6L591G, resultant colonies 
were screened by PCR for the presence of cdc6L591G by PCR, using a forward primer that anneals 
within, and a reverse primer that anneals downstream of the gene.  The presence of a LoxP site 
initially used to integrate the mutant cdc6 causes a band shift and allows for selection of positive 
colonies.  D.  Colonies that contained cdc6L591G were screened by immunoblotting using an anti-GFP 
antibody to ensure the presence of the GFP-tagged RNase H2 subunit.
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DNA  polymerase  d  containing  an  L591G  mutation  at  the  catalytic  site.    To  introduce  the  
mutant  polymerase  d,  encoded  by  the  gene  cdc6,  strains  of  S.  pombe  containing  the  
mutant  polymerase  were  crossed  with  strains  containing  each  of  the  C-­‐terminally  tagged  
RNase  H2   subunits.      To   screen   for   the   presence   of   the  mutant   polymerase  d   in   the  
crossed  strains,  random  spore  analysis  was  carried  out  by  PCR  using  a  forward  primer  
that  annealed  within  the  cdc6  gene  and  a  reverse  primer  that  annealed  downstream  of  
a  LoxP  site  that  had  been  previously  used  to  introduce  the  mutant  cdc6  gene  (Figure  4-­‐
2  C).    The  presence  of  the  LoxP  site  downstream  of  the  mutant  cdc6L591G  gene  causes  an  
increase  in  amplicon  size  in  comparison  to  amplicons  from  gDNA  containing  wild  type  
cdc6.    2  out  of  6  rnh201-­‐GFP  colonies  screened  were  found  to  contain  cdc6L591G  (colonies  
2  &  6)  and  4  out  of  6  colonies  screened  for  both  rnh202-­‐GFP  and  rnh203-­‐GFP  were  found  
to  contain  cdc6L591G  (colonies  1,  2,  4  &  6  and  colonies  1,  2,  3  &  5  respectively).  
  
To  verify  that  these  colonies  containing  cdc6L591G  still  contained  the  desired  GFP-­‐tagged  
RNase  H2  subunits,  2  colonies  of  each  were  screened  again  by  immunoblotting  using  an  
antibody   against  GFP   and   all   colonies   screened  were   found   to   still   have  GFP-­‐tagged  
rnh201,  rnh202  or  rnh203  (Figure  4-­‐2  D).  
  
4.2.2     Assessing  the  effect  of  C-­‐terminal  GFP  tags  on  each  of  the  three  subunits  on  
catalytic  activity  of  the  RNase  H2  holoenzyme  
   The   presence   of   the   2’-­‐OH   on   the   ribose   moiety   of   a   ribonucleotide   within  
genomic   DNA   renders   the   sugar   phosphate   backbone   at   that   point   five   times  more  
susceptible  to  alkaline  hydrolysis   than  bonds  between  adjacent  deoxyribonucleotides  
(Clausen  et  al.  2015).    As  such,  the  level  of  RNase  H2  activity  can  be  inferred  from  the  
extent   of   smearing   of   genomic   DNA   due   to   the   presence   of   unrepaired   genomic  
ribonucleotides  when  subjected  to  alkaline  hydrolysis  and  agarose  gel  electrophoresis.  
  
To  assess  the  extent  to  which  catalytic  activity  of  the  RNase  H2  trimer  is  affected  when  
one  of  the  subunits  contains  a  C-­‐terminal  GFP  tag  we  compared  the  extent  of  smearing  
of   gDNA   following   alkaline   hydrolysis   and   agarose   gel   electrophoresis   from   strains  
containing  C-­‐terminal  GFP  tags  on  each  of  the  three  RNase  H2  subunits  in  combination  
with   the   cdc6L591G   allele  with   gDNA   from  a  wild   type   strain   of  S.   pombe  and   strains  
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containing  the  cdc6L591G  allele  with  untagged  RNase  H2  subunits,  strains  containing  the  
cdc6L591G  allele  with  one  of  the  RNase  H2  subunits  knocked  out  and  with  strains  with  
wild  type  cdc6  with  GFP-­‐tagged  RNase  H2  subunits.  
  
Since  smearing  of  gDNA  when  run  on  agarose  gels  following  alkaline  hydrolysis  could  
appear  to  be  greater  if  the  gDNA  had  been  damaged  during  the  purification  process,  we  
subjected  untreated  gDNA  from  each  of  the  strains  to  agarose  gel  electrophoresis  to  
assess  the  integrity  of  extracted  gDNA  (Figure  4-­‐3  A-­‐C).     With  the  exception  of  gDNA  
extracted  from  strain  1392  (cdc6WT  rnh203-­‐GFP;  Figure  4-­‐3  C),  gDNA  from  all  strains  used  
for  this  study  appeared  undamaged  by  the  purification  process.    Since  strain  1392  would  
not   be   expected   to   have   excessive   amounts   of   genomic   ribonucleotides   due   to   the  
presence  of  wild  type  polymerase  d,  the  data  from  this  strain  were  less  informative  to  
us  than  that  provided  by  the  strain  containing  the  cdc6L591G  allele  in  which  rnh203  had  
been  knocked  out  and  taking  into  consideration  a  separate  trial  that  had  shown  RNase  
H2   catalytic   activity   in   this   strain   to   be   unaffected   by   GFP-­‐tagged   rnh203   (data   not  
shown),  we  decided  that  we  would  be  able  to  infer  the  information  we  needed  despite  
the  poor  gDNA  integrity  of  this  strain.  
  
The  gel  images  in  Figure  4-­‐3  A-­‐C  were  used  to  calculate  the  concentration  of  extracted  
gDNA  by  comparing  the  signal  intensity  of  each  band  with  a  known  mass  of  DNA  in  the  
DNA  size  marker  using  ImageJ  (Schneider  et  al.  2012),  such  that  equal  masses  of  gDNA  
could  be  subjected  to  alkaline  hydrolysis.    To  assess  the  extent  of  unrepaired  genomic  
ribonucleotides,  gDNA  from  each  of  the  strains  was  either  treated  with  0.3M  KOH  at  
55°C  for  1  hour  or  left  untreated  and  subjected  to  2%  agarose  gel  electrophoresis  (Figure  
4-­‐3  D-­‐F).    To  ensure  that  signal  from  alkaline-­‐treated  samples  would  be  visible  on  the  gel  
in   the  event  of  high   levels  of  alkaline  hydrolysis,   three   times  more  gDNA  was  alkali-­‐
treated  and  run  on  agarose  gels  than  was  run  for  the  untreated  samples.    Furthermore,  
this   was   an   important   control   since   alkaline   hydrolysis   can   also   occur   stochastically  
between   adjacent   deoxyribonucleotides   such   that   a   certain   level   of   smearing   is  
expected  even  with  gDNA  from  wild  type  cells.  
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Figure 4-3  The presence of a C-terminal GFP tag on each of the three subunits of RNase H2 in 
S. pombe has no discernable eﬀect on enzyme activity
A-C.  Genomic DNA (gDNA) from cells with the stated genotypes was run on agarose gels to infer 
the integrity of the gDNA, with greater smearing indicating greater shearing of the gDNA during 
the extraction process.  D-F.  gDNA from the indicated strains was either left untreated (UT) or 
treated with alkali (T) and run on agarose gels.  Decreased RNase H2 function can be inferred 
from increased gDNA smearing following treatment with alkali due to elevated ribonucleotide 
levels in gDNA resulting in increased hydrolysis of gDNA.  GFP-tagged rnh201 (D), rnh202 (E) and 
rnh203 (F) in combination with ribo-incorporating cdc6L591G show similar levels of degradation to 
wild type suggesting that the RNase H2 holoenzyme retains full function.
A
FD Ernh201 rnh202 rnh203
B C
   80  
In  wild  type  cells,  the  low  levels  of  ribonucleotides  incorporated  by  polymerase  d  are  
rapidly  repaired  by  RNase  H2  and  as  such  signal  intensity  between  bands  for  untreated  
and  treated  are  equal.    Cells  containing  the  cdc6L591G  allele  are  expected  to  incorporate  
higher  than  wild  type  levels  of  ribonucleotides  but  in  the  presence  of  wild  type  RNase  
H2   these   ribonucleotides   are   rapidly   repaired.      Accordingly,   the   signal   intensity   for  
untreated  and  treated  gDNA  from  this  strain   is  equal  on  all   three  gels   (Figure  4-­‐3  D:    
cdc6L591G  rnh201WT;  Figure  4-­‐3  E:    cdc6L591G  rnh202WT;  Figure  4-­‐3  F:    cdc6L591G  rnh203WT).    
In  the  absence  of  any  of  the  three  RNase  H2  subunits,  catalytic  activity  of  the  RNase  H2  
is  reduced  such  that  in  strains  additionally  harboring  the  cdc6L591G  allele,  a  large  level  of  
gDNA  smearing  is  seen  following  alkaline  hydrolysis  (Figure  4-­‐3  D:    cdc6L591G  rnh201D;  
Figure  4-­‐3  E:    cdc6L591G  rnh202D;  Figure  4-­‐3  F:    cdc6L591G  rnh203D).    The  presence  of  C-­‐
terminal  GFP  tags  on  each  of  the  three  RNase  H2  subunits   in  an  otherwise  wild  type  
background  has  no  effect  on  smearing  (Figure  4-­‐3  D:    cdc6WT  rnh201-­‐GFP;  Figure  4-­‐3  E:    
cdc6WT  rnh202-­‐GFP;  Figure  4-­‐3  F:    cdc6WT  rnh203-­‐GFP).    There  is  no  discernible  difference  
in  signal  intensity  between  untreated  and  treated  gDNA  from  strains  harboring  a  GFP  
tag  on  each  of  the  three  RNase  H2  subunits   in  combination  with  the  cdc6L591G  allele,  
indicating  that  the  presence  of  the  GFP  tag  has  little  or  no  impact  on  catalytic  activity  
(Figure  4-­‐3  D:    cdc6L591G  rnh201-­‐GFP;  Figure  4-­‐3  E:    cdc6L591G  rnh202-­‐GFP;  Figure  4-­‐3  F:    
cdc6L591G   rnh203-­‐GFP).     As  such,   it  was  decided   that   theoretically  all   three  RNase  H2  
subunits  could  be  tagged  at  the  C-­‐terminus  without  affecting  catalysis.  
  
4.3      Regulation  of   human  RNase  H2A  with   an   auxin   inducible  
degron  tag.  
As  described  in  section  1.4.3  human  RNase  H2  is  a  heterotrimer  consisting  of  a  
catalytic  subunit,  RNase  H2A  and  two  accessory  subunits  RNase  H2B  and  RNase  H2C.    
Since   the   sustained   presence   of   misincorporated   ribonucleotides   (rNTPs)   within  
genomic  DNA   is  an  essential  principle  of  Polymerase  Usage  sequencing   (PU-­‐seq),  we  
decided  in  the  first  instance  to  attempt  to  tag  human  RNase  H2A  with  a  degron  tag  which  
would  allow  a  temporary  knockdown  of  RNase  H2A  and  a  subsequent  decrease  in  RNase  
H2  catalytic  activity.     Furthermore,  temporal  ablation  of  RNase  H2  activity  offers  the  




Figure 4-4 Crystal structure of the human RNase H2 holoenzyme
Shown is the overall structure of the human RNase H2 complex coloured by subunits (green, A; 
yellow, B; orange, C) with the N- and C-termini of RNase H2A indicated, imaged using JSmol 
(Hanson et al., 2013).  Structure from PDB ID:  3PUF (Figiel. et al., 2011).
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advantage  that  upon  release  from  knockdown,  cellular  levels  of  RNase  H2  activity  would  
return   to   normal   thereby   allowing   removal   of  misincorporated   rNTPs.         In   contrast  
complete  knockout  of  RNase  H2  function,  as  used  in  S.  pombe  PU-­‐seq,  does  not  allow  
for   the   repair   of   genomic   rNTPs   between   experiments,   increasing   the   chances   of  
ribonucleotide-­‐derived   DNA   damage   and   increasing   the   background   ribonucleotide  
signal.      It   is   advantageous   to   be   able   to   remove   genomic   rNTPs   since   the   sustained  
presence  of  genomic  rNTPs  over  time  can  cause  widespread  genome  instability  in  yeast,  
mice  and  human  cells  (Nick  McElhinny,  Kumar,  et  al.  2010;  Hiller  et  al.  2012b;  O’Connell  
et  al.  2015;  Pizzi  et  al.  2015;  Reijns  et  al.  2011).  
  
In   silico   analysis  of   the  crystal   structure  of   the  RNase  H2  heterotrimer   revealed   that  
RNase   H2A   has   a   free   N-­‐terminus   (Figure   4-­‐4)   whilst   the   C-­‐terminus   appeared   less  
accessible  due  to  its  requirement  in  stabilising  the  formation  of  the  holoenzyme  through  
its   interactions   with   the   RNase   H2B-­‐RNase   H2C   heterodimer.      Furthermore   this  
interaction  mediated  by  the  C-­‐terminus  of  RNase  H2A  is  essential  for  enzymatic  function  
(Reijns  et  al.  2011).    However,  due  to  our  discovery  that  a  C-­‐terminal  GFP  tag  on  RNase  
H2A   has   no   discernible   effect   on   RNase   H2   catalysis   in   S.   pombe,   and   due   to   the  
increased  difficulty  in  tagging  the  N-­‐terminus  of  proteins,  it  was  decided  as  a  starting  
point  to  attempt  to  tag  the  C-­‐terminus  of  RNase  H2A  with  an  auxin  inducible  degron  
(AID)  tag  (Nishimura  et  al.  2009).    This  decision  was  also  taken  since  a  strategy  for  tagging  
the  C-­‐termini  of  a  range  of  different  proteins  with  AID  had  already  been  established  in  
the  Takeda  laboratory  where  much  of  this  preliminary  work  was  carried  out.  
  
Auxins  are  a  widespread  family  of  plant  hormones,  the  most  common  of  which  is  indole-­‐
3-­‐acetic  acid   (IAA)  which   is   responsible   for   the   regulation  of  many  genes   involved   in  
plant   development      (Teale  et   al.   2006).      In   plants,   auxin   family   hormones   cause   the  
degradation  of  a  family  of  transcriptional  repressors  known  as  Aux/IAAs  by  mediating  
an  interaction  between  the  Aux/IAAs  and  the  F-­‐box  transport  inhibitor  response  1  (TIR1)  
subunit  of  the  SCFTIR1  E3  ubiquitin  ligase  complex.    SCFTIR1  then  recruits  an  E2  ubiquitin  
conjugating  enzyme  which  polyubiquitinates  the  SCFTIR1-­‐associated  Aux/IAA,  marking  it  
for  proteasomal  degradation  (Figure  4-­‐5)  (Abel  &  Theologis  1996;  Teale  et  al.  2006;  Tan  
et  al.  2007).     This  system  has  been  reconstituted   in  yeast  and  human  cells   to   induce  

























Figure 4-5  Schematic illustration of the AID system
Auxin and auxin-family hormones such as indole-3-acetic acid (IAA) promote the interaction 
between the AID degron tag (AID) of the target protein and OsTIR1.  The OsTIR1-SCF complex acts 
as an E3 ubiquitin ligase to recruit an E2 ubiquitin ligase which polyubiquitinates the degron tag, 
marking the target protein for proteasomal degradation.















Figure 4-6  RNASEH2A C-terminal AID tagging strategy
A Cas9-induced double strand break is targeted as close as possible after the stop codon of the 
terminal coding exon of the gene.  The break is repaired by homology directed repair using a 
repair template designed such that both the endogenous stop codon and the 20bp gRNA 
sequence are excluded upon repair.  OsTIR1 is ectopically expressed constitutively from the 
AAVS1 locus.
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degradation  of  specific  proteins  by  using  Arabidopsis  thaliana  IAA17  as  a  degron,  fused  
with  the  target  protein  in  the  presence  of  IAA  and  Oryza  sativa  TIR1  (OsTIR1)  (Nishimura  
et  al.  2009;  Natsume  et  al.  2016).  
  
We  decided  to  tag  the  C-­‐terminus  of  RNase  H2A  with  a  mini  AID  degron  tag  fused  to  
eGFP  in  human  TK6  cells.     To  target  the  tag  to  the  C-­‐terminus  of  RNase  H2A,  106  TK6  
cells   expressing   OsTIR1   from   the   AAVS1   locus   were   co-­‐transfected   using   Neon  
electroporation  (Invitrogen;  1350  V,  10  ms,  ×3  pulse,  10μl  Neon  tip)  with  two  plasmids,  
one  to  express  both  Cas9  and  a  gRNA  (pX330)  and  the  second,  a  repair  template.    For  
each  transfection,  cells  were  transfected  with  200  ng  pX330  and  800  ng  repair  template.    
The  gRNA  was  designed  to  target  a  Cas9-­‐induced  DSB  to  as  close  as  possible  to  the  stop  
codon  of  RNASEH2A.    The  repair  template  was  designed  with  homology  arms  that  would  
exclude  the  20bp  gRNA  sequence  upon  repair  and  so  that  upon  repair,  the  C  terminus  
of  RNase  H2A  would  be  fused  to  a  mini  AID  degron  tag  and  eGFP.    The  repair  construct  
also   contains   an   antibiotic   resistance   marker   (G418R)   under   the   control   of   a   PGK  
promoter  (Figure  4-­‐6).    Two  days  after  transfection,  cells  were  selected  in  1  mg/ml  G418  
for   10   days   to   isolate   potentially   successfully   targeted   clones.      Clones   that   survived  
selection  were  further  screened  for  the  presence  of  the  tagging  cassette  at  the  correct  
locus  by  PCR  using  a  forward  primer  that  anneals  within  the  G418  resistance  gene  and  
a  reverse  primer  that  anneals  outside  the  right  homology  arm  (data  not  shown).    This  
work  was  started  in  the  Takeda  laboratory  during  my  collaboration,  after  which  we  were  
provided  with  a  candidate  clone  to  carry  out  further  screening.  
  
The  candidate  clone  was  further  screened  by  immunoblotting  using  two  different  anti-­‐
RNase  H2A  antibodies   to   check   for   the  presence  of   the  mAID-­‐eGFP   fusion   tag  either  
before  or  after  growth  in  1mg/ml  IAA  (=  571  µM).    Using  Bethyl  antibody  A304-­‐149A  
(Figure  4-­‐7,  top  panel)  bands  corresponding  to  endogenous,  untagged  RNase  H2A  (~32  
kDa)  and  bands  at  a  molecular  weight  corresponding  to  RNase  H2A  tagged  with  mAID-­‐
eGFP  (~55  kDa)  can  be  seen  both  before  and  after  growth  in  IAA,  suggesting  that  this  
clone  was  only  tagged  heterozygously.     However,  when  probed  with  Bethyl  antibody  
A304-­‐150A   (Figure   4-­‐7,   bottom   panel)   bands   can   only   be   seen   corresponding   to  
endogenous  untagged  RNase  H2A  and  not  for  a  tagged  version  of  the  protein.      






































Figure 4-7  C-terminally AID-tagged RNase H2A candidate TK6 cells are either 
not successfully targeted or are only targeted heterozygously and the AID 
degron is non-functional.
Immunoblot of wild type, RNase H2A knockout candidate and C-terminally 
AID-tagged RNase H2A candidate (-/+ IAA) TK6 cells probed with two diﬀerent 
anti-RNase H2A antibodies.  Both antibodies show that the AID-tagged 
candidates still express endogenous, untagged RNase H2A (~32 kDa).  Antibody 
Bethyl A304-149A (top panel) shows that whilst at least one copy of RNASEH2A 
may be tagged (~55 kDa), there is no decrease in signal seen after 24 hours 
growth in IAA.  The absence of a band at 55 kDa when probing with antibody 
Bethly A304-150A (bottom panel) suggests that RNASEH2A may not have been 
successfully targeted.
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Figure 4-8  The RNase H2A C-terminal AID degron tag in TK6 cells is 
non-functional.
Immunoblot of C-terminal mAID-tagged candidate TK6 cells probed with an 
anti-RNase H2A antibody.  Whole cell extract was taken either before addition 
of, or after the stated amounts of time of growth in 500 μM IAA.  The lack of 
decrease in signal over time suggests that the mAID tag does not cause 
signiﬁcant degradtion of RNase H2A
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Concurrent  with  our  screening,  the  Takeda  laboratory  carried  out  a  further  screen  for  
the   presence   of   the   mAID   tag   and   to   check   the   efficiency   of   protein   degradation  
following  growth   in   IAA.     C-­‐terminal  RNase  H2A  mAID-­‐tagged  TK6   cell   extracts  were  
immunoblotted  with  an  anti-­‐RNase  H2A  antibody  (Bethyl  A304-­‐149A)  after  growth  in  
500  µM  IAA  at  a  range  of  time  points  (Figure  4-­‐8).        The  signal  intensity  of  the  band  that  
is  presumed  to  correspond  to  mAID-­‐tagged  RNase  H2A  shows  no  decrease  in  time  even  
after  growth  in  IAA  for  48  hours.    Previous  work  in  the  Takeda  laboratory  (e.g.  Hoa  et  al.  
2015)  has  found  that  after  48  hours,  other  proteins  tagged  using  the  same  construct  
used  to  tag  RNase  H2A  with  mAID  are  significantly  degraded  which  would  suggest  that  
the  mAID  tag  on  RNase  H2A  was  not  functional.  
  
The  results  of  these  Western  blots  suggest  that  either  RNase  H2A  is  untagged  and  the  
bands  seen  at  ~55  kDa  using  Bethyl  antibody  A304-­‐149A  (Figure  4-­‐7,  top  panel)  are  non-­‐
specific  or  that  RNase  H2A  is  tagged  but  not  degraded  by  growth  in  auxin.    The  presence  
of   faint   bands   at   the   same  molecular  weight   as   tagged  RNase  H2A   in  wild   type   cell  
extract  using  Bethyl  antibody  A304-­‐149A  (Figure  4-­‐7,  top  panel)  suggest  that  this  band  
could  be  non-­‐specific,  however,  the  cells  provided  to  us  by  the  Takeda  laboratory  did  
express   eGFP   suggesting   that   the   mAID   tagging   construct   had   been   successfully  
incorporated  at  the  correct  locus.    No  decrease  in  GFP-­‐positive  cells  could  be  seen  after  
growth  in  1  mg/ml  IAA  for  24  hours  (data  not  shown)  suggesting  that  the  mAID-­‐eGFP  
was  expressed  but  non-­‐functional  in  TK6  cells.     It   is  possible  that  the  presence  of  the  
mAID-­‐eGFP  tag  masks  the  epitope  used  for  raising  Bethyl  antibody  A304-­‐150A  (Figure  
4-­‐7,  bottom  panel),  which  could  account  for  the  absence  of  a  band  at  ~55  kDa.  
  
4.4    Tagging  the  C-­‐terminus  of  RNase  H2A  with  a  novel  double  
degron  tag.  
   Concurrent  with  attempts  to  tag  the  C-­‐terminus  of  RNase  H2A  with  the  mini  AID  
degron  (mAID),  we  attempted  to  tag  the  RNase  H2A  C-­‐terminus  with  a  novel  double  
degron   tag   composed   of   mAID   fused   with   a   newly   published   self-­‐cleaving   Small  
Molecule  Assisted  Shutoff  degron  tag  (SMASh)   (Chung  et  al.  2015)   (Figure  4-­‐9).      The  




















Figure 4-9  Schematic illustration of the AID-SMASh system
A.  The SMASh tag consists of a HCV NS3 protease joined to a degron tag which is fused with the 
target protein via the recognition sequence for NS3.  Under normal conditions, the SMASh tag 
self-cleaves and is degraded by the proteasome allowing stable expression of the target protein.  
B.  Addition of the NS3 inhibitor asunaprevir (ASV) results in the proteasomal degradation of the 
majority of newly synthesised protein (bold arrow).  Addition of IAA allows degradation via the 
AID degron system (dashed arrows) in the event that SMASh self-cleaves from newly synthesised 
protein before interaction with ASV, and to degrade any residual protein from which SMASh had 
self-cleaved before ASV addition.
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SMASh  tag  is  a  self-­‐cleaving  degron  allowing  tunable  and  reversible  protein  degradation.    
It  consists  of  the  hepatitis  C  virus  (HCV)  NS3  protease  fused  with  a  degron  derived  from  
the   HCV   NS4A   protein,   joined   to   the   target   protein   via   the   NS3   protease   cleavage  
sequence.    The  NS3  protease  can  be  inhibited  by  a  number  of  non-­‐toxic,  cell  permeable  
drugs  including  asunaprevir  (ASV)  (Lamarre  et  al.  2003;  McPhee  et  al.  2012;  Talwani  et  
al.  2013;  Jiang  et  al.  2014).    In  the  absence  of  ASV,  the  protease  cleaves  itself  and  the  
degron  off  the  target  protein  allowing  stable  expression  of  the  protein.    In  the  presence  
of  ASV,  the  protease  activity  of  NS3  is  inhibited,  preventing  cleavage  of  the  degron  and  
targeting  the  protein  for  degradation  via  the  proteasomal  pathway.  
  
Theoretically  we  could  increase  the  efficiency  of  degradation  by  fusing  the  SMASh  tag  
with  the  mAID  tag.    We  hypothesized  that  upon  addition  of  ASV,  the  majority  of  newly  
synthesized  proteins  would  be  targeted  for  proteasomal  degradation  and  any  protein  
that  had  already  lost  the  SMASh  degron  would  be  degraded  via  the  mAID  tag  (Figure  4-­‐
9).    The  rationale  behind  this  approach  offers  three  distinct  advantages  over  the  tagging  
system  described  in  section  4.3  used  to  attempt  to  tag  RNase  H2A  with  a  mAID-­‐eGFP  
fusion.    Firstly,  the  AID  system  depends  upon  the  interaction  of  a  second  component  
SCFTIR1   mediated   by   auxin/IAA   for   degradation   whereas   the   SMASh   tag   is   a   single-­‐
component  system.    As  a  result,  it  is  presumed  that  the  SMASh  tag  offers  a  more  robust  
method  of  protein  degradation  than  mAID.    Secondly,  post-­‐translational  degradation  via  
the  SMASh  tag  can  only  target  proteins  synthesized  after  the  addition  of  ASV  allowing  
the  persistence  of   forms  of   the  protein   from  which   the  SMASh   tag  has  already   self-­‐
cleaved.    The  presence  of  the  mAID  tag  on  these  residual  proteins  therefore  allows  for  
their  degradation.    Thirdly,  since  the  C-­‐terminus  of  RNase  H2A  is  required  for  stabilizing  
the  formation  of  the  holoenzyme  by  interacting  with  the  RNase  H2B-­‐RNase  H2C  dimer  
(Reijns  et  al.  2011),  we  assumed  that  the  smaller  the  tag,  the  less  likely  it  would  be  to  
disrupt  trimer  formation.    It  is  possible  that  the  presence  of  the  eGFP  component  of  the  
tag  that  we  attempted  to  introduce  in  section  4.3,  which  was  unnecessary  for  protein  
degradation,   disrupted   formation   of   the   trimer   sufficiently   that   homozygous   tagging  
would  have  been  lethal.    By  removing  eGFP  from  this  construct,  it  was  hoped  that  the  
mAID  tag  alone  was  sufficiently  small  to  allow  for  trimer  formation.  
  
   91  
Attempts  to  tag  the  C-­‐terminus  of  RNase  H2A  with  an  AID-­‐SMASh  double  degron  were  
initially  carried  out  in  a  human  TK6  cell  line  constitutively  expressing  OsTIR1  from  the  
AAVS1  locus.    For  attempts  to  tag  RNase  H2A  with  the  AID-­‐SMASh  double  degron  we  
used  the  same  gRNA  sequence  and  repair  template  homology  arms  as  used  for  tagging  
with  the  mAID  degron  described  in  section  4.3.    The  repair  template  was  designed  such  
that   upon   repair   the   AID-­‐SMASh   degron   would   be   fused   to   the   terminal   exon   of  
RNASEH2A  via  a  short  peptide  linker  (GSGAGA).    The  repair  template  was  also  designed  
to   incorporate   a   LoxP-­‐flanked   antibiotic   resistance   marker   under   control   of   a   PGK  
promoter  allowing  for  selection  and  subsequent  marker  removal  (Figure  4-­‐10).    106  TK6  
cells  were  co-­‐transfected  with  200  ng  of  pX330  and  800  ng  repair  template  (either  800  
ng   of   G418R   or   hygromycinR   repair   template   or   400   ng   of   each)   using   Neon  
electroporation   (Invitrogen;  1350  V,  10  ms,  ×3  pulse,  10μl  Neon  tip).     48  hours  after  
transfection,  cells  were  selected  in  either  1  mg/ml  G418  or  625  µg/ml  hygromycin  to  
select   for   heterozygously   targeted   clones   or   both   1   mg/ml   G418   and   625   µg/ml  
hygromycin  to  select  for  homozygously  targeted  clones.    In  all  three  instances,  no  clones  
grew  following  selection.      
  
To   check   that   the   failure   to   generate   AID-­‐SMASh-­‐tagged   TK6   cells   was   not   cell   line  
specific  and  working  under  the  assumption  that  this  failure  may  have  been  due  to  the  
poor  transfection  efficiency  with  TK6  cells,  attempts  were  made  to  fuse  the  AID-­‐SMASh  
tag  to  RNase  H2A  in  human  retinal  pigment  epithelium  cells  (RPE1),  a  wild  type  cell  line  
immortalized  with  hTERT  which  offer  the  advantage  of  a  very  stable  karyotype  and  a  
modal  chromosome  number  of  46  in  over  90%  of  cells.    The  RPE1  cells  used  in  this  study  
express   OsTIR1   conditionally   from   the   ROSA26   locus  which  would   allow   for   protein  
degradation  via  the  mAID  degron.      Initially,  we  only  sought  to   isolate  heterozygously  
targeted  clones  since  we  still  assumed  that  presence  of  the  mAID  tag  could  prove  lethal  
if  present  homozygously.    106  RPE1  cells  were  transfected  with  0.5  µg  of  pX330  and  1.5  
µg  G418R  repair  template  using  Neon  electroporation  (Invitrogen;  10  µl  tip,  1350  V,  20  
ms,  2  pulses).     48  hours  after  transfection,  cells  were  selected  in  1  mg/ml  G418  for  2  
weeks  during  which  some  colonies  started  to  grow  very  slowly  but  after  several  rounds  
of  mitosis  all  cells  eventually  died.    A  subsequent  second  attempt  to  introduce  the  AID-­‐
SMASh   tag   to   the   C-­‐terminus   of   RNase   H2A   in   RPE1   cells   was  made   using   a   repair  



















Figure 4-10  RNASEH2A C-terminal AID-SMASh tagging strategy
A Cas9-induced double strand break is targeted as close as possible after the stop codon of the 
terminal coding exon of the gene.  The break is repaired by homology directed repair using a 
repair template designed such that both the endogenous stop codon and the 20bp gRNA 
sequence are excluded upon repair.  Integration of a LoxP-ﬂanked antibiotic resistance gene 
allows for selection and subsequent marker removal.  OsTIR1 is constitutively expressed 
ectopically from the AAVS1 locus.
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template  containing  a  gene  conferring  resistance  to  blasticidin  in  case  the  previous  slow  
growth  phenotype  was  anything  to  do  with  selection  in  G418.    Cells  were  transfected  
using  the  same  conditions  and  reagents  as  before  but  with  1.5  µg  of  blasticidinR  repair  
template  instead  of  the  G418R  template  and  48  hours  after  transfection  were  selected  
in  10  µg/ml  blasticidin  for  2  weeks.     As  with  selection  using  G418,  some  clones  grew  
during  selection  but  ultimately  died  within  2  weeks.      
  
Presuming  that  at  least  some  of  the  clones  that  started  to  grow  following  tagging  with  a  
C-­‐terminal  AID-­‐SMASh  tag  on  RNase  H2A  were  only  tagged  heterozygously,  we  assumed  
that  the  presence  of  a  C-­‐terminal  tag  on  RNase  H2A  would  be  lethal,  even  if  only  present  
at  one  allele.    As  such  we  decided  it  may  be  necessary  to  change  our  approach  and  target  
one  of  the  two  RNase  H2  accessory  subunits,  RNase  H2B  and  RNase  H2C.  
  
4.5      Regulating   RNase   H2B   and   RNase   H2C  with   a   C-­‐terminal  
double  degron  tag  in  human  RPE1  cells  
   Having  discovered  that  the  presence  of  a  C-­‐terminal  GFP  tag  on  both  RNase  H2B  
and   RNase   H2C   in   S.   pombe   had   an   undetectable   effect   on   catalytic   activity   of   the  
holoenzyme,  we  set  out  to  tag  the  C-­‐termini  of  both  accessory  subunits  with  a  double  
degron  tag  in  human  RPE1  cells.    Since  deletion  of  a  large  part  of  the  C-­‐terminus  of  RNase  
H2B  (residues  234-­‐312)  causes  only  a  very  slight  decrease  in  RNase  H2  catalytic  activity  
and  does  not  affect  trimer  formation   in  vitro  (Figiel  et  al.  2011),  it  was  expected  that  
disruption  of  this  terminus  with  a  degron  tag  may  have  little  effect  on  complex  stability  
and  activity.    In  contrast,  the  C-­‐terminus  of  RNase  H2C  is  essential  for  trimer  formation  
(Reijns  et  al.  2011)  so  we  expected  that  tagging  this  subunit  may  be  harder  due  to  the  
destabilizing  effect  of  the  degron  tag  on  trimer  formation.  
  
We  decided  to  attempt  to  tag  the  C-­‐terminus  of  RNase  H2B  or  RNase  H2C  with  a  double  
degron  tag  consisting  of  a  mini  AID  fused  with  a  SMASh  tag  which  functions  in  the  same  
way  as  described  in  section  4.4  and  Figure  4-­‐9.    This  work  was  carried  out  in  human  RPE1  
cells   that   conditionally   express   Os-­‐TIR1   from   the   ROSA26   locus   allowing   for   protein  



















Figure 4-11  RNASEH2A C-terminal AID-SMASh tagging alternative strategy
A Cas9-induced double strand break is targeted as close as possible to the stop codon of the 
terminal coding exon of the gene.  The break is repaired by homology directed repair using a 
repair template designed such that the original PAM sequence is mutated, preventing cutting of 
the repair template by Cas9, and the endogenous stop codon is excluded upon repair.  A P2A 
peptide between the SMASh tag and the antibiotic resistance marker (G418R) allows for 
selection.  OsTIR1 is constitutively expressed ectopically from the AAVS1 locus.
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degradation  via  the  mAID  degron.    The  knockin  construct  used  to  attempt  to  tag  the  C-­‐
termini  of  RNase  H2B  and  RNase  H2C  differed  from  that  used  to  attempt  to  tag  RNase  
H2A   in  TK6  cells   in   that   it  encoded  a   longer   linker  between   the  protein  and   the   tag  
(VGASAASAAGAGGASGSAAGGRVGSGAGA  compared  to  GSGAGA).    This  longer  linker  had  
been  previously  shown  to  work  for  tagging  other  proteins  with  the  mAID-­‐SMASh  double  
degron   and   it   was   hoped   that   its   greater   length   would   cause   increased   flexibility  
resulting   in   better   folding   of   the   tagged   RNase   H2B   and   RNase   H2C   and   increased  
interaction  with  protein  partners.    In  addition  antibiotic  resistance  was  conferred  by  in-­‐
frame  coupling  of  a  G418R  selection  marker  using  the  T2A  ribosomal  skipping  motif  (J.  
H.  Kim  et  al.  2011)  rather  than  via  integration  of  an  antibiotic  resistance  gene  with  its  
own   promoter.      This   system   offers   the   advantage   that   cells   should   only   develop  
antibiotic  resistance  following  integration  of  the  tagging  construct  at  the  correct  locus.    
A  further  advantage  of  using  this  tagging  construct  was  that  it  had  been  developed  by  
the  Hochegger  laboratory  and  had  been  used  to  successfully  degrade  several  proteins  
(unpublished  data)  so  we  knew  that  the  mAID-­‐SMASh  tag  in  this  form  was  functional.  
  
To  tag  the  C-­‐termini  of  RNASEH2B  and  RNASEH2C  with  the  mAID-­‐SMASh  double  degron  
tag,  106  human  RPE1  cells  were  co-­‐transfected  with  0.5  µg  of  pX330  expressing  a  gRNA  
designed  to  target  Cas9  to  as  close  as  possible  to  the  stop  codon  of  either  RNASEH2B  or  
RNASEH2C  and  1.5  µg  of  a  repair  plasmid  containing  ~500  bp  homology  arms  (Figure  4-­‐
11)  using  Neon  electroporation  (Invitrogen;  10  µl  tip,  1350  V,  20  ms,  2  pulses).    48  hours  
after   transfection,   transfected   cells  were   transferred   into  media   containing   1  mg/ml  
G418  for  21  days  to  select  single  successfully  targeted  clones.    For  tagging  of  RNase  H2B,  
more  than  20  clones  grew  and  18  were  expanded  for  further  screening.    For  tagging  of  
RNase  H2C,  7  clones  grew  and  were  expanded  for  further  screening.  
  
4.5.1      Screening  C-­‐terminal  mAID-­‐SMASh   tagged  RNase  H2B  candidates   for   correct  
integration  of  the  tagging  construct  
Following   selection   18   C-­‐terminal   mAID-­‐SMASh-­‐tagged   RNase   H2B   candidate  
clones  were  grown  up  and  whole  cell  extracts  were  immunoblotted  using  an  antibody  
against  RNase  H2B  (Invitrogen  MA523523)  to  check  for  the  presence  of  the  tag.    This  
antibody   is   raised  against  a   sequence  within   the  centre   region   of  RNase  H2B  so   the  
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presence   of   a   C-­‐terminal   tag   should   not   prevent   epitope   recognition.      Successfully  
tagged   RNase   H2B   should   result   in   a   band   at   ~50   kDa   which   would   represent   the  
combined  size  of  the  wild  type  protein  (~40  kDa)  plus  the  ~10  kDa  size  shift  caused  by  
the  presence  of  the  mAID  tag.    No  signal  should  be  visible  for  the  fully  mAID-­‐SMASh-­‐
tagged  version  of  the  protein  (~75  kDa)  as  the  SMASh  portion  of  the  double  degron  self-­‐
cleaves  upon  translation.      
  
A  band  corresponding  to  wild  type  RNase  H2B  (Figure  4-­‐12;  top  panel)  can  be  seen  in  all  
18  of  the  candidate  clones  and  in  wild  type  whole  cell  extracts  however  no  band  was  
present  at  the  size  corresponding  to  mAID-­‐tagged  RNase  H2B.     Whilst  high  exposure  
causes  the  appearance  of  bands  that  could  correspond  to  mAID-­‐tagged  RNase  H2B  in  
clones  12  and  13  (Figure  4-­‐12;  bottom  panel)  these  bands  are  significantly  weaker  than  
those  created  by  wild  type  RNase  H2B.    It  is  not  possible  to  determine  if  this  is  because  
the  bands  are  a  result  of  non-­‐specific  interactions  of  the  antibody,  or  if  the  protein  is  
being  made,  but  due  to  poor  folding  is  being  degraded.    Thus,  even  if  these  clones  were  
heterozygously  targeted  they  would  be  unsuitable  for  our  purposes  as  wild  type  RNase  
H2B  would   still  be  present   in   cells   resulting   in  a   certain   level  of  wild   type  RNase  H2  
activity.      Assuming   that   all   18   clones   screened   were   false   positives   and   therefore  
untagged  (or  only  tagged  heterozygously  and  the  protein  highly  unstable)  we  decided  
to  focus  further  work  on  the  C-­‐terminally  mAID-­‐SMASh-­‐tagged  RNase  H2C  clones.  
  
4.5.2      Screening   C-­‐terminal  mAID-­‐SMASh   tagged  RNase  H2C   candidates   for   correct  
integration  of  the  tagging  construct  and  efficient  protein  degradation  
   The   7   C-­‐terminal   mAID-­‐SMASh-­‐tagged   RNase   H2C   clones   that   grew   after  
selection  were  expanded  and  their  whole  cell  extracts  immunoblotted  with  an  antibody  
against  RNase  H2C  (Atlas  Antibodies  HPA065375)  (Figure  4-­‐13).    Clones  1  and  3  only  had  
a  signal  corresponding  to  wild  type  untagged  RNase  H2C  and  were  assumed  to  be  false  
positives.     Clone  4  had  bands  corresponding  to  both  wild  type  (~20  kDa)  and  tagged  
RNase  H2C  (~30  kDa)  and  was  assumed  to  be  targeted  heterozygously.    Clones  2,  5,  6  
and  7  only  had  bands  corresponding  to  tagged  RNase  H2C  and  had  lost  the  wild  type  
untagged  signal  and  were  therefore  assumed  to  be  targeted  homozygously  with  the  C-­‐
terminal  double  degron  tag.  
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Figure 4-12  RNASEH2B is not able to be C-terminally AID-SMASh 
tagged
RNASEH2B C-terminal AID-SMASh candidate clones were screened by 
immunoblotting using an antibody against RNase H2B.  Signal can be 
seen for endogenous wild type RNase H2B (~40 kDa), whilst no signal is 
detected at ~50 kDa which would represent RNase H2B tagged with AID 
only (the SMASh tag having self-cleaved) therefore all clones were 
assumed to be negative.








Figure 4-13  Tagging RNase H2C with a C-terminal AID-SMASh double 
degron tag
RNASEH2C C-terminal AID-SMASh candidate clones were screened by 
immunoblotting using an antibody against RNase H2C.  Clones 2, 5, 6 
and 7 only have a signal at a size corresponding to RNase H2C tagged 
with AID (the SMASh tag having already self-cleaved) and are assumed 
to be tagged homozygously.  Clone 4 has signal for both untagged and 
tagged RNase H2C and is assumed to be targeted heterozygously.  
Clones 1 and 3 only have a signal for untagged RNase H2C and are 












Figure 4-14  A C-terminal AID-SMASh double degron tag causes rapid 
depletion of RNase H2C in human RPE1 cells
Wild type RPE-1 cells and two C-terminally mAID-SMASh tag RPE1 
clones (5 & 6) were treated with 1 mg/ml IAA and 3 μM ASV, following 
2 hours growth in the presence of 1 μM doxycycline to drive 
expression of Os-TIR1 and immunoblotted using an antibody against 
RNase H2C.  Depletion of RNase H2C can be seen after 2 hours with 
comprehensive protein degradation seen after only 4 hours.
IAA + ASV (hrs) 0     2      4 0     2      4 0     2      4
25 kDa
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To  check  for  the  ability  of  the  double  degron  system  to  rapidly  deplete  tagged  RNase  
H2C,   two   clones   (5   and   6)   were   selected   for   further   screening.      These   clones  were  
selected  as  exemplars  expressing  close  to  wild  type  levels  of  tagged  RNase  H2C  (clone  
5)  and  expressing  reduced  levels  of  the  tagged  RNase  H2C  relative  to  wild  type  (clone  
6).    RPE1  cells  expressing  OsTIR-­‐1  from  the  ROSA26  locus  under  control  of  tetracycline-­‐
controlled  transcriptional  activation  that  were  otherwise  wild  type  and  clones  5  and  6  
were  pre-­‐treated  with  1  µM  doxycycline  for  2  hours  to  drive  expression  of  OsTIR1  then  
grown  in  media  containing  1  µM  doxycycline,  1  mg/ml  IAA  and  3  µM  ASV;  samples  were  
taken   before,   or   2   and   4   hours   after,   addition   of   IAA   and  ASV.      Protein   levels  were  
determined   by   immunoblotting   with   an   antibody   against   RNase   H2C   (Figure   4-­‐14).    
Marked  RNase  H2C  depletion  can  be  seen  after  2  hours  growth  in  IAA  and  ASV  in  both  
clones  5  and  6  with  undetectable  levels  of  the  protein  after  just  4  hours.    The  low  level  
of   total   protein   loaded   at   the   4-­‐hour   time   point   for   clone   5   prevents   definitive  
conclusions  being  drawn  about  RNase  H2C  depletion  but  it  is  assumed  that  RNase  H2C  
levels   decrease   in   the   same   manner   as   seen   for   clone   6.      Interestingly,   levels   of  
endogenous  RNase  H2C  in  wild  type  cells  decrease  as  time  in  IAA-­‐and  ASV-­‐containing  
growth  medium  increases  however  this  phenomenon  has  been  reported  in  the  case  of  
other  proteins  in  the  case  of  persistent  OsTIR1  expression  (Natsume  et  al.  2016).  
  
4.6     Two-­‐tiered  regulation  of  RNase  H2C  at   the  transcriptional  
and  protein  level  
   In  parallel  to  the  work  carried  out  in  section  4.5  we  developed  a  system  whereby  
expression  of  RNase  H2C  could  be  regulated  by  a  two-­‐tier  system  targeting  transcription  
and  protein  stability.    The  transcriptional  regulation  system  of  the  Tn10  bacterial  operon  
has  been   repurposed   for  use   in  eukaryotic   systems   to   switch   transcription  on   in   the  
presence  (Tet-­‐on)  or  absence  (Tet-­‐off)  of  Tetracycline  (Tc)  and  its  more  stable  derivative  
doxycycline  (dox)  (Gossen  &  Bujard  1992;  Gossen  et  al.  1995).    The  Tet-­‐on  system  was  
developed  by  fusing  the  transcription  activation  domain  of  herpes  simplex  virus  VP16  
protein   to   a   mutant   reverse   Tet   Repressor   protein   (rTetR)   to   form   the   reverse  


























Figure 4-15  Schematic of the Tet-on method of tetracycline-controlled transcriptional 
activation
A.  In the absence of doxycycline, the reverse tetracycline-controlled transactivator (rtTA) is 
unable to bind to the TRE3GS promoter and transcription is shut oﬀ.  B.  A conformational 
change in rtTA brought about by interaction with doxycycline allows binding of rtTA to tet 
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Figure 4-16  Schematic illustration of the two-tiered mechanism of regulating ectopic expression 
of RNase H2C
A.  Transcription of C-terminally SMASh-tagged RNASEH2C can be driven by the interaction of the 
reverse tetracycline-controlled transactivator (rtTA) with the TRE3GS promoter in the presence of 
doxycycline.  In the absence of asunaprevir (ASV), the SMASh tag self-cleaves allowing stable 
protein expression.  B.  In the absence of doxycycline or tetracycline, transcription is turned oﬀ.  In 
the event of leakiness in the system (dashed arrow), any synthesised RNase H2C is targeted for 
proteasomal degradation via the SMASh degron in the presence of ASV.
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tetracycline-­‐controlled  transcriptional  activator  (rtTA)  that  binds  the  tet  operator  and  
drives  transcription  in  the  presence  of  Tc/dox  (Figure  4-­‐15).  
  
We   hoped   that   we   could   significantly   downregulate   transcription   of   RNase   H2C   by  
placing  it  under  the  control  of  the  TRE3GS  promoter  (Heinz  et  al.  2011)  and  expressing  
it  ectopically  at  the  ROSA26  locus.    Despite  the  tight  control  of  gene  transcription  offered  
by   the  TRE3GS  promoter   (Loew  et  al.  2010;  Heinz  et  al.  2011)   some   leakiness   in   the  
system  is  expected.    In  the  event  that  transcriptional  leakiness  allowed  expression  of  
some  protein,  we  added  an  N-­‐terminal  SMASh  tag  (Chung  et  al.  2015)  to  RNase  H2C  
which  would  allow  for  protein  degradation  via  the  proteasomal  pathway  (Figure  4-­‐16).  
  
This   work  was   carried   out   in   HT1080  HP-­‐I-­‐RT   cells   that   contain   an   I-­‐SceI   restriction  
enzyme  recognition  sequence  within  exon  6  of  the  HPRT  gene  as  described  in  section  
3.3.1.    It  was  hoped  that  using  a  cell  line  containing  a  site  for  inducible  double  strand  
break   (DSB)   formation   may   prove   useful   further   down   the   line   if   we   wished   to  
investigate  DNA  replication  dynamics  in  the  context  of  a  specific  DSB.    To  integrate  the  
this  two-­‐tiered  expression  system  at  the  ROSA26  locus,  106  HT1080  HP-­‐I-­‐RT  cells  were  
transfected   using  Amaxa   nucleofection   (Kit   T,   programme   L-­‐005)  with   0.4  µg   pX330  
encoding  a  gRNA  targeting  Cas9  to  a  region  within  the  ROSA  26  locus  and  1.6  µg  of  repair  
template.    The  repair  template  was  designed  such  that  repair  of  the  Cas9-­‐induced  DSB  
would  incorporate  a  cassette  containing  three  different  components:    1)  a  PGK  promoter  
driving  constitutive  expression  of  the  rtTA  (Tet-­‐on  protein);  2)  an  N-­‐terminally  FLAG-­‐
SMASh-­‐tagged,  human  codon  optimised,  Cas9-­‐resistant  RNASEH2C  cDNA  and  3)  an  SV40  
promoter  driving  constitutive  expression  of  a  zeocin  resistance  gene  (Figure  4-­‐17).  
  
48  hours  after  transfection,  cells  were  transferred  to  growth  medium  containing  400  
µg/ml  zeocin  for  14  days  to  isolate  single  successfully-­‐targeted  clones.    To  minimise  the  
risk  of  zeocin-­‐mediated  DNA  damage,  cells  were  selected  in  a  concentration  of  zeocin  at  
the  lower  end  of  the  concentration  required  to  kill  cells  in  a  kill  curve  experiment  (kill  
curve  data  not  shown).    To  show  that  clones  that  survived  selection  in  zeocin  did  so  due  
to  integration  of  the  zeocin  resistance  gene  (ZeoR)  and  not  due  to  the  low  concentration  
of  zeocin  used  for  a  selection,  an  initial  PCR  screen  was  used  to  verify  presence  of  ZeoR  











Figure 4-17  Two-tiered regulation of RNase H2C knockin strategy
A cas9-induced double strand break is targeted within the ROSA26 locus.  Repair of the break by 
homology directed repair introduces a cassette that constitutively expresses the reverse 
tetracycline-controlled transactivator (rtTA) and confers zeocin resistance (ZeoR) to successfullly 
targeted cells.  Additionally the cassette contains human codon optimised, cas9-resistant 
RNASEH2C cDNA tagged N-terminally with both ﬂag and SMASh tags, under control of the 
TRE3GS promoter.
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using  forward  and  reverse  primers  that  both  annealed  within  ZeoR  (Figure  4-­‐18  A).    All  
13   of   the   clones   screened   contained   ZeoR   and   were   therefore   assumed   to   have  
integrated  the  repair  template.    A  further  PCR  to  verify  integration  of  the  repair  template  
at  the  correct  locus  was  carried  out  using  a  forward  primer  that  anneals  within  ZeoR  and  
a   reverse   primer   that   anneals   outside   the   region   used   for   the   right   homology   arm.    
Despite  several  attempts  to  optimise  the  PCR  using  different  combinations  of  primer  
sequences  and  a  variety  of  thermocycling  parameters,  no  conclusive  data  was  obtained  
from  this  experiment  (data  not  shown).    Since  all  of  the  components  required  for  this  
two-­‐tiered   system   were   contained   within   the   knockin   construct   and   were   not  
dependent  on  regulatory  sequences  within  or  around  the  ROSA26  locus,  it  was  decided  
that  even  random  integration  within  the  genome  would  be  suitable  for  our  purposes  so  
no  further  work  was  carried  out  to  ascertain  the  location  of  cassette  integration.  
  
To  check  for  expression  of  N-­‐terminally  SMASh-­‐tagged  RNase  H2C,  10  candidate  clones  
were  grown  for  24  hours  in  medium  containing  1  µM  doxycycline  and  3  µM  ASV  with  
the   final   4   hours   either   with   or   without   10   µM   MG132   proteasome   inhibitor   and  
immunoblotted  using  an  anti-­‐FLAG  antibody  which  recognises  the  FLAG  epitope  placed  
upstream  of  the  SMASh  tag  in  this  construct  (Figure  4-­‐18  B).    In  this  system,  doxycycline  
drives  overexpression  of  the  SMASh-­‐tagged  RNase  H2C  whilst  ASV  prevents  SMASh  tag  
self-­‐cleavage.    To  allow  stable  expression  of  the  SMASh-­‐tagged  RNase  H2C  and  detection  
of   the   tagged  protein  via   the  FLAG   tag,  protein   degradation  was   inhibited  by  use   of  
MG132.    SMASh-­‐tagged  RNase  H2C  (~55  kDa)  can  be  seen  in  clones  1,  2,  3,  6,  7,  9  and  
12  with  an  increase  in  signal  for  each  seen  4  hours  after  addition  of  MG132  showing  that  
degradation  occurs  via  the  proteasomal  pathway.    It  is  assumed  that  the  differences  in  
expression  level  of  the  tagged  RNase  H2C  can  be  accounted  for  by  either  heterozygous  
(low  expression)  or  homozygous  (high  expression)  integration  of  the  knockin  construct  
or   by   homozygous   (low   expression)   or   multiple   random   integration   of   the   knockin  
construct  (high  expression).  
  
A   further   immunoblot   using   an   antibody   against   RNase   H2C   (Atlas   Antibodies  
HPA065375)  was  carried  out  on  the  four  clones  that  express  the  highest  levels  of  SMASh-­‐
tagged  RNase  H2C  as  seen  in  Figure  4-­‐18  B  (clones  1,  2,  6  and  9;  Figure  4-­‐18  C)  using  the  
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Figure 4-18  N-terminally SMASh-tagged RNase H2C can be ectopically expressed from the 
ROSA26 locus in human HT1080 cells and is degraded via the proteasomal pathway.
A.  Clones were screened by PCR using primers that anneal within ZeoR to verify the presence of 
the zeocin resistance gene (ZeoR) in the genome of targeted cells.  B.  To check for the presence of 
the SMASh tag and to verify that degradation occurs via the proteasome, clones were grown in 
media supplemented with 1 μM doxycycline to drive expression of ectopically expressed 
SMASh-tagged RNase H2C and screened by immunoblot using an anti-ﬂag antibody either before, 
or 4 hours after, addition of the proteasome inhibitor MG132 (25 μM).  Clones 1-3, 6, 7, 9 & 12 
were successfully targeted and the increased signal in the presence of MG132 indicates 
proteasomal degradation.  C & D.  Clones expressing higher levels of tagged RNase H2C as 
determined from ﬁgure B (C; clones 1, 2, 6, 9.  D; clones 2, 9) and those expressing lower levels (D; 
clones 3, 7) were treated as in B and analysed by immunoblotting using an antibody against RNase 
H2C.  The self-cleaving of the SMASh-tag leaves a short peptide on the N-terminus of RNase H2C 
resulting in a slight upshift in molecular weight in relation to endogneous RNase H2C, seen in the 
middle panels of C and D.
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same  drug-­‐treatment  conditions  as  described  in  the  previous  section.    As  before,  all  4  
candidate  clones  have  bands  at  ~55  kDa  corresponding  to  full  length,  uncleaved  SMASh-­‐
tagged  RNase  H2C  in  addition  to  a  band  corresponding  to  endogenous  RNase  H2C  (~20  
kDa).    Cleavage  of  the  SMASh  tag  leaves  a  short  peptide  at  the  N-­‐terminus  of  ectopically  
expressed  RNase  H2C  consisting  of   the   linker  and  a  part  of   the   protease   recognition  
sequence.    This  peptide  results  in  a  slight  upshift  in  molecular  weight  which  can  be  seen  
for  all  4  candidate  clones,  but  in  particular  for  clone  1  at  the  4-­‐hour  time  point.    Together  
these   results   indicate   that   doxycycline   drives   transcription   of   ectopically   expressed  
SMASh-­‐tagged   RNase   H2C   and   that   the   SMASh-­‐tag   is   functional   in   terms   of   self-­‐
cleavage.  
  
In  the  event  that  it  would  be  advantageous  to  have  lower  overall  cellular  levels  of  the  
ectopically  expressed  SMASh-­‐tagged  RNase  H2C,  a  further  immunoblot  was  carried  out  
using   the   same   methods   as   described   for   Figure   4-­‐18   C   to   check   that   clones   that  
expressed   low   levels   of   SMASh-­‐tagged   RNase   H2C   when   probed   with   an   anti-­‐FLAG  
antibody  (clones  3  &  7)  showed  similar  low  expression  when  probed  with  an  anti-­‐RNase  
H2C  antibody   (Figure   4-­‐18  D).     Clone   3  exhibited   lower  expression  of   SMASh-­‐tagged  
RNase  H2C   than  a  previously   identified  high  expressor   (clone  2);   by   contrast   clone  3  
showed  higher  expression  than  another  previously  identified  high  expressor  (clone  9).    
Furthermore,  clone  7  showed  expression  levels  of  SMASh-­‐tagged  RNase  H2C  similar  to  
clone  2.    Despite  the  inconsistencies,  the  data  from  this  immunoblot  do  however  suggest  
that  clone  3  would  be  a  suitable  candidate  for  a  clone  expressing  low  levels  of  SMASh-­‐
tagged  RNase  H2C.  
  
To   assess   the   extent   to   which   the   tetracycline-­‐controlled   transcriptional   activation  
system  could  downregulate  expression  of  SMASh-­‐tagged  RNase  H2C,  candidate  clones  
were  cultured  for  24  hours  either  in  growth  medium  supplemented  with  Tet-­‐free  serum,  
regular  serum  or  regular  serum  with  1  µM  doxycycline  and  immunoblotted  using  an  anti-­‐
RNase  H2C  antibody  (Atlas  Antibodies  HPA065375)  (Figure  4-­‐19  A).    For  all  four  clones  
screened  (1,  2,  6  &  9),  growth  in  doxycycline  causes  overexpression  of  SMASh-­‐tagged  
RNase  H2C  as  seen  by  the  presence  of  a  strong  band  at  a  molecular  weight  slightly  above  
that  of  endogenous  RNase  H2C.    The  absence  or  near-­‐absence  of  a  band  corresponding  
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Figure 4-19  Ectopically expressed RNase H2C can be downregulated in a two-tiered manner by 
tetracycline-controlled transcriptional acitvation and SMASh tag-mediated degradation.
A.  To assess the ability of the Tet-on system to shut oﬀ transcription of RNASEH2C, cells were 
grown for 24 hours in DMEM supplemented with 1 μM doxycycline (+), DMEM with regular FCS (R) 
or DMEM with tetracycline-free FCS (TF) and immunoblotted using an antibody against RNase 
H2C.  Growth in doxycycline resulted in overexpression of  SMASh-tagged RNase H2C whilst cells 
grown in regular or tet-free media have expression of RNase H2C shut oﬀ at the transcriptional 
level.  B.  To assess the ability of the two-tiered system to knock down expression of RNase H2C, 
cells were grown in regular media (R) or tet-free media either with or without Asunaprevir (ASV) 
and immunoblotted with an anti-RNase H2C antibody.  Downregulating RNase H2A at the 
transcriptional and protein levels results in a strong knockdown of the protein.
*
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to  endogenous  RNase  H2C  for  all  four  clones  when  grown  in  doxycycline  suggests  that  
expression  of  endogenous  RNase  H2C  is  transcriptionally  downregulated.    For  all  four  
clones  growth  in  medium  containing  regular  serum,  which  may  contain  trace  amounts  
of  tetracycline  resulting  in  some  transcriptional  leakiness,  and  medium  containing  tet-­‐
free  serum  expression  of  SMASh-­‐tagged  RNase  H2C  was  undetectable  suggesting  very  
tight  transcriptional  control.  
  
To  check  whether  growth   in  ASV   in  combination  with  transcriptional  downregulation  
would  have  an  additive  effect  on  protein  expression   in  comparison  to  transcriptional  
downregulation   only,   cells   were   grown   in   the   presence   or   absence   of   3   µM  ASV   in  
medium  supplemented  with  either  regular  serum  or  tet-­‐free  serum  and  immunoblotted  
using  an  antibody  against  RNase  H2C  (Atlas  Antibodies  HPA065375)  (Figure  4-­‐19  B).    Due  
to  the  tight  downregulation  of  SMASh-­‐tagged  RNase  H2C  in  the  absence  of  doxycycline  
seen  in  Figure  4-­‐19  B,  it  is  unsurprising  that  for  all  4  clones  screened,  no  signal  is  seen  at  
a  size  corresponding  to  ectopically  expressed  RNase  H2C  from  which  the  SMASh  tag  has  
self-­‐cleaved.      It   is  however  assumed   that  any  SMASh-­‐tagged  RNase  H2C  synthesized  
after  addition  of  ASV  is  directly  degraded  and  would  have  no  additive  effect  on  the  signal  
seen  just  above  the  band  corresponding  to  endogenous  RNase  H2C.  
  
4.7    DISCUSSION  
   In   this   chapter   I  have  shown   that   the  C-­‐terminus  of  RNase  H2A   is  not  a  valid  
target   for  homozygous  tagging  with  a  range  of  degron  tags,  despite  the  homologous  
protein  in  S.  pombe  tolerating  a  C-­‐terminal  GFP  tag.    Through  failure  to  C-­‐terminally  tag  
endogenous  RNase  H2B  with  an  mAID-­‐SMASh-­‐tag  in  RPE1  cells  as  described  in  section  
4.5.1,  I  have  shown  that  it  is  likely  not  possible  to  introduce  large  tags  to  the  C-­‐terminus  
of  RNase  H2B.    Furthermore,  unsuccessful  attempts  to  generate  HT1080  HP-­‐I-­‐RT  cells  
expressing  N-­‐terminally   SMASh-­‐tagged  RNase  H2B   from   the  ROSA26   locus   using   the  
same  methods  described  in  4.5.2  (data  not  shown)  suggest  that  the  N-­‐terminus  of  RNase  
H2B  may  also  be  unsuitable  for  tagging.    In  the  latter  case,  some  colonies  grew  following  
selection  but  died  after  a  few  cell  cycles,  despite  the  persistence  of  endogenous  RNase  
H2B.    It  was  thought  in  this  case  that  expression  of  the  tagged  version  of  RNase  H2B  was  
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sufficiently   high   in   comparison   to   expression   of   endogenous   RNase   H2B   that   the  
majority  of  RNase  H2B-­‐RNase  H2C  heterodimers  were  formed  using  the  tagged  version  
of  RNase  H2B  and  that  the  presence  of  the  tag  prevented  association  of  the  RNaseH2B-­‐
RNase   H2C   dimer  with   RNase   H2A.      Furthermore,   it  was   assumed   that   the   damage  
resulting  from  persistent  genomic  ribonucleotides  caused  by  the  failure  to  form  stable  
RNase  H2  trimers  was  tolerated  for  a  certain  time  before  proving  lethal.  
  
I  have  developed  two  different  systems  to  downregulate  expression  of  RNase  H2C   in  
two  different  human  cell  lines.    Despite  the  efficacy  of  the  N-­‐terminally  SMASh-­‐tagged  
RNase   H2C   under   the   control   of   tetracycline-­‐controlled   transcriptional   activation  
generated  in  HT1080  cells,  further  work  in  these  cells  was  halted  due  to  time  constraints  
and   the   requirement   to   knock   out   endogenous   RNase   H2C   before   any   studies   on  
holoenzyme  activity   could  be  carried  out.      Further   screening   to  assess   the   impact  of  
RNase  H2C  depletion  via  the  double  degron  tag  described  in  section  4.5  is  carried  out  
and  described  in  chapter  5.  
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Chapter  5  
Developing  an  assay  to  quantify  
ribonucleotide  incorporation  in  human  
genomic  DNA  
5.1    Introduction  
   Key   to   the   methodology   of   Polymerase   Usage   Sequencing   (PU-­‐seq)   is   the  
persistence  of  ribonucleotides  misincorporated  into  genomic  DNA  by  DNA  polymerases  
containing  active  site  mutations  that  decrease  their  fidelity.    For  PU-­‐seq  in  S.  pombe,  the  
catalytic   subunit   (RNase   H2A)   of   RNase   H2,   the   major   enzyme   responsible   for   the  
removal  of  misincorporated  ribonucleotides,  is  knocked  out.    As  described  in  chapter  4  
RNase  H2A  knockout  is  not  possible  in  most  human  cells  so  we  developed  a  system  in  
which  an  accessory  subunit  of  RNase  H2,  RNase  H2C,  can  be  conditionally  knocked  down  
via  a  C-­‐terminal  mAID-­‐SMASh  double  degron  tag.    To  assess  the  impact  on  RNase  H2  
catalysis   of  mAID-­‐SMASh-­‐mediated   RNase   H2C  depletion,   we   needed   to   develop   an  
assay   that   would   allow   us   to   examine   the   decrease   in   ribonucleotide   removal   from  
genomic  DNA.     Moreover,   it  was   hoped   that   this   assay  would   be   useful   to   us  when  
screening   candidate   ribo-­‐incorporating   mutations   in   the   two   major   replicative  
polymerases.  
  
Work  in  this  chapter  therefore  focuses  on  the  development  of  such  an  assay  as  well  as  
recapitulating  two  previously  published  methods  to  assess  RNase  H2  activity  in  vitro  and  
to  infer  the  extent  of  ribonucleotide  incorporation  in  genomic  DNA.  
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5.2      Quantifying   ribonucleotide   incorporation   by   alkaline  
hydrolysis  and  alkaline  agarose  gel  electrophoresis  
     The   current   method   used   in   the   Carr   laboratory   to   assess   the   extent   of  
ribonucleotide  (rNTP)  incorporation  in  strains  of  S.  pombe  that  are  used  in  Polymerase  
Usage  sequencing  experiments  involves  treating  5  µg  genomic  DNA  extracted  from  each  
strain  with  0.3  M  KOH  or  NaOH  at  55°C  for  2  hours.    The  alkali-­‐treated  gDNA  was  then  
resolved  on  a  1%  alkaline  agarose  gel.    The  presence  of  the  2’-­‐OH  on  the  ribose  moiety  
of  a  misincorporated  rNTP  embedded  in  gDNA  causes  the  sugar  phosphate  backbone  at  
this  point  to  be  5  times  more  susceptible  to  alkaline  hydrolysis  (Clausen  et  al.  2015);  as  
such,  the  greater  the  amount  of  rNTPs  incorporated  within  gDNA,  the  greater  the  extent  
of   smearing   is   seen   on   agarose   gels   due   to   the   increased   hydrolysis   of   the   DNA  
backbone.      This   increase   in   smearing   of   alkali-­‐treated   gDNA   can   be   seen   when  
comparing  strains  of  S.  pombe  containing  increasingly  more  effective  methods  of  RNase  
H2A  knockdown  that  result  in  decreasing  levels  of  cellular  RNase  H2  activity  (Figure  5-­‐1  
A).  
  
We  suspect  that  the  increased  complexity  of  human  genomic  DNA  in  comparison  to  that  
of  S.  pombe  may  make   this  method  unsuitable   for  assessing  genomic   ribonucleotide  
incorporation.    In  order  to  test  this  theory,  we  were  able  to  use  genomic  DNA  from  two  
well   characterized   Aicardi-­‐Goutières   Syndrome   (AGS)   patient   cell   lines   containing  
hypomorphic  mutations   in   either   RNase  H2AG37S   or   RNase  H2BA177T   (a   kind   gift   from  
Professor  Andrew  Jackson).    1.6  µg  gDNA  from  each  of  the  two  patient  cell   lines  and  
from  a  wild  type  lymphoblast  cell  line  (a  kind  gift  from  Professor  Mark  O’Driscoll)  were  
treated   with   0.3M   KOH   at   55°C   for   2   hours   and   subjected   to   1%   agarose   gel  
electrophoresis  alongside  untreated  gDNA  from  each  of  the  three  cell  lines  (Figure  5-­‐1  
B).     Since  the  reduction   in  RNase  H2  activity   in  cells  containing  the  G37S  mutation   is  
more  severe  than  in  cells  containing  the  A177T  mutation,  and  both  have  lower  activity  
than  wild  type  RNase  H2  (Pizzi  et  al.  2015)  we  would  expect  to  see  a  greater  level  of  
smearing  of  gDNA  following  alkaline  hydrolysis  and  gel  electrophoresis  from  wild  type  





































Figure 5-1  Alkaline hydrolysis and gel elctrophoresis is an unsuitable method to 
assess human genomic ribonucleotide incorporation
A.  Alkali-treated gDNA from strains of S. pombe containing increasingly eﬃcient 
mechanisms to downregulate expression of RNase H2A.  Lower cellular RNase H2 
levels result in greater smearing of gDNA due to increased alkaline hydrolysis at sites 
of genomic ribonucleotides.  Image from Catherine Doust MSc dissertation.  B.  
Genomic DNA from human cell lines with the indicated genotypes was left 
untreated or treated with 0.3M KOH at 55˚C for 2 hours and subjected to 1% 
agarose gel electrophoresis.  The resultant DNA signal following alkaline hydrolysis 
was too diffuse to determine differences between treated samples.  C.  Genomic 
DNA was treated as in B and subjected to 2% agarose gel electrophoresis.  No 
discernable difference in signal intensity could be seen between treated samples 
from cell lines with different levels of RNase H2 activity and wild type cells.
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to  A177T  and  from  A177T  to  G37S,  however  the  extent  of  hydrolysis  in  all  three  samples  
was  sufficiently  high  that  no  information  could  be  determined  from  this  assay.  
  
To  increase  the  signal  intensity  for  alkali-­‐treated  gDNA  following  gel  electrophoresis,  1.2  
µg  gDNA  from  the  three  cell  lines  was  treated  with  0.3  M  KOH  at  55°C  for  2  hours  as  
before,  but  resolved  on  a  2%  agarose  gel  and  run  alongside  0.4  µg  untreated  gDNA  from  
each  of  the  cell  lines  (Figure  5-­‐1  C)  in  a  similar  assay  as  described  for  S.  pombe  in  section  
4.2.2.    Whilst  the  bands  for  each  of  the  alkali-­‐treated  samples  appear  more  diffuse  than  
their  corresponding  untreated  samples,  there  is  no  discernable  difference  between  the  
three   alkali-­‐treated   samples,   suggesting   that   this   method   of   assessing   genomic  
ribonucleotide  incorporation  is  unsuitable  for  human  gDNA.  
  
5.3     Developing   a   genomic   ribonucleotide   incorporation   assay  
using  an  Arabidopsis  thaliana  tRNA  ligase  
     
5.3.1    Arabidopsis  thaliana  tRNA  Ligase  
As  described  in  section  5.2  the  current  method  used  by  the  Carr  laboratory  to  
assess  the  extent  of  unrepaired  ribonucleotides  in  genomic  DNA  in  S.  pombe  involves  
extracting  gDNA   from   the   required   strains,   treating   it  with  alkali   and   subjecting   it   to  
agarose  gel  electrophoresis.    As  shown  in  section  5.2,  this  method  is  unsuitable  for  use  
with  human  gDNA  and  furthermore  this  method  does  not  discriminate  between  breaks  
caused  by  alkaline  hydrolysis  at  sites  of  genomic  ribonucleotides  and  stochastic  DNA  
breaks  (Figure  5-­‐2  A).  
  
In   developing   an   assay   sensitive   enough   to   detect   differences   in   ribonucleotide  
incorporation  between  different  human  cell   lines  and  with  the  ability  to  discriminate  
between  fragments  of  DNA  with  ribonucleotides  at  the  3’  termini  and  those  fragments  
arising   as   a   result   of   stochastic   breaks   between   neighbouring   deoxyribonucleotides  
following  alkaline  hydrolysis,  we  decided  to  exploit  the  distinctive  ligation  mechanism  
of   an  Arabidopsis   thaliana   tRNA   ligase   (AtRNL).      Alkaline   hydrolysis   at   the   site   of   a  


















Figure 5-2  Arabidopsis thaliana tRNA ligase mechanism and assay principle
A.  Following alkaline hydrolysis, genomic DNA from polymerase usage sequencing cells breaks at 
sites of ribonucleotides (rNTPs; red and blue dots) leaving single stranded DNA fragments terminat-
ing with an rNTP moiety at the 3’ end.  A further source of DNA breaks arises through stochastic 
breaks between adjacent deoxyribonucleotides.  B.  Upon alkaline hydrolysis, rNTP termini form 
either 2’,3’-cyclic phosphate or 2’-phosphate moieties.  Arabidopsis thaliana tRNA ligase (AtRNL) 
performs two key functions to speciﬁcally select for DNA fragments terminating with these rNTP 
moieties:  it ﬁrst converts any cyclic phosphate groups into 2’-phosphates and it then ligates the 5’ 
termini of other nucleotides to these ends .  C.  Ligating an internally biotinylated oligonucleotide 
pre-adenylated at the 5’ end and blocked at the 3’ end with dideoxycytidine (ddC) allows for 
probing with a streptavidin-HRP conjugate.
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genomic   ribonucleotide   leaves   either   2’-­‐phosphate   or   2’,3’-­‐cyclic   phosphate   termini.  
AtRNL   possesses   two   catalytic   activities   that   allow   it   to   select   only   those   fragments  
terminating  in  a  ribonucleotide:    firstly,  it  converts  2’,3’-­‐cyclic  phosphate  groups  to  2’-­‐
phosphates  and  it  then  ligates  these  2’-­‐phosphate  termini  to  the  5’  end  of  DNA  or  RNA  
(Schutz  et  al.  2010;  Koh  et  al.  2015)  (Figure  5-­‐2  B).      
  
5.3.2    Quantifying  ribonucleotide  incorporation  using  biotin  
Our   initial   intention   was   to   use   a   commercially   available   Quant*Tag   biotin  
quantitation   kit   (Vector   Laboratories)   to   quantify   how   many   moles   of   biotinylated  
oligomer   ligated   to   ribo-­‐terminating   ends   of   alkali-­‐treated   gDNA   were   present   in   a  
sample.     Strains  of  S.  pombe  with  rnh201,   the  gene  encoding  the  catalytic  subunit  of  
RNase  H2,  knocked  out  are  estimated  to   incorporate  at   least  one  ribonucleotide  per  
3000  nucleotides  polymerized.    1  µg  of  gDNA  from  rnh201D  would  therefore  contain  
~3´1011  ribonucleotides  meaning  that  the  Quant*Tag  kit  and  subsequent  assays  would  
have  to  be  sensitive  to  quantities  of  biotin   in  the  range  of  1-­‐10  pmoles.     To  test  the  
sensitivity  of  the  Quant*Tag  kit  and  in  order  to  plot  a  standard  curve  from  which  future  
quantities   of   biotin   could   be   inferred   a   range   of   quantities   from   0.01-­‐10   nmol   of  
biotinylated   oligomer   were   prepared   as   per   the   manufacturer’s   instructions   and  
subjected   to   spectrophotometry.     Whilst   quantities   of   biotin   in   excess   of   0.05   nmol  
provided  absorbance   readings  >0.001,  quantities  below   this  amount  were  below   the  
range  of  sensitivity  of  the  spectrophotometer  (Table  5-­‐1)  and  as  such  it  was  decided  to  
proceed   with   experiments   using   streptavidin-­‐alkaline   phosphatase   (AP)   to   quantify  
biotin.  
  
5.3.3    The  principle  of  the  ribonucleotide  incorporation  assay  using  AtRNL  
Following  alkaline  hydrolysis  of  genomic  DNA  from  PU-­‐seq  cell  lines,  we  hoped  
that  we  would  be  able  to  use  AtRNL  to  ligate  internally  biotinylated  DNA  oligomers  to  
ribo-­‐terminating  gDNA  fragments  and  visualize  the  resultant  ligation  products  using  a  
streptavidin-­‐HRP  or  streptavidin-­‐AP  conjugate  (Figure  5-­‐2  C).    This  process  would  require  
six   steps:      1)   alkaline   hydrolysis   of   genomic   DNA;   2)   ligation   of   biotinylated  
oligonucleotide  to  2’-­‐phosphate  groups;  3)  removal  of  unligated  oligomers;  4)  transfer  
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Table 5-1  Quant*Tag spectrophotometer absorbance values
The stated amounts of biotinylated 18mer oligonucleotide were 
prepared using the Quant*Tag biotin quantitation kit and analysed by 
spectrophotometry.  Amounts of biotin below 0.05 nmol were 
undetectable by this assay.  NR = no reading.
0.01
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of   ligated   DNA   fragments   to   a   membrane;   5)   hybridization   of   streptavidin-­‐HRP/AP  
conjugate   to   biotinylated   DNA   fragments;   6)   chemiluminescent   visualization   and  
quantification  of  HRP/AP  to  determine  molar  quantity  of  biotin  in  the  sample.  
  
5.3.4    Optimizing  biotin  quantification  using  streptavidin-­‐alkaline  phosphatase  
   To  assess  the  sensitivity  of  detecting  and  differentiating  between  quantities  of  
biotin  in  the  predicted  range  (~1-­‐10  pmoles)  and  to  ascertain  the  lowest  possible  levels  
of  detection  in  the  event  of  low  ligation  efficiency,  the  biotinylated  18mer  was  diluted  
in  Nucleospin  Gel  and  PCR-­‐Clean-­‐up  elution  buffer  NE  (Macherey  Nagel)  to  obtain  stocks  
with  varying  concentrations  ranging  from  5´10-­‐5  pmoles/µl  to  50  pmoles/µl.    1  µl  of  each  
stock   was   blotted   onto   Genescreen   nylon   hybridization   transfer   membrane   (Perkin  
Elmer)  and  allowed  to  dry  then  UV  crosslinked  at  1200´100µJ/cm2.    The  membrane  was  
blocked  using  Tropix  I-­‐BLOCK  (Invitrogen),  probed  with  streptavidin-­‐AP  and  visualized  
using  CDP-­‐Star  chemiluminescent  substrate  (GE  Healthcare)  in  an  ImageQuant  LAS  4000  
imager   (GE   Healthcare)   (Figure   5-­‐3).      This   method   of   biotin   quantification   allows  
detection  of  signal  within  the  predicted  range  of  required  sensitivity  1-­‐10  pmoles)  as  
well  as  detecting  amounts  of  biotin  as  low  as  0.05  fmoles.  
  
Having  established  the  sensitivity  of  biotin  quantification  using  streptavidin-­‐AP,  we  used  
slot   blotting   to   apply   50   µl   of   biotinylated   18mer   to   the   membrane   to   reflect   the  
requirement  for  analyzing  larger  volumes  of  samples  following  removal  of  the  unligated  
18mer  oligonucleotide  following  the  AtRNL  ligation  step  (Figure  5-­‐4  A).    This  method  of  
blotting   allowed   detection   of   0.05   pmoles   of   biotinylated   18mer   after   1   minute   of  
exposure  by  ImageQuant  LAS  4000  but  required  longer  exposure  times  (>5  minutes)  to  
see  amounts  of  biotinylated  18mer  below  0.005  pmoles.  
  
The   intensity   of   the   biotin-­‐streptavidin-­‐AP   signal   can   be   assigned   a   numerical   value  
based  on  pixel  saturation  using  ImageJ  (Schneider  et  al.  2012),  however  this  function  
suffers   from   the   problem  of  pixel   saturation   of   high   intensity   signals  when   trying   to  
compare  the  intensity  of  a  high  concentration  signal  with  that  of  a  signal  at  the  lower  
end   of   the   range   of   sensitivity.      To   overcome   this   problem,   a   plugin   for   ImageJ  was  
designed  by  Dr.  Alex  Herbert  that  stacks  images  taken  at  1-­‐minute  time  points  and  plots  
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Figure 5-3  Visualising biotinylated DNA with streptavidin-alkaline phosphatase is highly 
sensitive
1 μl of the indicated amounts of an internally biotinylated 18 nucleotide oligomer were 
dot-blotted onto nylon transfer membrane, incubated with streptavidin-alkaline phosphatase 
and visualised using an ImageQuant LAS 4000.  This method of detection was sensitive to 
quantities of biotinylated oligomer in the attomole range.  Amounts of biotinylated oligomer 
in the expected range for the AtRNL assay were comfortably within the limits of detection of 
this method.































Figure 5-4  Quantifying slot-blotted biotinylated DNA with an image layering-based ImageJ 
plugin
A.  50 μl of the indicated amounts of an internally biotinylated 18 nucleotide oligomer were 
slot-blotted onto nylon transfer membrane, incubated with streptavidin-alkaline 
phosphatase and visualised using an ImageQuant LAS 4000 at one minute intervals for 16 
minutes.  B.  An ImageJ plugin was designed to plot the signal intensity of each concentration 
of 18mer at each time point to assign numerical values to each sample based on the gradient 
of the resultant curve during the linear phase of signal intensity increase (red line).  Shown 
are representative curves for 50 pmoles oligomer and 0.1 pmoles oligomer.  The results 
indicate that this method of quantiﬁcation would allow for sensitive quantiﬁcation of biotin 
amounts over a range of concentrations.
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the  signal  intensity  of  each  sample  over  time.    The  gradient  of  the  linear  phase  of  the  
resultant  curve  for  each  sample  is  then  used  to  assign  a  numerical  value  to  each  sample,  
where   the  concentration  of  biotin   in  a   sample   is  proportional   to   the  gradient  of   the  
curve.    Representative  curves  for  samples  containing  50  pmoles  and  0.1  pmoles  of  biotin  
can  be   seen   in   figure  5-­‐4  B.      This  method  proved   sensitive   for  determining  differing  
amounts  of  biotin  in  samples  as  seen  by  the  steeper  gradient  of  the  exponential  phase  
of  the  curve  for  50  pmoles  in  comparison  to  that  for  0.1  pmoles  biotin.    It  was  decided  
that  this  method  of  detection  would  be  suitable  for  our  purposes  were  we  to  continue  
with   slot  blotting  of   samples.     However,  due   to   problems  associated  with   inefficient  
removal   of   unligated   adaptor   (described   in   section   5.3.5-­‐5.3.7)   and   due   to   technical  
inconsistencies  with  the  slot  blotting  method  itself,  we  decided  that  we  would  continue  
using   a   Southern   blotting   method   (described   in   section   5.3.7)   having   established   a  
system  to  optimize  AtRNL  ligation  efficiency  and  18mer  oligonucleotide  removal.  
  
5.3.5    Optimizing  Urea-­‐PAGE  loading  and  18mer  removal  
   To   determine   the   amount   of   DNA   that   should   be   loaded   to   visualize   AtRNL  
ligation  efficiency  in  an  in  vitro  reaction  described  in  section  5.3.6,  we  subjected  differing  
amounts  of  a  70-­‐nucleotide  oligomer,  ranging  from  0.1  to  50  pmoles,  to  denaturing  urea  
polyacrylamide  gel  electrophoresis   (Figure   5-­‐5  A).      It  was   determined   that   loading   1  
pmole   of   70mer   provided   the   strongest   signal   without   seeing   signal   derived   from  
degradation  of  the  70mer.  
  
Having  established   the  optimal  amount   of   70mer   to   load,  we  wanted   to   look  at   the  
ability  of  Nucleospin  Gel  and  PCR-­‐Clean-­‐up  columns  (Macherey  Nagel)  to  remove  any  
unligated  18mer  from  ligation  reactions.    To  do  this,  10  pmoles  of  70mer  and  50  pmoles  
of  biotinylated  18mer  in  50  µl  water  were  added  to  100  µl  of  different  dilutions  of  NTI  
binding  buffer  and  subjected  to  Nucleospin  Gel  and  PCR-­‐Clean-­‐up.    1/10  of  the  eluate  
volume  of  each  sample  and  an  untreated  control  were  then  subjected  to  urea  PAGE  
(Figure   5-­‐5   B).      The   greatest   amount   of   the   18mer   oligonucleotide  was   removed  by  
dilution  in  100%  buffer  NTI,  however  this  condition  led  to  the  greatest  loss  of  the  70mer  
oligonucleotide,  whereas  as  the  concentration  of  buffer  NTI  decreased,  greater  levels  of  
70mer  were  retained  but  the  ability  to  remove  the  18mer  decreased.    It  was  decided  to  
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Figure 5-5  Optimising urea-PAGE DNA loading and 18mer removal
A.  5 μl of the indicated amounts of 70 nucleotide oligomer, internally biotinylated 18mer  and 
unbiotinylated 18mer were subjected to urea-PAGE gel electrophoresis and stained with 
SYBR Green to determine the optimal quantity of DNA to load for future AtRNL ligation 
eﬃciency assay  B.  To assess the ability of Macherey-Nagel Gel and PCR cleanup columns to 
remove 18mers whilst retaining as much 70mer as possible, 10 pmoles of 70mer and 50 
pmoles of biotinylated 18mer were suspended in 50 μl H2O and diluted in 100 μl of the 
indicated dilutions of Macherey-Nagel buﬀer NTI then subjected to Macherey-Nagel Gel and 
PCR cleanup, eluting in 20 μL elution buﬀer.  Following cleanup, 2 μL of each sample eluate 
and an untreated control (UT) were subjected to urea-PAGE gel electrophoresis.  Dilution in 
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use   undiluted   buffer   NTI   to   clean-­‐up   ligation   reactions   since   efficiency   of   unligated  
18mer   removal  was   a   priority   over   retention   of   shorter  DNA   fragments,   particularly  
since  the  rate  of  ribonucleotide  incorporation  in  PU-­‐seq  strains  of  S.  pombe  would  result  
in  fragments  with  an  average  length  of  hundreds  of  nucleotides.  
  
5.3.6    Optimizing  AtRNL  ligation  efficiency  
   AtRNL  was  purified  by  Jonathan  Wing,  a  colleague  in  the  Carr  laboratory  using  
plasmid  pET28a-­‐At-­‐TRL  (Addgene  plasmid  #  32242),  a  kind  gift  from  Professor  Stan  Fields  
(Schutz  et  al.  2010).    An   in  vitro  assay  was  designed  to  assess  the  catalytic  activity  of  
AtRNL   on   a   substrate   generated   by   alkaline   hydrolysis   of   a   70-­‐nucleotide   oligomer  
containing   an   internal   ribonucleotide   towards   the   3’   end   (rTOP),   resulting   in   a   65-­‐
nucleotide   substrate   with   a   ribonucleotide   terminus   to   which   the   18   nucleotide  
internally  biotinylated  oligomer  could  be  ligated.    A  parallel  reaction  was  carried  out  on  
an   oligonucleotide   of   the   same   length   and   same   sequence   but   containing   only  
deoxyribonucleotides  (dTOP)  (Figure  5-­‐6  A).    100  pmoles  of  rTOP  and  dTOP  were  treated  
with  0.3  M  NaOH  at  55°C  for  2  hours  after  which  10  pmoles  of  each  substrate  was  used  
in  a  30-­‐minute  room  temperature  ligation  reaction  with  AtRNL  and  a  5-­‐fold  molar  excess  
of  biotinylated  18mer.    Following  ligation  ~1  pmole  of  rTOP/dTOP  ligation  mixture  and  
5  pmoles  of  biotinylated  18mer  were  subjected  to  denaturing  urea  PAGE.    All  of  the  rTOP  
subjected  to  treatment  with  NaOH  was  hydrolyzed  however  only  a  small  amount  of  the  
resultant  substrate  was  ligated  to  the  biotinylated  18mer  indicating  that  whilst  AtRNL  
was  active,  ligation  efficiency  was  low.  
  
We  were  unable  to  determine  the  concentration  of  AtRNL  in  the  storage  buffer  since  it  
co-­‐purified  with  a  large  amount  of  a  70  kDa  protein  that  we  assumed  to  be  a  molecular  
chaperone.    Since  we  assumed  the  concentration  of  AtRNL  in  the  storage  buffer  to  be  
low  we  hoped  that  by  increasing  the  volume  of  AtRNL  in  the  reaction,  and  by  increasing  
incubation  time  we  might  increase  ligation  efficiency.    Taking  into  account  the  negative  
effect   of   glycerol   in   the   storage   buffer   on   the   ability   of   proteins   to   move   freely   in  
solution,  we  limited  the  total  volume  of  AtRNL  in  the  reaction  to  20%.    Increasing  the  
percentage  of  AtRNL  in  the  reaction  mixture  from  10%  to  20%  increased  the  amount  of  
biotinylated  18mer  ligated  to  alkali-­‐treated  rTOP  and  a  further  increase  in  ligation  was  
































Figure 5-6  AtRNL shows speciﬁc activity on an alkali-treated ribonucleotide-containing 
70mer
A.  100 pmoles of a ribonucleotide-containing 70mer (rTOP) and a DNA-only control (dTOP) 
were alkali-treated and used as substrate in a reaction with Arabidopsis thaliana tRNA ligase 
(AtRNL).  AtRNL showed low eﬃciency speciﬁcity for substrate terminating in a 
3’-ribonucleotide.  B.  Reactions were carried out as in A but using either 10% or 20% of the 
ﬁnal volume of AtRNL and incubating for 30 or 120 minutes.  The greatest ligation eﬃciency 
was seen using 20% AtRNL in a 120 minute reaction.
   125  
seen  by  incubating  the  reaction  for  120  minutes  over  a  30-­‐minute  incubation  (Figure  5-­‐
6  B).  
  
5.3.7    AtRNL  ligation  assay  with  S.  pombe  gDNA  and  Southern  blotting  
   Having  established  the  best  conditions  for  ligation  and  for  removal  of  unligated  
18mer,   we   set   out   to   test   the   efficiency   of   our   assay   in   the   context   of   ligating   the  
biotinylated  18mer  onto  a  substrate  derived  from  alkali-­‐treated  gDNA  from  a  strain  of  
S.  pombe   lacking  RNase  H2  activity  due  to  deletion  of  rnh201.     Following  Nucleospin  
column   cleanup,   we   resolved   ligation   reactions   on   agarose   gels   to   help   separate  
unligated  18mer  by  size  from  those  higher  molecular  weight  fragments  resulting  from  
ligation  of  the  18mer  to  ribo-­‐terminating  DNA  fragments.    It  was  hoped  that  this  would  
overcome   the   problem   caused   by   incomplete   removal   of   unligated   adapter   that  we  
would   have   encountered   by   slot   blotting   samples.     With   slot   blotting,   any   unligated  
adaptor  would  bind  to  the  membrane  along  with  successfully  ligated  products,  causing  
an  unwanted  additive  effect  on  signal  intensity.  
  
500  ng  of  alkali   treated   rnh201D  S.  pombe  gDNA  was  used  as  substrate   in  an  AtRNL  
ligation   reaction   with   50   pmoles   of   biotinylated   18mer.      After   incubation   at   room  
temperature  for  2  hours  the  ligation  reaction  was  cleaned  up  using  Nucleospin  columns  
and  samples  resolved  by  agarose  gel  electrophoresis  and  Southern  blotting.    Samples  
were   imaged   in  an   ImageQuant   LAS  4000   in   1-­‐minute   increments   (Figure  5-­‐7).      Raw  
images  taken  at  1-­‐,  4-­‐  and  7-­‐minutes  exposure  time  (Figure  5-­‐7  i)  show  an  abundance  of  
signal   at   ~0.1   kb.      Exposure   for   4   and   7  minutes   reveals   the   presence   of   fragments  
between  ~0.3  and  1  kb,  with  fewer  fragments  >1kb.    Visualizing  the  membrane  using  an  
ImageQuant  function  that  colours  saturated  pixels  in  red  shows  that  the  signal  produced  
by   the   high   amount   of   the   lowest   molecular   weight   fragments   may   cause   pixel  
saturation  in  areas  of  the  membrane  populated  by  higher  molecular  weight  fragments  
(Figure  5-­‐7  ii).    In  the  event  that  this  early  saturation  of  pixels  at  molecular  weights  >0.3  
kb  was  caused  by  the  intensity  of  signal  from  the  lowest  molecular  weight  fragments,  
the  membrane  was   cut   at   ~0.3   kb   and   re-­‐exposed   (Figure   5-­‐7   iii)   however   the   pixel  
saturation  of  fragments  >0.3  kb  after  7  minutes  is  comparable  both  before  and  after  the  









































Figure 5-7  Macherey Nagel Nucleospin column cleanup
Genomic DNA from strains of S. pombe with the indicated genotypes were treated with 0.3 M 
NaOH at 55˚C for 2 hours.  Hydrolysed DNA was ligated to a biotinylated 18mer oligonucleotide via 
2’ phosphate groups of the resultant ribonucleotide-terminating DNA fragments then run on an 
agarose gel followed by southern blotting and hybridisation with a streptavidin-AP probe.  Blots 
were imaged with GE Imagequant LAS 4000 at 1 minute increments either as a raw image (i), 
images in which red pixels indicate pixel saturation (ii & iii).  Blots in iii were cut just above the 
molecular weight that contained the highest signal (~0.1 kb; cut at ~0.3 kb).  Selected timepoints 
only are shown.  Whilst after longer exposures signal can be seen at a range of molecular weights 
>0.5 kb, the high intensity of signal at ~0.1 kb possibly indicates that Macherey Nagel Nucleospin 
columns did not completely remove unligated oligo.
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membrane  was  cut,  suggesting  that  the  high  concentration  of  signal  at  ~0.1  kb  does  not  
affect  signal  intensity  of  fragments  of  0.3  kb  and  greater.  
  
This   assay   did   however   show   that   AtRNL   is   able   to   ligate   short,   biotinylated  
oligonucleotides  onto  ribo-­‐terminating  gDNA  fragments.    The  majority  of  signal  appears  
at   low   molecular   weights,   suggesting   either   that   ribonucleotides   are   incorporated  
regularly  with  on  average   less  than  ~0.5  kb  between  them  and  that  misincorporated  
ribonucleotides   separated   by   more   than   1   kb   are   rare,   or   that   AtRNL   ligates  
preferentially   onto   shorter   fragments.      Surprisingly,   this   assay   showed   very   little  
difference  in  signal  intensity  between  wild  type  and  rnh201D  gDNA.  
  
5.3.8    Reducing  background  signal  caused  by  biotinylated  oligomer    
   It  was  assumed  that  the  high  amount  of  signal  seen  at  ~0.1  kb  in  Figure  5-­‐7  was  
caused  either  by  unligated  18mer,  or  because  AtRNL  had  a  preference  for   ligating  to  
short   fragments   of   ribo-­‐terminating   gDNA.      We   decided   to   optimize   the   unligated  
oligomer  removal  step  by  shortening  the  length  of  the  oligomer  from  18  nucleotides  to  
9   nucleotides   and   by   using   Illustra   MicroSpin   G-­‐50   columns   (GE)   which   exclude  
fragments  <20  bases  using  size  exclusion  rather  than  relying  on  matrix-­‐binding  efficiency  
as  is  the  case  with  Nucleospin  columns.    We  first  tested  the  ability  of  AtRNL  to  ligate  the  
biotinylated  9mer  to  alkali-­‐treated  rTOP  using  the  same  assay  as  described  in  section  
5.3.6  and  found  that  ligation  was  at  least  as  efficient  as  ligation  of  the  biotinylated  18mer  
(Figure  5-­‐8  A).    Furthermore,  removal  of  the  biotinylated  9mer  from  a  mixed  sample  of  
9mer  and  untreated  rTOP  using  Microspin  G-­‐50  columns  was  highly  efficient  with  very  
little  9mer  visible  after  treatment,  even  at  long  exposure  times  (Figure  5-­‐8  B).  
  
We  repeated  the  AtRNL  ligation  reaction  described  in  section  5.3.7  with  gDNA  from  a  
Pu-­‐seq   strain   of  S.   pombe   lacking   rnh201   and   containing   the   ribo-­‐incorporating   Pole  
mutation  M630F.    A  biotinylated  9mer  oligonucleotide  was  used  rather  than  the  18mer  
and  sample  clean-­‐up  was  carried  out  using  Microspin  G-­‐50  columns  to  remove  unligated  
9mer  (Figure  5-­‐9).    To  give  an  idea  of  how  signal  intensity  may  differ  between  samples  
containing   low   and   high   levels   of   genomic   ribonucleotides,   either   10   %   or   90%  
respectively  of  the  total  ligation  reaction  was  loaded  onto  the  gel.    Whilst  there  is  a  clear  
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2:  Hydrolysed rTOP
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4:  Ligation product (9mer)
Figure 5-8  AtRNL ligates a 9 nucleotide biotinylated oligomer speciﬁcally onto 
ribonucleotide-terminating substrates
A.  100 pmoles of a ribonucleotide-containing 70mer (rTOP) and a DNA-only control (dTOP) were 
alkali-treated and used as substrate in a reaction with Arabidopsis thaliana tRNA ligase (AtRNL) 
and internally biotinylated 18mer or 9mer oligonucleotides.  AtRNL showed speciﬁcity for ligating 
onto ribonucleotide terminating substrates only and ligated these ends to both 9mers and 18mers 
with similar eﬃciency.  B.  To assess the ability of Illustra G-50 columns to remove 9mers whilst 
retaining as much 70mer as possible, 10 pmoles of 70mer and 50 pmoles of biotinylated 9mer 
were suspended in 50 μl H2O and subjected to G-50 column treatment.  G-50 columns were found 














Figure 5-9  The AtRNL assay with Southern blotting lacks the desired sensitivity
Genomic DNA from strains of S. pombe with the indicated genotypes was alkali treated and used 
as a substrate in a reaction with AtRNL and biotinylated 9mer.  Following incubation, samples 
were cleaned up using Illustra Nucleopsin G-50 columns and subjected to agarose gel 
electrophoresis and Soutern blotting.  To assess the sensitivity of this assay to diﬀerent levels of 
biotin, either 90% or 10% of the total reaction volume was loaded.  Despite small diﬀerences in 
signal intensity between wild type and mutant genomic DNA, the diﬀerence was insuﬃcient for 
reliable information to be obtained.
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difference  in  signal  intensity  between  gDNA  treated  with  AtRNL  and  the  no  ligase  control  
sample,  there  remains  a  significant  amount  of  signal  between  0.1  and  0.2  kb  in  the  no  
ligase   control   sample,   suggesting   that   in   spite   of   the   apparent   robustness   of   9mer  
removal   exhibited   in   figure   5-­‐8   B,   this   removal   is   incomplete.      Furthermore,   the  
difference  in  signal  intensities  between  wild  type  DNA  and  Pu-­‐seq  DNA  across  the  range  
of  fragment  sizes  is  not  as  marked  as  would  have  been  expected  and  there  still  appeared  
to  be  a  preference  for  ligation  onto  low  molecular  weight  fragments.  
  
In  light  of  these  concerns  and  due  to  the  inactivity  of  AtRNL  purified  from  a  second  batch  
(data   not   shown),  we   decided   that   despite   the   potential   promise   of   this   assay,   two  
previously  published  assays  would  be  sufficient  for  our  purposes.  
  
5.4    Using  a  FRET-­‐based  assay  to  assess  RNase  H2  activity  
   A  key  principle  of  the  S.  pombe  Pu-­‐seq  system  is  an  absence  of  RNase  H2  function  
achieved  by  knocking  out  the  RNase  H2  catalytic  subunit,  RNase  H2A.    As  discussed  in  
chapter  4,  RNase  H2A  knockout  in  many  human  cell  lines  is  not  possible,  however  we  
were  able  to  develop  two  different  methods  of  inducibly  knocking  down  RNase  H2C  to  
levels   undetectable   by   Western   blot.      Although   levels   of   RNase   H2C   following  
degradation   are   undetectable   by  Western   blot   it   is   possible   that   a   small   amount   of  
RNase  H2C  remains  stably  expressed.    In  this  event  it  is  possible  that  enough  RNase  H2  
trimers   form   to   efficiently   undertake   ribonucleotide   excision   repair.      To   ensure   that  
knockdown  of  RNase  H2C  resulted  in  a  decrease  of  RNase  H2  catalytic  activity  we  took  
advantage  of  a  previously  published  fluorescence-­‐based  RNase  H2  activity  assay  (White  
et  al.  2013).    The  assay  assesses  the  ability  of  RNase  H2  in  whole  cell  extract  to  cleave  
an   oligonucleotide   duplex   containing   an   internal   ribonucleotide   in   one   strand.      The  
strand   containing   the   internal   ribonucleotide   contains   a   3’-­‐fluorescein   fluorophore  
which  is  quenched  by  a  5’-­‐dabcyl  on  the  opposite  strand.    RNase  H2-­‐mediated  hydrolysis  
of  the  ribonucleotide  releases  the  fluorescein  resulting  in  an  increase  in  fluorescence  
signal.      An   oligonucleotide   duplex   substrate   of   the   same   sequence   but   lacking   the  
internal   ribonucleotide   was   used   to   assess   the   level   of   non-­‐RNase   H2-­‐mediated  
fluorophore  release  (Figure  5-­‐10  A).  













Figure 5-10  Design and implementation of a ﬂuorescence-based assay to determine RNase H2 
activity
A.  Schematic representation of the RNase H2 activity assay substrate.  RNase H2 activity on the 
ribonucleotide-containing duplex (DRD:DNA) causes release of the 3’-ﬂuorescein fragment from 
the 5’-dabcyl quencher resulting in an increase in ﬂuorescence intensity.  A DNA-only substrate 
(DNA:DNA) is used as a control in some experiments to control for non-RNase H2 
derived-substrate cleavage.  B & C.  The RNase H2 activity assay carried out using cell extract from 
HEK293 (B) and U2OS (C) over a range of protein concentrations.  For both cell lines, maximum 
ﬂuorescence intensity is seen using 10 ng/μl ﬁnal protein concentration.  D.  RNase H2 activity 
assay using whole cell extract from wild type human lymphocytes and human cells containing a 
hypomorphic A177T mutation in RNase H2B shows the decrease in RNase H2 activity resulting 
from the RNase H2B mutation.  Error bars:  ± SDM from three independent biological replicates.
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At   the   time   of   optimizing   this   assay,   we   had   been   trying   to   set   up   a   system   to  
downregulate   RNase   H2   using   HEK-­‐293   and   U2OS   cell   lines.      We   first   set   out   to  
determine  the  optimal  final  concentration  of  HEK-­‐293  and  U2OS  whole  cell  extract  to  be  
used  in  each  100  µl  reaction  by  carrying  out  an  assay  in  which  different  concentrations  
of  cell  extract  were  used  in  a  90-­‐minute  reaction,  after  which  an  endpoint  fluorescence  
readout  was  calculated  after  quenching  the  reaction  with  EDTA  (Figure  5-­‐10  B  &  C).    This  
allowed  us  to  determine  a  final  protein  concentration  within  the  linear  range  of  increase  
in  fluorescence  intensity  that  could  be  used  in  experiments  looking  at  the  increase  in  
fluorescence  over  time.    With  whole  cell  extract  from  both  HEK-­‐293  (Figure  5-­‐10  B)  and  
U2OS  (Figure  5-­‐10  C)  a  linear  increase  in  fluorescence  was  seen  between  1.25  ng/µl  and  
10   ng/µl   after   which   a   decrease   in   fluorescence   was   observed.      It   is   possible   that  
incubation   with   10   ng/µl   whole   cell   extract   for   90   minutes   was   sufficient   for   all  
ribonucleotide-­‐containing  substrate  (DRD)  to  be  cleaved,  whilst  cleavage  of  the  DNA-­‐
only  duplex  proceeded  at  a  slower  rate.    Since  fluorescence  values  were  calculated  by  
subtracting  the  fluorescence  readings  from  DNA-­‐only  substrate  from  those  from  DRD  
substrate,  it  is  possible  to  account  for  the  decrease  in  adjusted  signal  intensity  due  to  
the  plateauing  of  DRD  signal  with  a  concurrent  continued   increase   in   fluorescence   in  
samples  containing  DNA-­‐only  substrate  with  concentrations  of  whole  cell  extract  over  
10  ng/µl.  
  
We  repeated  this  assay  using  whole  cell  extract  from  wild  type  human  lymphoblasts  and  
from   cells   containing   a   hypomorphic   A177T   mutation   in   RNase   H2B   to   assess   the  
sensitivity  of  this  assay  in  detecting  differences  in  cellular  RNase  H2  activity  (Figure  5-­‐10  
D).    Pleasingly,  differences  in  efficiency  of  substrate  cleavage  were  seen  between  the  
two  cell  lines  at  final  protein  concentrations  from  2.5  ng/µl  up  to  40  ng/µl.    With  wild  
type  cell   extract  a  decrease   in  adjusted   fluorescence   intensity  was   seen  at  80  ng/µl,  
whilst  fluorescence  intensity  for  RNase  H2B  A177T  continued  to  increase.      
  
Since  the  rate  of  substrate  cleavage  by  mutant  RNase  H2  would  proceed  at  a  slower  rate  
than  for  wild  type  RNase  H2,  it  would  require  a  higher  concentration  of  mutant  RNase  
H2  than  wild  type  RNase  H2  for  fluorescence  intensity  to  plateau  over  90  minutes.    As  
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such,  assuming  that  DNA-­‐only  substrate  cleavage  proceeds  at  a  slower  rate  than  DRD  
cleavage  and  at  an  equal  rate  in  the  presence  of  whole  cell  extract  from  either  wild  type  
cells  or  RNase  H2  mutant  cells,  it  is  possible  that  after  subtracting  DNA-­‐only  fluorescence  
intensity   from  DRD  fluorescence  that  a  decrease   in  adjusted  fluorescence   intensity   is  
seen.      This   observation   further   supports   the   theory   that   the   decrease   in   adjusted  
fluorescence  intensity  seen  above  10  ng/µl  for  HEK-­‐293  and  U2OS  was  caused  by  the  
adjustment   calculation   rather   than   by   a   true   decrease   in   fluorescence   intensity   in  
samples  containing  the  DRD  substrate.  
  
5.5      Assessing   the   efficiency   of   mAID-­‐SMASh-­‐mediated  
knockdown   of   RNase   H2C   in   RPE1   cells   using   the   FRET-­‐based  
assay  
   To  determine  the  extent  to  which  RNase  H2  activity  in  RPE1  whole  cell  extract  
was  downregulated  following  degradation  of  RNase  H2C  via  the  mAID-­‐SMASh  double  
degron  described  in  chapter  4,  we  carried  out  a  kinetic  time  course  assay  to  assess  the  
rate  of  cleavage  of  the  ribonucleotide-­‐containing  oligonucleotide  duplex  described   in  
section  5.4.    RPE1  cells  conditionally  expressing  OsTIR1  in  the  presence  of  doxycycline  
but   that   were   otherwise   wild   type,   and   RPE1   cells   expressing   mAID-­‐SMASh-­‐tagged  
RNase  H2C  were  pre-­‐treated  with  1  µM  doxycycline  for  2  hours  then  grown  in  media  
containing  1  µM  doxycycline,  1  mg/ml  IAA  and  3  µM  ASV  with  whole  cell  extract  taken  
before,  or  2  and  24  hours  after,  addition  of  IAA  and  ASV.    Due  to  time  constraints  we  
were   unable   to   perform  endpoint   assays   to   determine   the   optimal   concentration   of  
RPE1  whole  cell  extract  to  be  used  in  the  time  course  assay  so  we  used  a  final  protein  
concentration   that   would   ensure   fluorescence   signal   saturation   with   wild   type   cell  
extract  within  the  course  of  the  experiment  and  additionally  did  not  include  the  DNA-­‐
only  duplex  substrate  to  avoid  problems  of  mean  adjusted  signal  intensity  decreasing  
beyond  a  certain  level  of  substrate  hydrolysis.  
  
Due   to   time   constraints   it   was   not   possible   to   carry   out   a   comprehensive   assay   to  
determine  a  final  protein  concentration  of  RPE1  cell  extract  that  would  fall  in  the  linear  
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range.    Since  the  final  protein  concentration  required  varies  between  different  cell  lines  
(Figure  5-­‐10)  a  quick  assay  was  carried  out  using  RPE1  cell  extract  to  determine  a  suitable  
protein  concentration  to  use  in  a  time  point  assay  (data  not  shown).    From  this  assay  it  
was   determined   that   a   final   protein   concentration   of   100   ng/µl   of   RPE1   cell   extract  
would  be  appropriate.    For  the  time  point  assay,  100  ng/µl  final  protein  concentration  
of   whole   cell   extract   was   used   in   each   100   µl   reaction   and   fluorescence   intensity  
recorded   at   10-­‐minute   intervals   for   130   minutes   (Figure   5-­‐11).      Treatment   with  
doxycycline,  IAA  and  ASV  had  no  significant  effect  on  overall  RNase  H2  activity  in  wild  
type  cells,  with  the  majority  of  substrate  hydrolysed  within  90  minutes,  after  which  rates  
of  hydrolysis  proceeded  at  a  markedly  slower  rate,  presumably  at  least  in  part  due  to  
non-­‐RNase  H2-­‐mediated  fluorophore  release.    The  rate  of  substrate  hydrolysis  in  clones  
5  (~43%  of  wild  type  activity)  and  6  (~28%)  is  significantly  lower  than  in  wild  type  cells  
prior  to  degradation  of  RNase  H2C  suggesting  that  the  presence  of  the  C-­‐terminal  mAID-­‐
SMASh   tag  on  RNase  H2C  causes  a   significant  decrease   in  overall  RNase  H2  catalytic  
activity.    Prior  to  addition  of  IAA  and  ASV,  clone  5  exhibits  a  greater  level  of  RNase  H2  
activity   than   clone   6;   this   is   probably   due   to   the   higher   levels   of   tagged  RNase  H2C  
expressed  by  clone  5  as  seen  by  Western  blot  (Figure  4-­‐13  and  Figure  4-­‐14)  resulting  in  
a  greater  number  of  RNase  H2  trimers.    A  significant  decrease  in  RNase  H2  activity  can  
be  seen  2  hours  after  addition  of  IAA  and  ASV  in  both  clones  5  and  6  (~22%  and  ~24%  of  
wild  type  activity  respectively).    Following  24  hours  growth  in  IAA  and  ASV,  RNase  H2  
activity  in  both  clone  5  and  clone  6  is  decreased  to  ~19%  of  wild  type  activity  with  no  
significant  difference  in  enzymatic  activity  exhibited  between  the  two  clones.    At  least  
some  of  this  residual   fluorescence   increase  is  presumed  to  be  due  to  non-­‐RNase  H2-­‐
mediated   fluorophore   release,   suggesting   that   activity   levels   of   RNase   H2   following  
degradation  of  RNase  H2C  are  a  maximum  of  19%  that  of  wild  type  RNase  H2.  
  
This   assay   provides   a   robust   method   to   demonstrate   that   AID-­‐SMASh-­‐mediated  
degradation   of   RNase   H2C   in   RPE1   cells   causes   a   significant   decrease   in   RNase   H2  
activity.    To  determine  the  true  extent  of  the  reduction  in  RNase  H2  activity  following  
knockdown  of  AID-­‐SMASh-­‐tagged  RNase  H2C  in  RPE1  cells,  it  would  be  advantageous  to  
compare  cell  extract  from  these  cells  after  treatment  with  Dox,  IAA  and  ASV  with  cell  


















Figure 5-11  Fluorescence-based RNase H2 activity assay shows that depletion of RNase H2C 
causes a signiﬁcant decrease in RNase H2 activity
Wild type RPE1 cells and two candidate RNase H2C mAID-SMASh double degron clones were 
pre-treated with 1 μM doxycycline for 2 hours then grown in media containing 1 μM doxycycline, 
1 mg/ml IAA and 3 μM ASV for 24 hours with samples taken before addition of IAA and ASV, 2 and 
24 hours after addition of IAA and ASV.  100 ng/μl of each sample was used in a kinetic assay time 
course with fluorescence intensity measured every 10 minutes.  Knockdown of RNase H2C causes 
a marked decrease in RNase H2 activity after 24 hours.  Error bars:  ± SDM from three 
independent biological replicates.
   136  
extract  from  Aicardi-­‐Goutières  Syndrome  patient  cells  and  perhaps  even  with  protein  
extracted  from  RNase  H2A  knockout  S.  pombe.      
  
Whilst  this  assay  is  sensitive  for  determining  differing  levels  of  RNase  H2  activity,  it  does  
not  show  that  the  decrease  in  activity  results  in  an  increase  in  ribonucleotide  presence  
in   the   genome   and   would   also   therefore   not   be   informative   when   analysing   ribo-­‐
incorporating  polymerase  mutations.      To   this  end,   I   also   looked  at  using   the  alkaline  
comet  assay  to  assess  the  extent  of  ribonucleotide  incorporation.  
  
5.6    Alkaline  comet  assay  
   Single  cell  gel  electrophoresis,  commonly  called  the  comet  assay,  is  a  sensitive  
method  to  determine  the  extent  of  DNA  damage  at  the  single  cell  level.    The  presence  
of   a   ribonucleotide   in   genomic   DNA   renders   the   sugar   phosphate   backbone   more  
susceptible   to  alkaline  hydrolysis  at   that  point.     As   such,   to  determine   the  extent  of  
ribonucleotide   presence   in   genomic  DNA,   the   comet   assay   can   be   performed  under  
alkaline  conditions   (Kind  et  al.  2018).      To   check   that   the  alkaline  comet  assay  would  
enable   us   to   differentiate   between   cells   containing   different   levels   of   genomic  
ribonucleotides,  we  subjected  two  Aicardi-­‐Goutières  Syndrome  (AGS)  patient  cell  lines  
to  alkaline  comet  assay  and  compared  them  to  wild  type  human  TK6  lymphocytes.    The  
AGS  cell  lines  contained  hypomorphic  mutations  in  RNase  H2B  (A177T)  or  RNase  H2A  
(G37S).      The   RNase   H2AG37S   mutation   has   a   more   severe   impact   on   RNase   H2  
holoenzyme  stability  than  RNase  H2BA177T  and  RNase  H2AG37S  cells  have  been  shown  to  
contain  a  higher  level  of  genomic  ribonucleotides  than  RNase  H2BA177T  cells  (Pizzi  et  al.  
2015).      These   differences   are   further   reflected   in   the   slower   growth   rate   of   cells  
harbouring   the   RNase   H2AG37S   mutation   over   cells   containing   the   RNase   H2BA177T  
mutation.    Consequently,  we  would  expect  the  greatest  mean  comet  tail  length  in  cells  
harbouring  the  RNase  H2AG37S  mutation,  with  RNase  H2BA177T  cells  providing  a  mean  
comet  tail  length  intermediate  between  RNase  H2AG37S  and  wild  type  cells.  
  
For  the  alkaline  comet  assay  ~3´104   cells  of  each  genotype  were  embedded   in  1.2%  
agarose  on  glass  slides  and  lysed  in  a  buffer  containing  2.5M  NaCl  at  pH10  for  1  hour  
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Figure 5-12  Alkaline comet assay to assess genomic ribonucleotide incorporation
Human lymphocytes with the stated genotypes were lysed in 2.5M NaCl at pH10 for 1 hour and 
subjected to alkaline electrophoresis.  Mean comet tail moment was calculated from 50 cells.  
Decreased RNase H2 activity resulting from cells harbouring mutations in either RNase H2A or 
RNase H2B leads to increased comet tail moments in comparison to wild type cells.
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and   subjected   to   alkaline   electrophoresis   at   12V   for   25   minutes.      Migration   of  
hydrolysed  DNA  towards  the  anode  resulted  in  the  formation  of  comet  tails  which  were  
stained  with  SYBR  Green  and  scored  (Figure  5-­‐12).    Whilst  the  shortest  comet  tail  lengths  
were  seen  for  wild  type  cells,  the  comet  tail  length  for  was  greater  for  cells  containing  
the   RNase   H2BA177T  mutation   that   for   cells   containing   the   RNase   H2AG37S  mutation.    
Since  these  are  the  results  of  one  single  biological  non-­‐blind  replicate  it  is  possible  that  
the  expected  results  would  be  seen  with  triplicate  blind  repeats.    Furthermore,  a  greater  
difference   in   alkaline   hydrolysis  may   be   seen   by   lengthening   the   incubation   in   lysis  
buffer  and  running  the  samples  in  a  more  alkaline  electrophoresis  buffer.    Similar  studies  
use  a  16-­‐18  hour  incubation  in  lysis  buffer  and  a  pH13  electrophoresis  buffer  in  addition  
to  synchronising  cells  by  serum  starvation  (Gunther  et  al.  2015).  
  
5.7    Discussion  
   In   this   chapter   I   have   outlined   the   steps   taken   in   attempting   to   develop   a  
ribonucleotide  incorporation  assay  using  an  Arabidopsis  thaliana  tRNA  ligase  (AtRNL).    
Whilst   previously   established   methods   of   quantifying   genomic   ribonucleotide  
incorporation   lack   the   specificity   for   recognizing   DNA   breaks   caused   only   by   the  
presence  of  an  embedded  ribonucleotide  that  the  AtRNL  assay  would  have  offered,  we  
encountered  too  many  problems  to  make  the  assay  worth  pursuing.  
  
In  this  chapter  I  also  described  an  in  vitro  assay  for  analyzing  the  activity  of  RNase  H2  
holoenzyme  in  whole  cell  extract  by  looking  at  rates  of  hydrolysis  of  a  ribonucleotide-­‐
containing   oligonucleotide   duplex   substrate.      I   used   this   assay   to   demonstrate   that  
overall   RNase   H2   catalysis   is   significantly   decreased   in   the   RNase   H2C  mAID-­‐SMASh  
double  degron  RPE1  cell  line  following  growth  in  doxycycline,  IAA  and  ASV  for  24  hours.    
Furthermore,  I  established  that  the  catalytic  activity  of  RNase  H2  in  the  absence  of  IAA  
and  ASV  in  the  RNase  H2C-­‐mAID-­‐SMASh  candidate  clone  5  is  higher  than  for  clone  6.    As  
such,  clone  5  is  the  best  candidate  to  proceed  with  knocking  in  polymerase  mutations  
since  the  ability  to  repair  misincorporated  ribonucleotide  between  PU-­‐seq  experiments  
will   be   greater   in   this   clone   than   in   clone   6.      The   importance   of   repairing   genomic  
ribonucleotides   between   experiments   is   twofold:      firstly,   persistent   genomic  
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ribonucleotide   presence   causes   replication   stress   and   genome   instability   (Pizzi   et   al.  
2015)  and  secondly,  the  accumulation  of  genomic  ribonucleotides  over  time  in  PU-­‐seq  
cell  lines  could  possible  result  in  higher  levels  of  background  noise  signal,  decreasing  the  
accuracy  of  experiments.  
  
Finally,   I   have   used   a   patient   cell   line   harbouring   hypomorphic   mutant   alleles   of  
RNASEH2A   (RNase   H2A-­‐G37S)   and   RNASEH2B   (RNase   H2B-­‐A177T)   to   show   that   the  
alkaline  comet  assay  offers  the  necessary  sensitivity  to  detect  different  levels  of  genomic  
ribonucleotide  presence.    This  will  be  important  when  screening  the  various  polymerase  
mutants  to  assess  the  extent  to  which  they  misincorporate  ribonucleotides.      
  
Further   work   for   the   work   outlined   in   this   chapter   therefore   would   be   to   knockin  
different  mutations  in  polymerases  delta  and  epsilon  in  the  RNase  H2-­‐regulatable  RPE1  
cell  line  described  in  this  chapter  and  in  chapter  4  and  to  subject  the  resultant  cell  lines  
to  the  alkaline  comet  assay.    Progress  in  screening  the  potential  polymerase  mutations  
is  described  in  chapter  6.  
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Chapter  6  
Investigating  ribonucleotide-­‐incorporating  
replicative  DNA  polymerase  mutations  
6.1    Introduction     
   One  of  the  key  features  of  the  S.  pombe  polymerase  usage  sequencing  (Pu-­‐seq)  
system  is  the  excess  incorporation  of  ribonucleotides  upon  DNA  replication  by  mutant  
alleles   of   the   two   major   replicative   polymerases,   polymerases   delta   and   epsilon.    
Decreased   ribonucleotide   discrimination   by   these   mutant   polymerases   is   achieved  
through  mutating  a  residue  adjacent  to  a  steric  gate  tyrosine  at  the  active  sites  (Pold-­‐
L591G  and  Pole-­‐M630F)  which  results  in  a  decreased  clash  with  the  2’-­‐OH  group  of  the  
incoming   ribonucleotide   (Nick   McElhinny,   Kumar,   et   al.   2010;   Miyabe   et   al.   2011;  
Daigaku  et  al.  2015;  Williams  et  al.  2016).  
  
Whilst   ribo-­‐incorporating   mutants   of   Pold   and   Pole   have   been   described   and  
characterized  in  both  S.  pombe  and  S.  cerevisiae,  there  is  little  evidence  of  such  ribo-­‐
incorporating  alleles  in  human  cells.    In  selecting  mutations  that  we  hoped  would  result  
in  increased  ribonucleotide  incorporation  in  human  cells,  we  used  sequence  alignments  
to  identify  the  conserved  leucine  and  methionine  in  Pold  (Leu606)  and  Pole  (Met630)  
respectively  (Figure  6-­‐1).    In  trying  to  identify  the  required  polymerase  mutations  it  is  
important  to  try  a  range  of  different  substitutions.    This  is  because  in  trying  to  generate  
strains  of  S.  pombe  containing  the  equivalent  ribo-­‐incorporating  substitution  used  in  S.  
cerevisiae  (S.  pombe:    M630G;  S.  cerevisiae:    M644G),  the  Carr  laboratory  discovered  
that  this  mutation  was  lethal  in  S.  pombe.    Since  the  equivalent  substitution  has  different  
effects  on  cell  viability  between  two  closely  related  yeast  species,  it   is   likely  that  the  
same  phenomenon  will  be  observed  when  trying  to  generate  equivalent  mutations  in  
human  cells.  
  











Figure 6-1  Identiﬁcation of human polymerase residues to be targeted for 
mutagenesis
Sequence alignments of human, S. pombe and S. cerevisiae polymerase delta and 
polymerase epsilon catalytic subunits showing the conserved leucine (polymerase 
delta) and methionine (polymerase epsilon) to be targeted for mutagenesis.
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For   the   human   Pold   ribo-­‐incorporating   mutation,   we   took   advantage   of   two   Pold  
mutations,  L606M  and  L606G,  that  have  been  shown  to  incorporate  higher  than  wild  
type  levels  of  ribonucleotides  in  in  vitro  studies  (Schmitt  et  al.  2010;  Clausen  et  al.  2013).    
In   addition,   we   decided   to   investigate   a   Pold   mutation,   L606K,   which   does   not  
incorporate   elevated   ribonucleotides   in   vitro   (Schmitt   et   al.   2010),   but   does   cause   a  
mutator  phenotype  in  heterozygously  targeted  mice,  a  phenomenon  seen  also  with  the  
L606G  allele  (Venkatesan  et  al.  2007).  
  
Since   there   are   no   known   mutations   in   human   Pole   that   result   in   increased  
ribonucleotide   incorporation  either   in  cells  or   in  vitro,   five  candidate  mutations  were  
chosen  that  it  was  hoped  would  decrease  the  steric  gate  effect  of  the  adjacent  tyrosine:    
M630F,  M630L,  M630V,  M630A  and  M630G,  in  increasing  order  of  likelihood  of  ribo-­‐
incorporation  based  upon  the  permissiveness  of  their  side  chains  for  allowing  access  of  
the  ribonucleotide  2’-­‐hydroxyl  group.  
  
In   this   chapter   I   will   outline   the   progress   made   towards   identifying   mutations   in  
polymerases   delta   and   epsilon   that   will   result   in   higher   than   wild   type   levels   of  
ribonucleotide  incorporation  which  can  be  combined  with  the  RNase  H2C  degradation  
system  described  in  chapter  4  to  establish  the  polymerase  usage  sequencing  system  in  
human  cells.  
  
6.2    Generating  human  cell  lines  expressing  mutant  polymerase  
delta  
     
6.2.1    Human  TK6  cells  can  express  Pold-­‐L606M  heterozygously  
To  generate  TK6  cells  expressing  mutant  Pold  we  designed  a  system  whereby  a  
mutant   allele   of   POLD1,   the   gene   encoding   Pold,   would   be   expressed   from   cDNA  
integrated  at  the  endogenous   locus.     To  do  this,  a  guide  RNA  was  designed  to  target  
Cas9  to  within  100bp  of  the  POLD1  start  codon.    The  resultant  double  strand  break  was  
repaired  using  a  repair  template  that  upon  repair  would  incorporate  the  mutant  POLD1  












Figure 6-2  Polymerase delta mutation strategy
Cas9 is targeted to within 100bp of the POLD1 start codon.  The resultant break is 
repaired using a plasmid template that upon repair results in the introduction of 
POLD1 cDNA and a LoxP-ﬂanked antibiotic resistance marker under the control of a 
PGK promoter allowing for selection and subsequent marker removal.  The use of 
repair templates containing diﬀerent antibiotic resistance genes allows for selection 
of homozygously targeted clones.
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cDNA  followed  by  a  PolyA  signal  and  a  LoxP-­‐flanked  antibiotic  resistance  marker  under  
the   control   of   its   own  promoter   (Figure   6-­‐2).      In   addition   to   attempting   to   knock   in  
mutant  POLD1  cDNA  we  also  targeted  cells  with  a  knockin  construct  that  contained  wild  
type  POLD1  cDNA.    This  was  done  as  a  control  in  the  event  that  we  failed  to  generate  
any  positive  clones  after  selection  to  allow  us  to  know  whether  it  was  the  presence  of  
the  mutation  or  the  design  of  the  system  itself  that  was  preventing  clone  growth.  Initial  
work  was  carried  out  in  the  Takeda  laboratory  and  sought  only  to  investigate  the  Pold-­‐
L606M  mutation.      
  
106  TK6  cells  were  co-­‐transfected  using  Neon  electroporation  (Invitrogen;  1350  V,  10  
ms,  ×3  pulse,  10μl  Neon  tip)  with  two  plasmids,  one  to  express  both  Cas9  and  a  gRNA  
(pX330)  and  a  repair  template.    For  each  transfection,  cells  were  transfected  with  200  
ng   pX330   and   800   ng   histidinolR   repair   template   (WT   or   L606M).      48   hours   after  
transfection,  cells  were  selected  in  500  µg/ml  histidinol  for  10  days.    Following  selection,  
we   isolated   14   candidate   clones   for   the   L606M   mutation   and   8   for   the   wild   type  
construct.      To   check   for   integration   of   the   repair   template   at   the   correct   locus,   we  
screened  each  clone  by  PCR  using  a  forward  primer  that  annealed  within  the  antibiotic  
resistance  gene  and  a   reverse  primer   that  annealed  outside   the   right  homology  arm  
(Figure  6-­‐3  A).    5  of  the  L606M  clones  and  2  of  the  wild  type  clones  had  bands  at  the  
correct  size.     To  check  that  the  L606M  candidate  clones  were  expressing  the  mutant  
cDNA,  each  clone  was  subjected  to  RT-­‐PCR  and  sequencing  to  check  for  the  presence  of  
mutant  mRNA  within  the  cells.    Following  sequencing,  4  of  the  5  clones  were  found  to  
express   the   mutant   allele   heterozygously,   with   no   homozygously   targeted   clones  
isolated  (Figure  6-­‐3  B).  
  
Subsequent  attempts  to  generate  homozygously  targeted  Pold-­‐L606M  TK6  cells  were  
unsuccessful  and  due  to  the  problems  associated  with  low  transfection  efficiency  of  TK6  
cells   described   in   chapter   3   it   was   decided   to   continue   investigations   into   ribo-­‐
incorporating  mutations  in  polymerases  delta  and  epsilon  in  the  human  HT1080  cell  line.  
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Figure 6-3  Polδ-L606M screening identiﬁes heterozygously targeted TK6 cells
A.  Following targeting with a Polδ-L606M or wild type Polδ knockin construct and 
selection, antibiotic-resistant clones were screened by PCR to check for integration 
of the knockin construct at the correct locus.  B.  Polδ-L606M clones that were 
correctly targeted were subjected to RT-PCR and sequencing.  4 of the 5 clones 
screened were found to be heterozygously targeted whilst one was untargeted.  
Sequencing traces show the sequence of the complementary strand:  CAG = reverse 
complement of CTG (Leu); CAT = reverse complement of ATG (Met).
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6.2.2    Human  HT1080  cells  can  express  Pold-­‐L606K  heterozygously  
   To  generate  cells  expressing  Pold-­‐L606K,  106  HT1080  cells  were  transfected  with  
0.5  µg  pX330  and  1.5  µg  puromycinR  repair  template  using  Amaxa  nucleofection  (Lonza;  
kit  T,  programme  L-­‐005).    48  hours  after  transfection,  cells  were  selected  in  0.4  µg/ml  
puromycin   for  two  weeks  after  which  14  clones  grew.     Two  of  these  14  clones  grew  
noticeably   slower   than   the   other   12   and   eventually   died   following   expansion   into   a  
larger  volume  of  non-­‐selective  medium.    Attempts  to  screen  the  remaining  12  clones  for  
integration   of   the   repair   template   at   the   correct   locus   were   unsuccessful   so   a  
subsequent  PCR   screen  was  carried  out   to   check   for   the  presence  of   the   puromycin  
resistance   gene   using   forward   and   reverse   primers   that   both   annealed   within   the  
marker   gene   (Figure   6-­‐4   A).      All   12   clones   screened  were   found   to   have   the   repair  
template  integrated  somewhere  in  their  genomes.    To  check  that  the  repair  templates  
in  these  clones  had  integrated  at  the  correct  locus  and  that  the  cells  were  able  to  express  
Pold-­‐L606K,  they  were  subjected  to  RT-­‐PCR  and  sequencing  (Figure  6-­‐4  B).    As  with  Pold-­‐
L606M  in  TK6  cells,  no  homozygous  mutants  were  found,  but  four  clones  (clones  1,  5,  6  
&  12)  were  found  to  express  Pold-­‐L606K  heterozygously.  
  
6.2.3    Failure  to  generate  Pold-­‐L606G  and  Pold-­‐L606M  in  the  HT1080  cell  line  
   In  parallel  with  work  to  generate  the  Pold-­‐L606K  HT1080  cell  line,  attempts  were  
also   made   to   generate   heterozygous   and   homozygous   Pold-­‐L606G   and   Pold-­‐L606M  
mutant   cell   lines   in  addition   to  a   cell   line  expressing  Pold-­‐L606K  homozygously.      106  
HT1080  cells  were  transfected  with  0.5  µg  pX330  and  1.5  µg  puromycinR  repair  template  
or   0.5  µg   pX330  and   0.75  µg  each   of   repair   templates   conferring   resistance   to  both  
blasticidin  and  puromycin  to  isolate  heterozygously-­‐  or  homozygously-­‐targeted  clones  
respectively.    48  hours  after  transfection,  cells  were  selected  in  0.4  µg/ml  puromycin  to  
select   for   heterozygously   targeted   clones   or   0.4   µg/ml   puromycin   and   5   µg/ml  
blasticidin  to  select  for  homozygously  targeted  clones.    In  all  instances,  no  clones  grew  
after  selection.    A  summary  of  attempts  to  generate  HT1080  cell  lines  expressing  mutant  
Pold  can  be  seen  in  Table  6-­‐1.  
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Figure 6-4  Polδ-L606K screening identiﬁes heterozygously targeted HT1080 cells
A.  Following targeting with a Polδ-L606K knockin construct and selection, 
antibiotic-resistant clones were screened by PCR to check for the presence of the 
puromycin resistance marker.  The knockin construct was used as a positive control 
(+).  B.  Polδ-L606K clones that contained the puromycin resitance marker were 
subjected to RT-PCR and sequencing to check for integration of the knockin 
construct at the correct locus and to check that the construct was expressed.  4 of 
the 11 clones screened were found to be heterozygously targeted.  Sequencing 
traces show the sequence of the coding strand:  CTG (Leu); NNG = mixed signal:  CTG 
(Leu) & AAG (Lys).














Table 6-1  Summary of attempts to generate mutant Polδ HT1080 cell lines
Summary of attempts to generate heterozygously-targeted (PuromycinR) and 
homozygously-targeted (BlasticidinR-PuromycinR) Polδ mutant HT1080 cell lines.  
White = succesfully targeted clones generated; blue = unsuccessful in HT1080 but 
succesfully targeted TK6 clones generated using histidinolR; red = unsuccessful.
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6.3    Generating  human  cell  lines  expressing  mutant  polymerase  
epsilon  
   Due   to   the   large   size   of   the   cDNA   of   POLE,   the   gene   encoding   the   catalytic  
subunit   of   human   Pole   (6861   nucleotides)   we   decided   against   trying   to   knock   in  
mutation-­‐containing  POLE  cDNA  at  the  endogenous  locus  due  to  the  size  of  the  plasmid  
that  would  be  required.    Instead  it  was  decided  to  directly  mutate  the  codon  coding  for  
Met630  which  resides  in  exon  17  of  POLE.    To  introduce  the  mutations  a  guide  RNA  was  
designed  to  target  Cas9  to  an  intronic  region  just  upstream  of  exon  17.    The  resultant  
double   strand   break  would   be   repaired   by   a   plasmid   repair   template   containing   the  
desired  mutation  within  the  right  homology  arm.    Successful  repair  of  the  break  would  
also  incorporate  a  LoxP-­‐flanked  antibiotic  resistance  gene  under  the  control  of  its  own  
promoter  into  the  intron  between  exons  16  and  17  allowing  for  selection  of  successfully  
targeted  cells   (Figure  6-­‐5).     As  a   control   to   check  whether   the  design  of  our  knockin  
construct  would   be   tolerated,   a   repair   template   containing   no  mutation   in   the   right  
homology  arm  was  also  designed.  
  
For   each  mutation   (M630G,  M630A,  M630V,  M630L  &  M630F)   or   wild   type   control  
knockin   (heterozygous   only),   106   HT1080   cells   were   transfected   using   Amaxa  
nucleofection  (Lonza;  kit  T,  programme  L-­‐005)  with  0.5  µg  pX330  and  1.5  µg  blasticidinR  
repair  template  or  0.5  µg  pX330  and  0.75  µg  each  of  blasticidinR  and  puromycinR  repair  
templates   to   isolate  heterozygously-­‐  and  homozygously-­‐targeted  clones   respectively.    
48  hours  after  transfection  cells  were  selected  in  5  µg/ml  blasticidin  (heterozygous)  or  
5  µg/ml  blasticidin  and  0.4  µg/ml  puromycin  (homozygous).      
  
We  tried  to  generate  heterozygous  M630G,  M630A,  M630V,  M630L  and  M630F  Pole  
mutations   twice   and   homozygous   mutations   once   but   in   all   cases   no   clones   grew  
following  selection.    A  summary  of  attempts  to  generate  HT1080  cell   lines  expressing  
mutant  Pole  can  be  seen  in  Table  6-­‐2.     Following  targeting  with  the  wild  type  control  
repair  template,  several  colonies  grew,  although  many  of  them  exhibited  a  significant  
slow   growth   phenotype.      13   clones  were   screened   by   PCR   to   check   that   the   repair  
template   had   integrated   at   the   desired   locus   using   a   forward   primer   that   annealed  















Figure 6-5  Polymerase epsilon mutation strategy
Cas9 is targeted to within the intron upstream of the POLE exon containing the 
codon to be targeted for mutagenesis.  The resultant break is repaired using a 
plasmid template that upon repair results in the introduction of the desired point 
mutations.  In addition a LoxP-ﬂanked antibiotic resistance marker under the control 
of a PGK promoter is incorporated into the intronic region allowing for selection.  
Repair of the Cas9-induced DSB also excludes the original 20bp gRNA targeting 
sequence.  The use of repair templates containing diﬀerent antibiotic resistance 
genes allows for selection of homozygously targeted clones.







51 2 3 4 1211109876Candidate clone + 13
Figure 6-6  Screening for incorporation of the Polε-WT repair template
Following targeting with a Polε-WT knockin construct and selection, 
antibiotic-resistant clones were screened by PCR to check for the presence of the 
puromycin resistance marker.  The knockin construct was used as a positive control 
(+).  All 13 clones screened were found to contain the puromycin resistance gene 
somewhere in their genomes.



























Table 6-2  Summary of attempts to generate mutant Polε HT1080 cell lines
Summary of attempts to generate heterozygously-targeted (BlasticidinR or 
PuromycinR) and homozygously-targeted (BlasticidinR-PuromycinR) Polε mutant 
HT1080 cell lines.  White = succesfully targeted clones generated subject to further 
screening; red = unsuccessful; NA = not attempted.
Attempts:  1
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within  the  puromycin  resistance  gene  and  a  reverse  primer  that  annealed  downstream  
of  the  right  homology  arm;  despite  several  stages  of  optimization  we  were  unable  to  
verify  that  these  clones  had  been  successfully  targeted.    To  verify  that  the  clones  that  
survived   selection   did   so   due   to   the   presence   of   the   puromycin   resistance   marker  
somewhere  in  their  genomes,  a  PCR  screen  was  carried  out  using  forward  and  reverse  
primers  that  both  annealed  within  the  puromycinR  fragment  (Figure  6-­‐6).    All  13  clones  
screened  were  found  to  contain  the  puromycinR  fragment  but  due  to  time  constraints  
we  were  unable  to  carry  out  further  screening  on  these  clones.      
  
6.4    Discussion  
   In  this  chapter  I  have  shown  that  it  is  possible  to  generate  heterozygous  L606M  
and  L606K  mutations  in  human  Pold.     Whilst  we  cannot  be  certain  from  these  results  
that   it   is   not   possible   to   generate   homozygous   Pold   mutants   in   human   cells,   mice  
harbouring  homozygous  mutations  at  the  corresponding  Pold  leucine  (L604G  and  L604K)  
die  in  utero  (Venkatesan  et  al.  2007)  suggesting  that  in  higher  eukaryotes  it  is  likely  that  
it  is  essential  to  have  at  least  one  wild  type  Pold  allele.    The  failure  to  generate  an  HT1080  
knockin  cell  line  harbouring  a  Pold-­‐L606G  mutation  was  surprising  but  it  is  thought  that  
this  failure  was  due  to  technical  error  rather  than  the  mutation  not  being  tolerated  in  
human  cells  since  we  also  failed  to  generate  an  HT1080  Pold-­‐L606M  cell  line  despite  the  
mutation  being  tolerated  in  TK6  cells  and  since  the  homologous  heterozygous  mutation  
(L604G)  is  tolerated  in  mice  (Venkatesan  et  al.  2007);  however  in  vitro  studies  suggest  
that  human  Pold-­‐L606G  is  50-­‐fold  more  error  prone  than  wild  type  Pold  so  it  is  possible  
that   the   presence   of   one   copy   of   the   Pold-­‐L606G   is   sufficient   to   cause   a  mutational  
burden  that  it  is  too  great  to  be  tolerated  in  human  cells.  
  
It  is  possible  that  one  single  ribo-­‐incorporating  Pold  mutant  allele  in  combination  with  
our   RNase   H2C   knockdown   system   will   result   in   a   sufficient   level   of   genomic  
ribonucleotides   for   human   Pu-­‐seq.      It   will   therefore   be   important   to   attempt   to  
introduce  the  Pold  mutations  into  the  RPE1  cell  line  containing  the  RNase  H2C  double  
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degron   system   to   assess   the   tolerance   of   the   different  mutations   and   to   assess   the  
extent  to  which  the  different  Pold  mutants  incorporate  ribonucleotides.  
  
In   this   chapter   I   have   also   described   the   failure   to   generate   any  mutations   in   Pole.    
Assuming  that  at  least  one  of  the  clones  obtained  from  targeting  cells  with  the  wild  type  
Pole   knockin   construct   is   correctly   targeted   and   that   the   slow   growth   phenotype  
observed  for  that  clone  is  a  result  of  the  introduction  of  the  knockin  construct,  it  may  
be  possible  that  the  presence  of  the  LoxP-­‐flanked  selection  marker  and  promoter  in  the  
intron  disrupt  splicing  activity  of  the  resultant  transcript.    Furthermore,  the  design  of  
the  knockin  construct  results  in  the  removal  of  the  20bp  gRNA  sequence  following  repair  
(Figure   6-­‐5).      It  may   therefore   be   possible   that   disrupted   splicing   in   tandem  with   a  
mutant  Pole  may  not  be  tolerated  by  cells.    If  this  is  the  case,  it  would  be  worth  trying  to  
knockin  mutant  Pole  cDNA  at  the  endogenous  locus  using  a  similar  strategy  to  that  used  
for  incorporating  Pold  mutants  in  spite  of  the  large  size  of  the  repair  template  plasmid  
that  this  strategy  would  necessitate.    It  could  also  be  possible  to  attempt  to  mutate  the  
M630   codon   in   a   scarless   manner   although   this   method   would   necessitate   a   large  
workload  to  screen  for  successfully  targeted  clones.  
  
In  the  event  that  we  are  unable  to  generate  ribo-­‐incorporating  homozygous  Pold  and/or  
Pole  mutants  or  that  the  presence  of  a  wild  type  allele  in  heterozygously  targeted  cells  
masks   the   ribo-­‐incorporating   effect   of   the  mutant   allele,   it   is   possible   to   imagine   a  
system  to  circumvent  this  problem  using  the  HT1080  cell  line  described  in  section  4.6  in  
which  RNase  H2C  is  downregulated  transcriptionally  by  doxycycline  and  at  the  protein  
level  via  an  N-­‐terminal  SMASh  tag.    In  this  system,  wild  type  Pold  or  Pole  cDNA  would  be  
ectopically  expressed  under  the  control  of  the  same  Tet-­‐on  promoter  (pTRE3GS)  as  used  
for  regulating  expression  of  RNase  H2C  whilst  the  endogenous  polymerase  alleles  would  
be   targeted   to   introduce   the   ribo-­‐incorporating   mutations   (either   homozygously,   or  
heterozygously   with   a   knockout   of   the   remaining   wild   type   endogenous   allele).    
Culturing  these  cells  in  doxycycline  would  therefore  turn  off  expression  of  RNase  H2C  
and   the   wild   type   ectopically   expressed   polymerase   cDNA,   resulting   in   temporary  
expression  of  the  mutant  endogenous  allele(s)  only.     




This  thesis  describes  progress  made  towards  developing  the  cell  lines  necessary  to  carry  
out  human  Polymerase-­‐usage  sequencing  using  CRISPR-­‐Cas9  technology.  
  
The  first  results  chapter  showed  that  RNase  H2A  is  essential  in  human  TK6  cells.     The  
essential  nature  of  RNase  H2A   is  perhaps  unsurprising   since   it   contains   the  catalytic  
domain  of  the  RNase  H2  complex  (Reijns  et  al.  2011).    Contrary  to  our  findings,  recently  
published  work  (Benitez-­‐Guijarro  et  al.  2018)  has  been  able  to  knock  out  RNase  H2A  in  
two  different  human  cells  lines,  Hela  and  HCT116.    In  that  study,  RNase  H2A  knockout  
in  HCT116  was  only  possible  in  cells  lacking  p53.    Although  the  authors  of  that  study  do  
not  mention  the  p53  status  of  the  Hela  cells  that  they  used,  it  is  possible  that  they  were  
already  p53  deficient,  or  that  the  low  p53  expression  in  Hela  cells  (Hoppe-­‐Seyler  &  Butz  
1993)   allows   tolerance   of   excessive   genomic   ribonucleotides.      The   role   of   p53   in  
signalling  damage  caused  by  RNase  H2  deficiency  can  be  seen  by  the  upregulation  of  
p53-­‐inducible  genes  in  RNase  H2  knockout  mouse  embryos  and  in  mice  harbouring  a  
homozygous  hypomorphic  mutation  in  RNase  H2B  (Hiller  et  al.  2012b;  Reijns  et  al.  2012).  
  
The  loss  of  either  of  the  two  RNase  H2  accessory  subunits,  RNase  H2B  and  RNase  H2C,  
abolishes   RNase   H2   catalytic   function   and   consequently   RNase   H2B   and   RNase   H2C  
knockout  mice  display  embryonic   lethality   (Hiller  et  al.  2012b;  Reijns  et  al.  2012).      In  
RNase   H2B   knockout  mouse   embryos,   not   only   is   RNase   H2B   itself   undetectable   by  
immunoblotting,  so  too  are  cellular  levels  of  RNase  H2A  and  RNase  H2C  (Reijns  et  al.  
2012).    Similarly,  RNase  H2A  knockout  in  human  cells  causes  a  significant  decrease  in  
the  levels  of  cellular  RNase  H2B  and  RNase  H2C.    Complementing  RNase  H2A  knockout  
cells  with  wild  type  RNase  H2A  restores  cellular  levels  of  all  three  RNase  H2  subunits  to  
wild  type  levels  (Benitez-­‐Guijarro  et  al.  2018).    These  results  suggest  that  the  absence  of  
   156  
one  RNase  H2  subunit  is  sufficient  to  destabilise  the  other  two  subunits  and  therefore  
that  all  three  subunits  are  necessary  for  complex  stability  and  catalytic  activity.  
  
Since   RNase  H2   knockout   is   probably   not   possible  without   concomitant   loss,   or   low  
expression  of  p53,  in  the  second  results  chapter  we  looked  at  ways  of  abolishing  RNase  
H2  activity  via  targeted  degradation  of  one  of  the  three  subunits.    This  method  offers  
two  distinct  advantages  over  permanent  loss  of  RNase  H2  function.    Firstly,  whilst  cells  
can  tolerate  loss  of  RNase  H2  function  in  the  absence  of  p53,  it  is  not  known  whether  
the  additional  burden  of  elevated  ribonucleotide  incorporation  by  mutant  polymerases  
would  still  be  tolerated.     Secondly,   the  ability  to  restore  RNase  H2   function  between  
experiments  would   allow   for   the   removal   of   ribonucleotides  misincorporated   under  
experimental   conditions.      This   would   help   to   restrict   ribonucleotide-­‐derived   DNA  
damage  and  reduce  background  ribonucleotide  signal.  
  
Whilst  we  were  able  to  tag  the  C-­‐terminus  of  RNase  H2A  with  a  mini  auxin-­‐inducible  
degron  (mAID),  RNase  H2A  was  not  degraded  in  the  presence  of  IAA,  the  drug  necessary  
for   mAID-­‐induced   degradation.      We   therefore   sought   to   target   the   two   RNase   H2  
accessory  subunits  and  to  investigate  different  methods  of  downregulation.  
  
The  second  approach  we  took  was  to  attempt  to  tag  the  C-­‐termini  of  RNase  H2B  and  
RNase  H2C  at  their  endogenous   loci  with  a  novel  double  degron  tag  consisting  of  an  
mAID  tag  fused  with  a  SMASh  tag,  termed  mAID-­‐SMASh.    We  were  unable  to  tag  the  C-­‐
terminus   of   RNase   H2B   with   mAID-­‐SMASh   in   RPE1   cells,   perhaps   indicating   a  
requirement  for  the  C-­‐terminus  of  RNase  H2B  in  mediating  interactions  with  the  other  
two  RNase  H2  subunits.    We  were  however  able  to  tag  the  C-­‐terminus  of  RNase  H2C  
with   the   mAID-­‐SMASh   double   degron   tag   in   RPE1   cells   and   to   show   that   following  
degradation,   cellular   RNase   H2C   levels   were   undetectable   by   immunoblotting.    
Furthermore,  in  the  third  results  chapter  we  showed  that  the  knockdown  of  RNase  H2C  
was  sufficiently  robust  to  greatly  reduce  cellular  RNase  H2  activity.  
  
The  third  approach  taken  to  downregulate  RNase  H2  activity  was  to  ectopically  express  
N-­‐terminally  SMASh-­‐tagged  RNase  H2B  and  RNase  H2C  at  the  ROSA26  locus,  under  the  
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control  of  tetracycline  controlled  transcriptional  activation  (TCTA)  in  HT1080  cells.    We  
were  unable  to  generate  cells  expressing  the  tagged  RNase  H2B,  despite  the  sustained  
expression  of  wild  type  RNase  H2B  in  these  cells.    We  assumed  that  the  tagged  RNase  
H2B   was   overexpressed   sufficiently   to   cause   several-­‐fold   excess   in   comparison   to  
endogenous  RNase  H2B  and  that  the  excessive  amounts  of  tagged  RNase  H2B  somehow  
had  a  destabilising  effect  on  RNase  H2  complex  formation.  
  
We  were  able  to  generate  HT1080  cells  expressing  N-­‐terminally  SMASh  tagged  RNase  
H2C  from  the  ROSA26  under  control  of  TCTA.    We  were  able  to  show  that  transcriptional  
shutoff  in  the  absence  of  doxycycline/tetracycline  was  rapid  and  efficient.    It  is  assumed  
that  SMASh-­‐mediated  degradation  also  contributes  to  the  absence  of  tagged  RNase  H2C  
signal  seen  by  immunoblotting.    Further  work  in  this  cell  line  will  require  the  endogenous  
copies  of  RNase  H2C  to  be  knocked  out  and  for  subsequent  RNase  H2  activity  assays  to  
be  carried  out  as  described  in  results  chapter  3.    The  RNASEH2C  cDNA  that  was  knocked  
in   using   this   construct  was   designed  with   several   silent   point  mutations   such   that   it  
would  not  be  targeted  by  the  Cas9  system  used  to  target  the  endogenous,  wild  type  
RNASEH2C  sequences.  
  
We   have   demonstrated   that   a   C-­‐terminal  mAID-­‐SMASh   tag   can   be   used   to   robustly  
degrade   endogenously   tagged   RNase   H2C   in   RPE1   cells   and   that   TCTA   causes   rapid  
shutoff  of  transcription  of  N-­‐terminally  SMASh-­‐tagged  RNase  H2C  at  the  ROSA26  locus  
in  HT1080  cells.    Further  work  can  therefore  investigate  knocking  in  C-­‐terminally  mAID-­‐
SMASh  tagged  RNase  H2C  under  TCTA  at  the  ROSA26  locus.    This  would  allow  for  a  rapid  
and  reversible  knockdown  of  RNase  H2C  in  three  ways:    i)  by  turning  off  transcription  of  
the  tagged  gene,  ii)  by  degrading  any  protein  synthesised  after  transcriptional  shutoff  in  
the  event  of  transcriptional  leakiness  and  iii)  by  degrading  any  pre-­‐existing  protein  via  
the  mAID  degron  tag.     It   is  hoped  that  this  would  further  reduce  the   level  of  cellular  
RNase  H2  activity  to  below  the  ~23%  of  wild  type  seen  using  the  endogenously  mAID-­‐
SMASh  tagged  RNase  H2C  system.  
  
The   third   results   chapter   describes   the   steps   taken   in   developing   a   novel   assay   for  
determining  genomic  ribonucleotide  incorporation.    This  assay  would  have  allowed  us  
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to  assess  the  extent  of  decreased  ribonucleotide  excision  repair  following  knockdown  
of  RNase  H2  and  the  effects  on  ribonucleotide  incorporation  of  different  mutations  in  
polymerases  d  and  e  (Pols  d  and  e).    Unfortunately,  this  assay  lacked  the  sensitivity  that  
we  had  hoped  to  achieve  and  after  showing  that  a  fluorescence-­‐based  oligonucleotide  
cleavage  assay  and  the  alkaline  comet  assay  would  allow  us  assess  decreased  RNase  H2  
activity   and   increased   polymerase   ribonucleotide   incorporation,   we   ceased   further  
optimization  of  the  assay.  
  
The  fourth  results  chapter  outlines  progress  made  towards  generating  mutant  alleles  of  
Pols  d  and  e  that  incorporate  excess  ribonucleotides.    We  have  shown  that  it  is  possible  
to  create  human  cell  lines  harbouring  heterozygous  L606M  and  L606K  mutations  in  Pold.    
Pold-­‐L606M  has  been  shown  to  incorporate  7-­‐fold  more  ribonucleotides  than  wild  type  
Pold  in  vitro  (Clausen  et  al.  2013),  whereas  Pold-­‐L606K  is  more  accurate  than  wild  type  
Pold  in  vitro  (Schmitt  et  al.  2010),  however  little  is  known  about  the  ribo-­‐incorporating  
effects  of  these  mutations  in  vivo.      
  
We  were  unable  to  generate  human  cells  containing  a  Pold-­‐L606G  mutation.    This  may  
have  been  a  result  of  technical  error,  however  the  L606G  mutation  causes  Pold  to  be  
highly  inaccurate  in  vitro  (Schmitt  et  al.  2010)  so  it  is  possible  that  Pold-­‐L606G  causes  
levels  of  mutations  that  are  not  tolerated  in  human  cells,  even  if  the  mutation  is  only  
present  at  one  allele.    Interestingly,  mice  harbouring  a  heterozygous  LG  mutation  at  the  
corresponding  residue  (Pold-­‐L604G)  have  a  longer  life  expectancy  and  a  lower  rate  of  
tumourigenesis  than  mice  harbouring  the  Pold-­‐L604K  mutation  (Venkatesan  et  al.  2007),  
suggesting  that  the  accuracy  of  polymerases  in  vitro  may  not  be  a  complete  indicator  of  
the  mutational  potential  of  mutant  polymerases  in  vivo.  
  
The  fourth  results  chapter  also  outlined  our   failure  to  generate  any  mutations  at  the  
active  site  of  Pole.    It  is  possible  that  the  introduction  of  nearly  ~1.8kb  of  DNA  from  the  
knockin  construct  into  the  intron  between  exons  16  and  17  negatively  affects  splicing  
sufficiently  that  cells  die.    Due  to  time  constraints,  we  were  unable  to  verify  that  this  
was  the  case  using  a  knockin  construct  containing  wild  type  sequence.    Should  future  
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work  fail  to  generate  ribonucleotide-­‐incorporating  mutant  alleles  of  Pole  in  human  cells,  
it  may  be  possible  to  investigate  the  possibility  of  using  proofreading-­‐deficient  Pole.    The  
exonucleolytic  proofreading  activity  of  S.   cerevisiae  Pole   accounts   for   the   removal  of  
approximately  one  third  of  misincorporated  ribonucleotides  (Williams  et  al.  2012).    It  is  
therefore   possible   that   the   absence   of   Pole   proofreading   may   elevate   the   level   of  
genomic  ribonucleotides  incorporated  by  a  mutant  Pole  to  a  level  that  is  sufficient  to  
detect   differences   over  wild   type   Pole   ribonucleotide   incorporation.      Encouragingly,  
mice   harbouring   homozygous   loss-­‐of-­‐proofreading   point   mutations   in   the   Pole  
exonuclease   domain   are   viable   but   have   increased   tumourigenesis   (Albertson   et   al.  
2009),   suggesting   that   the   corresponding   loss-­‐of-­‐proofreading   mutations   may   be  
tolerated  in  human  cells.    
  
The  work  in  this  thesis  has  shown  that  RNase  H2  can  be  successfully  downregulated  in  
two  different  human  cell  lines.    Furthermore,  in  RPE1  cells  it  has  been  shown  that  the  
downregulation  of  RNase  H2C  causes  a  significant  decrease  in  cellular  RNase  H2  activity.    
These  discoveries,  and  the  verification  that  previously  published  assays  to  determine  
RNase  H2  activity  and  genomic  ribonucleotide  presence  are  suitable  for  our  purposes,  
lay  a  good  foundation  for  further  development  of  the  human  Pu-­‐seq  system.    The  RNase  
H2  shutoff  cell  lines  can  be  used  to  knock  in  polymerase  mutations  to  assess  the  extent  
of  ribonucleotide  incorporation  by  each  of  the  mutations.    Once  the  desired  polymerase  
mutations  are   identified,   these  cell   lines  can  be  used  for  Pu-­‐seq  experiments  to  help  
map   the   location   of   origins   in   human   cells   and   to   investigate  whether   responses   to  
replication  stress  seen  by  the  Carr  laboratory  in  S.  pombe  are  also  true  in  human  cells.  
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